1	Thrombosis	NNP	ORGANIZATION	Thrombosis	nn	2	SENT_1	[p1l6t135r289b178],
2	Research	NNP	ORGANIZATION	Research	dep	6	SENT_1	[p1l313t135r532b178],
3	(	CD	NUMBER	(	dep	2	SENT_1	[p1l558t135r710b189],
4	2007	CD	DATE	2007	num	5	SENT_1	[p1l558t135r710b189],
5	)	NN	O	)	dep	6	SENT_1	[p1l558t135r710b189],
6	119	CD	NUMBER	119	dep	22	SENT_1	[p1l740t135r846b187],
7	,	,	O	,	_	0	SENT_1	[p1l740t135r846b187],
8	301	CD	NUMBER	301	num	14	SENT_1	[p1l874t135r950b178],
9	-303	CD	NUMBER	-303	num	14	SENT_1	[p1l970t135r1102b178],
10	SEVI	NNP	O	SEVI	nn	14	SENT_1	[p1l16t582r388b690],
11	REGULAR	NNP	O	REGULAR	nn	14	SENT_1	[p1l12t819r354b883],
12	ARTICLE	NN	O	article	nn	14	SENT_1	[p1l383t819r687b883],
13	Antithrombotic	JJ	MISC	antithrombotic	amod	14	SENT_1	[p1l6t1012r1006b1120],
14	effects	NNS	O	effect	appos	6	SENT_1	[p1l1054t1013r1503b1120],
15	of	IN	O	of	_	0	SENT_1	[p1l1549t1013r1681b1120],
16	aspirin	NN	O	aspirin	nn	19	SENT_1	[p1l1720t1015r2153b1148],
17	glycoprotein	NN	O	glycoprotein	nn	19	SENT_1	[p1l9t1182r829b1318],
18	Illa	NN	PERSON	illum	nn	19	SENT_1	[p1l939t1186r1118b1290],
19	polymorphism	NN	O	polymorphism	prep_of	6	SENT_1	[p1l1220t1182r2141b1318],
20	coronary	JJ	O	coronary	amod	22	SENT_1	[p1l10t1383r594b1488],
21	artery	NN	O	artery	nn	22	SENT_1	[p1l647t1363r1053b1488],
22	disease	NN	O	disease	_	0	SENT_1	[p1l1107t1352r1581b1461],

1	TI-IROMBOSIS	NN	O	ti-irombosis	_	0	SENT_2	[p1l876t1911r2124b2048],

1	RESEARCH	NN	O	research	_	0	SENT_3	[p1l1036t2197r1975b2330],

1	intl.elsevierhealth.com/journals/thre	NN	O	intl.elsevierhealth.com/journals/thre	_	0	SENT_4	[p1l406t2618r2154b2717],
2	based	VBN	O	base	_	0	SENT_4	[p1l6t2953r677b3151],
3	on	IN	O	on	prepc_based_on	1	SENT_4	[p1l767t3008r1044b3151],
4	PLA1/A2	NN	O	pla1/a2	pobj	1	SENT_4	[p1l1148t2958r2146b3148],
5	in	IN	O	in	_	0	SENT_4	[p1l75t3270r280b3460],
6	patients	NNS	O	patient	prep_in	4	SENT_4	[p1l475t3270r1444b3513],
7	with	IN	O	with	_	0	SENT_4	[p1l1620t3265r2140b3462],
8	Je	NN	PERSON	je	nn	9	SENT_4	[p1l97t3590r159b3633],
9	Dropinski	NN	PERSON	dropinskus	prep_with	6	SENT_4	[p1l270t3588r533b3644],
10	,	,	O	,	_	0	SENT_4	[p1l270t3588r533b3644],
11	Jacek	NNP	PERSON	Jacek	nn	12	SENT_4	[p1l558t3588r714b3633],
12	Musial	NNP	PERSON	Musial	appos	9	SENT_4	[p1l734t3588r915b3643],
13	,	,	O	,	_	0	SENT_4	[p1l734t3588r915b3643],
14	Marek	NN	PERSON	marek	nn	15	SENT_4	[p1l941t3588r1104b3633],
15	Sanak	NNP	PERSON	Sanak	appos	9	SENT_4	[p1l1125t3588r1295b3643],
16	,	,	O	,	_	0	SENT_4	[p1l1125t3588r1295b3643],
17	Wojciech	NNP	PERSON	Wojciech	nn	18	SENT_4	[p1l1320t3588r1565b3644],
18	Wegrzyn	NNP	PERSON	Wegrzyn	appos	9	SENT_4	[p1l1587t3590r1835b3644],
19	,	,	O	,	_	0	SENT_4	[p1l1587t3590r1835b3644],
20	Ra	NNP	PERSON	Ra	nn	21	SENT_4	[p1l100t3653r161b3696],
21	Nizankowski	NNP	PERSON	Nizankowski	appos	9	SENT_4	[p1l254t3652r599b3706],
22	,	,	O	,	_	0	SENT_4	[p1l254t3652r599b3706],
23	Andrew	NNP	PERSON	Andrew	nn	25	SENT_4	[p1l625t3652r831b3696],
24	Szczeklik	NNP	PERSON	Szczeklik	nn	25	SENT_4	[p1l853t3644r1136b3696],
25	*	NN	O	*	appos	9	SENT_4	[p1l853t3644r1136b3696],

1	Department	NNP	O	Department	_	0	SENT_5	[p2l97t44r318b84],
2	of	IN	O	of	_	0	SENT_5	[p2l334t44r373b84],
3	Medicine	NNP	O	Medicine	prep_of	1	SENT_5	[p2l385t44r561b82],
4	,	,	O	,	_	0	SENT_5	[p2l385t44r561b82],
5	Jagiellonian	NNP	ORGANIZATION	Jagiellonian	nn	7	SENT_5	[p2l579t44r802b84],
6	University	NNP	ORGANIZATION	University	nn	7	SENT_5	[p2l820t44r1007b84],
7	School	NNP	ORGANIZATION	School	appos	1	SENT_5	[p2l1022t44r1138b76],
8	of	IN	ORGANIZATION	of	_	0	SENT_5	[p2l1154t44r1194b84],
9	Medicine	NNP	ORGANIZATION	Medicine	prep_of	7	SENT_5	[p2l1205t44r1382b82],
10	,	,	O	,	_	0	SENT_5	[p2l1205t44r1382b82],
11	Cracow	NNP	LOCATION	Cracow	appos	1	SENT_5	[p2l1403t44r1542b82],
12	,	,	O	,	_	0	SENT_5	[p2l1403t44r1542b82],
13	Poland	NNP	LOCATION	Poland	appos	1	SENT_5	[p2l1561t44r1696b82],
14	,	,	O	,	_	0	SENT_5	[p2l1561t44r1696b82],
15	31-066	CD	NUMBER	31-066	num	16	SENT_5	[p2l1715t44r1837b76],
16	Krakow	NNP	LOCATION	Krakow	appos	1	SENT_5	[p2l1853t44r1994b82],
17	,	,	O	,	_	0	SENT_5	[p2l1853t44r1994b82],
18	ul	NN	O	ul	appos	1	SENT_5	[p2l2014t44r2058b76],
19	.	.	O	.	_	0	SENT_5	[p2l2014t44r2058b76],

1	Skawinska	FW	O	skawinska	_	0	SENT_6	[p2l98t94r283b126],
2	8	CD	NUMBER	8	dep	1	SENT_6	[p2l299t94r329b132],
3	,	,	O	,	_	0	SENT_6	[p2l299t94r329b132],
4	Poland	NNP	LOCATION	Poland	appos	2	SENT_6	[p2l349t94r474b126],

1	Received	VBN	O	receive	_	0	SENT_7	[p2l99t207r243b236],
2	30	CD	DATE	30	dobj	1	SENT_7	[p2l259t207r295b236],
3	September	NNP	DATE	September	tmod	1	SENT_7	[p2l310t207r488b243],
4	2005	CD	DATE	2005	num	3	SENT_7	[p2l502t207r588b242],
5	;	:	O	;	_	0	SENT_7	[p2l502t207r588b242],
6	received	VBN	O	receive	parataxis	1	SENT_7	[p2l607t207r745b236],
7	in	IN	O	in	_	0	SENT_7	[p2l761t208r789b235],
8	revised	JJ	O	revised	amod	9	SENT_7	[p2l806t207r920b236],
9	form	NN	O	form	prep_in	6	SENT_7	[p2l936t207r1011b236],
10	22	CD	DATE	22	num	9	SENT_7	[p2l1027t207r1063b235],
11	February	NNP	DATE	February	tmod	9	SENT_7	[p2l1079t207r1224b243],
12	2006	CD	DATE	2006	num	11	SENT_7	[p2l1238t207r1324b242],
13	;	:	O	;	_	0	SENT_7	[p2l1238t207r1324b242],
14	accepted	VBN	O	accept	parataxis	1	SENT_7	[p2l1342t207r1491b243],
15	8	CD	DATE	8	dobj	14	SENT_7	[p2l1507t207r1524b236],
16	March	NNP	DATE	March	tmod	15	SENT_7	[p2l1537t207r1634b236],
17	2006	CD	DATE	2006	num	16	SENT_7	[p2l1650t207r1725b236],
18	Available	JJ	O	available	amod	15	SENT_7	[p2l96t252r245b281],
19	online	NN	O	online	prep	15	SENT_7	[p2l260t252r360b281],
20	3	CD	DATE	3	dep	19	SENT_7	[p2l375t252r391b281],
21	May	NNP	DATE	May	tmod	14	SENT_7	[p2l405t253r469b288],
22	2006	CD	DATE	2006	num	21	SENT_7	[p2l483t252r558b281],

1	KEYWORDS	NNS	O	keyword	dep	18	SENT_8	[p2l121t396r329b427],
2	Abstract	JJ	O	abstract	amod	4	SENT_8	[p2l669t395r812b424],
3	Myocardial	JJ	O	myocardial	amod	4	SENT_8	[p2l119t441r296b477],
4	Infarction	NN	O	infarction	dep	1	SENT_8	[p2l312t441r480b476],
5	;	:	O	;	_	0	SENT_8	[p2l312t441r480b476],
6	Glycoprotein	NN	PERSON	glycoprotein	nn	7	SENT_8	[p2l120t490r329b526],
7	Illa	NN	PERSON	illum	dep	1	SENT_8	[p2l347t491r403b525],
8	;	:	O	;	_	0	SENT_8	[p2l347t491r403b525],
9	Objective	NNP	O	Objective	dep	7	SENT_8	[p2l671t486r841b521],
10	:	:	O	:	_	0	SENT_8	[p2l671t486r841b521],
11	The	DT	O	the	det	16	SENT_8	[p2l860t486r921b514],
12	diallelic	JJ	O	diallelic	amod	16	SENT_8	[p2l937t486r1066b514],
13	glycoprotein	NN	O	glycoprotein	nn	16	SENT_8	[p2l1083t486r1286b522],
14	Illa	NN	PERSON	illum	nn	16	SENT_8	[p2l1305t487r1351b514],
15	polumorphism	NN	O	polumorphism	nn	16	SENT_8	[p2l1368t486r1597b522],
16	P1A1/A2	NN	O	p1a1/a2	nsubjpass	18	SENT_8	[p2l1616t486r1753b514],
17	was	VBD	O	be	auxpass	18	SENT_8	[p2l1769t494r1830b514],
18	attributed	VBN	O	attribute	_	0	SENT_8	[p2l1846t486r2013b514],
19	to	TO	O	to	_	0	SENT_8	[p2l2030t489r2063b514],
20	Thrombin	NN	O	thrombin	prep_to	18	SENT_8	[p2l119t535r286b569],
21	;	:	O	;	_	0	SENT_8	[p2l119t535r286b569],
22	be	VB	O	be	cop	26	SENT_8	[p2l671t531r709b559],
23	an	DT	O	a	det	26	SENT_8	[p2l724t539r760b559],
24	inherited	VBN	O	inherit	amod	26	SENT_8	[p2l776t531r925b559],
25	risk	NN	O	risk	nn	26	SENT_8	[p2l942t531r998b559],
26	factor	NN	O	factor	dep	20	SENT_8	[p2l1012t531r1111b559],
27	for	IN	O	for	_	0	SENT_8	[p2l1125t531r1172b559],
28	coronary	JJ	O	coronary	amod	29	SENT_8	[p2l1186t539r1329b566],
29	events	NNS	O	event	prep_for	26	SENT_8	[p2l1343t534r1460b559],
30	.	.	O	.	_	0	SENT_8	[p2l1343t534r1460b559],

1	Whether	IN	O	whether	complm	4	SENT_9	[p2l1477t531r1619b559],
2	this	DT	O	this	det	3	SENT_9	[p2l1633t531r1691b559],
3	polymorphism	NN	O	polymorphism	nsubj	4	SENT_9	[p2l1707t531r1934b567],
4	affects	VBZ	O	affect	csubjpass	18	SENT_9	[p2l1950t531r2063b559],
5	Aspirin	NN	O	aspirin	dobj	4	SENT_9	[p2l119t579r241b615],
6	;	:	O	;	_	0	SENT_9	[p2l119t579r241b615],
7	response	NN	O	response	dep	5	SENT_9	[p2l671t583r813b611],
8	to	TO	O	to	_	0	SENT_9	[p2l828t578r860b604],
9	aspirin	NN	O	aspirin	prep_to	7	SENT_9	[p2l875t576r982b611],
10	in	IN	O	in	_	0	SENT_9	[p2l998t576r1025b603],
11	patients	NNS	O	patient	prep_in	4	SENT_9	[p2l1042t576r1174b611],
12	with	IN	O	with	_	0	SENT_9	[p2l1188t575r1259b604],
13	coronary	JJ	O	coronary	amod	15	SENT_9	[p2l1274t583r1418b611],
14	artery	NN	O	artery	nn	15	SENT_9	[p2l1432t578r1532b611],
15	disease	NN	O	disease	prep_with	11	SENT_9	[p2l1546t575r1664b604],
16	is	VBZ	O	be	auxpass	18	SENT_9	[p2l1679t576r1702b604],
17	not	RB	O	not	neg	18	SENT_9	[p2l1717t578r1769b604],
18	known	VBN	O	know	_	0	SENT_9	[p2l1785t575r1898b604],
19	.	.	O	.	_	0	SENT_9	[p2l1785t575r1898b604],

1	Platelets	NNS	O	platelet	nn	2	SENT_10	[p2l121t624r264b653],
2	Methods	NNS	O	method	_	0	SENT_10	[p2l673t620r826b649],
3	:	:	O	:	_	0	SENT_10	[p2l673t620r826b649],
4	We	PRP	O	we	nsubj	5	SENT_10	[p2l855t621r905b649],
5	assessed	VBD	O	assess	dep	2	SENT_10	[p2l931t620r1070b649],
6	thrombin	NN	O	thrombin	nn	8	SENT_10	[p2l1098t620r1248b649],
7	generation	NN	O	generation	nn	8	SENT_10	[p2l1275t621r1454b656],
8	(	NN	O	(	iobj	5	SENT_10	[p2l1484t620r1702b656],
9	prothrombin	NN	O	prothrombin	nn	11	SENT_10	[p2l1484t620r1702b656],
10	fragment	NN	O	fragment	nn	11	SENT_10	[p2l1729t620r1882b656],
11	F1	NN	O	f1	dobj	5	SENT_10	[p2l1909t621r1939b648],
12	+2	CD	NUMBER	+2	num	13	SENT_10	[p2l1953t620r2006b656],
13	)	NN	O	)	nsubj	18	SENT_10	[p2l1953t620r2006b656],
14	in	IN	O	in	_	0	SENT_10	[p2l2034t621r2062b649],
15	consecutive	JJ	O	consecutive	amod	17	SENT_10	[p2l670t667r864b695],
16	blood	NN	O	blood	nn	17	SENT_10	[p2l884t666r972b695],
17	samples	NNS	O	sample	prep_in	13	SENT_10	[p2l992t666r1122b702],
18	collected	VBN	O	collect	rcmod	11	SENT_10	[p2l1141t666r1292b695],
19	from	IN	O	from	_	0	SENT_10	[p2l1313t666r1388b695],
20	bleeding-time	JJ	O	bleeding-time	amod	21	SENT_10	[p2l1410t666r1638b702],
21	wounds	NNS	O	wound	prep_from	18	SENT_10	[p2l1657t666r1779b695],
22	in	IN	O	in	_	0	SENT_10	[p2l1799t667r1826b694],
23	28	CD	NUMBER	28	num	24	SENT_10	[p2l1847t666r1883b695],
24	men	NNS	O	man	prep_in	21	SENT_10	[p2l1904t674r1971b695],
25	with	IN	O	with	_	0	SENT_10	[p2l1991t666r2062b695],
26	coronary	JJ	O	coronary	amod	28	SENT_10	[p2l670t719r814b747],
27	artery	NN	O	artery	nn	28	SENT_10	[p2l828t714r928b747],
28	disease	NN	O	disease	prep_with	24	SENT_10	[p2l942t711r1071b746],
29	;	:	O	;	_	0	SENT_10	[p2l942t711r1071b746],
30	P1A2	NN	O	p1a2	nn	31	SENT_10	[p2l1090t711r1167b739],
31	carriers	NNS	O	carrier	dep	24	SENT_10	[p2l1182t712r1317b746],
32	,	,	O	,	_	0	SENT_10	[p2l1182t712r1317b746],
33	n	NN	O	n	appos	31	SENT_10	[p2l1335t711r1414b746],
34	=	JJ	O	=	amod	33	SENT_10	[p2l1335t711r1414b746],
35	9	CD	NUMBER	9	tmod	34	SENT_10	[p2l1335t711r1414b746],
36	;	:	O	;	_	0	SENT_10	[p2l1335t711r1414b746],
37	P1A1/A1	NN	O	p1a1/a1	dep	24	SENT_10	[p2l1433t711r1582b746],
38	,	,	O	,	_	0	SENT_10	[p2l1433t711r1582b746],
39	n	NN	O	n	appos	37	SENT_10	[p2l1600t711r1698b740],
40	=	JJ	O	=	amod	24	SENT_10	[p2l1600t711r1698b740],
41	19	CD	NUMBER	19	tmod	40	SENT_10	[p2l1600t711r1698b740],
42	.	.	O	.	_	0	SENT_10	[p2l1600t711r1698b740],

1	Thrombin	NN	O	thrombin	nn	2	SENT_11	[p2l1715t711r1870b740],
2	generation	NN	O	generation	nsubjpass	7	SENT_11	[p2l1887t712r2062b747],
3	and	CC	O	and	_	0	SENT_11	[p2l670t756r727b785],
4	bleeding	JJ	O	bleeding	amod	5	SENT_11	[p2l744t756r883b792],
5	time	NN	O	time	conj_and	2	SENT_11	[p2l897t757r972b785],
6	were	VBD	O	be	auxpass	7	SENT_11	[p2l985t764r1066b785],
7	measured	VBN	O	measure	conj_and	7	SENT_11	[p2l1082t756r1238b785],
8	before	IN	O	before	_	0	SENT_11	[p2l1255t756r1361b785],
9	and	CC	O	and	_	0	SENT_11	[p2l1375t756r1432b785],
10	after	IN	O	after	_	0	SENT_11	[p2l1448t756r1529b785],
11	2	CD	DURATION	2	num	12	SENT_11	[p2l1543t756r1560b785],
12	weeks	NNS	NUMBER	week	prep_before	7	SENT_11	[p2l1574t756r1675b785],
13	of	IN	O	of	_	0	SENT_11	[p2l1689t756r1721b785],
14	aspirin	NN	O	aspirin	nn	16	SENT_11	[p2l1735t757r1842b792],
15	300	CD	NUMBER	300	num	16	SENT_11	[p2l1858t756r1914b785],
16	mg	NN	O	mg	prep_of	12	SENT_11	[p2l1929t757r1993b792],
17	/	:	O	/	punct	18	SENT_11	[p2l1929t757r1993b792],
18	day	NN	DURATION	day	dep	12	SENT_11	[p2l1997t756r2059b792],
19	.	.	O	.	_	0	SENT_11	[p2l1997t756r2059b792],

1	Results	NNS	O	result	_	0	SENT_12	[p2l674t802r803b831],
2	:	:	O	:	_	0	SENT_12	[p2l674t802r803b831],
3	Aspirin-depressed	JJ	O	aspirin-depressed	amod	5	SENT_12	[p2l823t802r1113b838],
4	thrombin	NN	O	thrombin	nn	5	SENT_12	[p2l1132t802r1280b831],
5	generation	NN	O	generation	nsubj	9	SENT_12	[p2l1299t803r1474b838],
6	in	IN	O	in	_	0	SENT_12	[p2l1493t803r1520b830],
7	A1	NN	O	a1	nn	8	SENT_12	[p2l1538t802r1573b830],
8	homozygotes	NNS	O	homozygote	prep_in	5	SENT_12	[p2l1597t802r1808b838],
9	(	VBP	O	(	dep	1	SENT_12	[p2l1828t802r1989b838],
10	p	NN	O	p	dobj	9	SENT_12	[p2l1828t802r1989b838],
11	=	JJ	O	=	advmod	9	SENT_12	[p2l1828t802r1989b838],
12	0.04	CD	NUMBER	0.04	num	13	SENT_12	[p2l1828t802r1989b838],
13	)	NN	O	)	dep	11	SENT_12	[p2l1828t802r1989b838],
14	,	,	O	,	_	0	SENT_12	[p2l1828t802r1989b838],
15	but	CC	O	but	_	0	SENT_12	[p2l2010t802r2063b831],
16	not	RB	O	not	conj_but	11	SENT_12	[p2l671t850r723b876],
17	in	IN	O	in	_	0	SENT_12	[p2l735t848r763b875],
18	A2	NN	O	a2	nn	19	SENT_12	[p2l775t847r815b875],
19	carriers	NNS	O	carrier	prep_in	16	SENT_12	[p2l828t848r963b876],
20	.	.	O	.	_	0	SENT_12	[p2l828t848r963b876],

1	Bleeding	VBG	O	bleed	_	0	SENT_13	[p2l980t847r1119b883],
2	time	NN	O	time	dobj	1	SENT_13	[p2l1131t848r1206b876],
3	after	IN	O	after	_	0	SENT_13	[p2l1218t847r1300b876],
4	aspirin	NN	O	aspirin	prep_after	1	SENT_13	[p2l1311t848r1418b883],
5	was	VBD	O	be	auxpass	7	SENT_13	[p2l1431t855r1492b876],
6	also	RB	O	also	advmod	7	SENT_13	[p2l1504t847r1567b876],
7	prolonged	VBN	O	prolong	aux	1	SENT_13	[p2l1580t847r1741b883],
8	in	IN	O	in	_	0	SENT_13	[p2l1755t848r1783b875],
9	A1	NN	O	a1	nn	10	SENT_13	[p2l1795t847r1830b875],
10	subjects	NNS	O	subject	prep_in	7	SENT_13	[p2l1848t847r1983b883],
11	only	JJ	O	only	amod	13	SENT_13	[p2l1995t847r2064b883],
12	(	NN	O	(	nn	13	SENT_13	[p2l672t893r833b928],
13	p	NN	O	p	nsubj	1	SENT_13	[p2l672t893r833b928],
14	=	JJ	O	=	amod	13	SENT_13	[p2l672t893r833b928],
15	0.02	CD	NUMBER	0.02	num	16	SENT_13	[p2l672t893r833b928],
16	)	NN	O	)	dep	14	SENT_13	[p2l672t893r833b928],
17	.	.	O	.	_	0	SENT_13	[p2l672t893r833b928],

1	Conclusion	NN	O	conclusion	_	0	SENT_14	[p2l676t938r862b967],
2	:	:	O	:	_	0	SENT_14	[p2l676t938r862b967],
3	Genotyping	NN	O	genotyping	nsubj	10	SENT_14	[p2l889t938r1075b974],
4	for	IN	O	for	_	0	SENT_14	[p2l1098t938r1145b967],
5	glycoprotein	NN	O	glycoprotein	nn	7	SENT_14	[p2l1167t938r1370b974],
6	Illa	NN	PERSON	illum	nn	7	SENT_14	[p2l1397t939r1442b967],
7	polymorphism	NN	O	polymorphism	prep_for	3	SENT_14	[p2l1467t938r1694b974],
8	might	MD	O	might	aux	10	SENT_14	[p2l1719t938r1811b974],
9	be	VB	O	be	cop	10	SENT_14	[p2l1835t938r1873b967],
10	helpful	JJ	O	helpful	dep	1	SENT_14	[p2l1897t938r2011b974],
11	in	IN	O	in	_	0	SENT_14	[p2l2034t939r2062b966],
12	predicting	VBG	O	predict	prepc_in	10	SENT_14	[p2l671t983r837b1019],
13	antithrombotic	JJ	O	antithrombotic	amod	14	SENT_14	[p2l859t983r1105b1012],
14	action	NN	O	action	dobj	12	SENT_14	[p2l1127t984r1227b1012],
15	of	IN	O	of	_	0	SENT_14	[p2l1249t983r1282b1012],
16	aspirin	NN	O	aspirin	prep_of	14	SENT_14	[p2l1303t984r1410b1019],
17	in	IN	O	in	_	0	SENT_14	[p2l1433t984r1460b1011],
18	secondary	JJ	O	secondary	amod	19	SENT_14	[p2l1483t983r1648b1019],
19	prevention	NN	O	prevention	prep_in	12	SENT_14	[p2l1669t984r1844b1019],
20	of	IN	O	of	_	0	SENT_14	[p2l1867t983r1900b1012],
21	coronary	JJ	O	coronary	amod	23	SENT_14	[p2l1920t991r2064b1019],
22	artery	NN	O	artery	nn	23	SENT_14	[p2l670t1031r770b1064],
23	disease	NN	O	disease	prep_of	19	SENT_14	[p2l784t1028r913b1057],
24	.	.	O	.	_	0	SENT_14	[p2l784t1028r913b1057],

1	©	RB	O	©	advmod	2	SENT_15	[p2l670t1076r696b1103],
2	2006	CD	DATE	2006	_	0	SENT_15	[p2l710t1074r786b1103],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	4	SENT_15	[p2l802t1074r929b1103],
4	Ltd.	NNP	ORGANIZATION	Ltd.	dep	2	SENT_15	[p2l944t1074r1005b1103],
5	.	.	O	.	_	0	SENT_15	[p2l944t1074r1005b1103],

1	All	DT	O	all	det	2	SENT_16	[p2l1021t1074r1064b1103],
2	rights	NNS	O	rights	nsubj	3	SENT_16	[p2l1080t1074r1170b1110],
3	reserved	VBN	O	reserve	_	0	SENT_16	[p2l1186t1074r1336b1103],
4	.	.	O	.	_	0	SENT_16	[p2l1186t1074r1336b1103],

1	Majority	NNP	O	Majority	nsubj	6	SENT_17	[p2l1118t1222r1270b1260],
2	of	IN	O	of	_	0	SENT_17	[p2l1287t1221r1323b1252],
3	acute	JJ	O	acute	amod	5	SENT_17	[p2l1340t1224r1441b1252],
4	coronary	JJ	O	coronary	amod	5	SENT_17	[p2l1458t1229r1618b1260],
5	syndromes	NNS	O	syndrome	prep_of	1	SENT_17	[p2l1635t1221r1827b1260],
6	(	VBP	O	(	_	0	SENT_17	[p2l1847t1221r1940b1260],
7	ACS	NN	ORGANIZATION	ac	nn	9	SENT_17	[p2l1847t1221r1940b1260],
8	)	JJ	O	)	amod	9	SENT_17	[p2l1847t1221r1940b1260],
9	result	NN	O	result	dobj	6	SENT_17	[p2l1960t1221r2063b1252],
10	from	IN	O	from	_	0	SENT_17	[p2l1118t1270r1202b1301],
11	the	DT	O	the	det	12	SENT_17	[p2l1222t1270r1281b1301],
12	formation	NN	O	formation	prep_from	9	SENT_17	[p2l1300t1270r1478b1301],
13	of	IN	O	of	_	0	SENT_17	[p2l1498t1270r1534b1301],
14	a	DT	O	a	det	16	SENT_17	[p2l1551t1278r1570b1301],
15	platelet-rich	JJ	O	platelet-rich	amod	16	SENT_17	[p2l1590t1270r1818b1309],
16	thrombus	NN	O	thrombus	prep_of	12	SENT_17	[p2l1838t1270r2008b1301],
17	at	IN	O	at	_	0	SENT_17	[p2l2027t1273r2063b1301],
18	the	DT	O	the	det	19	SENT_17	[p2l1119t1319r1178b1351],
19	site	NN	O	site	prep_at	6	SENT_17	[p2l1196t1320r1260b1351],
20	of	IN	O	of	_	0	SENT_17	[p2l1278t1319r1315b1351],
21	a	DT	O	a	det	24	SENT_17	[p2l1331t1328r1350b1351],
22	ruptured	VBN	O	rupture	amod	24	SENT_17	[p2l1370t1319r1526b1359],
23	atherosclerotic	JJ	O	atherosclerotic	amod	24	SENT_17	[p2l1546t1319r1823b1351],
24	plaque	NN	O	plaque	prep_of	19	SENT_17	[p2l1842t1319r1974b1359],
25	.	.	O	.	_	0	SENT_17	[p2l1842t1319r1974b1359],

1	The	DT	O	the	det	2	SENT_18	[p2l1995t1319r2063b1351],
2	*	CD	NUMBER	*	_	0	SENT_18	[p2l118t1368r128b1378],
3	Corresponding	VBG	O	correspond	partmod	2	SENT_18	[p2l147t1367r355b1399],
4	author	NN	O	author	dobj	3	SENT_18	[p2l366t1367r465b1392],
5	.	.	O	.	_	0	SENT_18	[p2l366t1367r465b1392],

1	Tel.	NNP	O	Tel.	_	0	SENT_19	[p2l478t1367r541b1392],
2	:	:	O	:	_	0	SENT_19	[p2l478t1367r541b1392],
3	+48	CD	NUMBER	+48	number	4	SENT_19	[p2l556t1367r605b1392],
4	12	CD	NUMBER	12	num	6	SENT_19	[p2l618t1367r648b1392],
5	430	CD	NUMBER	430	number	6	SENT_19	[p2l659t1367r710b1392],
6	51	CD	NUMBER	51	dep	1	SENT_19	[p2l722t1368r749b1392],
7	69	CD	NUMBER	69	dep	6	SENT_19	[p2l765t1367r807b1398],
8	;	:	O	;	_	0	SENT_19	[p2l765t1367r807b1398],
9	fax	NN	O	fax	dep	1	SENT_19	[p2l820t1367r874b1392],
10	:	:	O	:	_	0	SENT_19	[p2l820t1367r874b1392],
11	+48	CD	NUMBER	+48	number	12	SENT_19	[p2l888t1367r937b1392],
12	12	CD	NUMBER	12	nsubj	20	SENT_19	[p2l950t1367r980b1392],
13	430	CD	NUMBER	430	num	15	SENT_19	[p2l991t1367r1042b1392],
14	ro	NN	O	ro	nn	15	SENT_19	[p2l1120t1369r1189b1400],
15	[	NN	O	[	npadvmod	12	SENT_19	[p2l1120t1369r1189b1400],
16	e	SYM	O	e	dep	15	SENT_19	[p2l1120t1369r1189b1400],
17	of	IN	O	of	_	0	SENT_19	[p2l1209t1369r1245b1400],
18	p	NN	O	p	prep_of	12	SENT_19	[p2l1264t1369r1408b1409],
19	[	CD	NUMBER	[	num	18	SENT_19	[p2l1264t1369r1408b1409],
20	ate	VBD	O	eat	dep	1	SENT_19	[p2l1264t1369r1408b1409],
21	[	CD	NUMBER	[	dobj	20	SENT_19	[p2l1264t1369r1408b1409],
22	et	FW	O	et	nsubj	25	SENT_19	[p2l1264t1369r1408b1409],
23	g	NN	O	g	nn	25	SENT_19	[p2l1427t1369r1653b1409],
24	[	CD	NUMBER	[	num	25	SENT_19	[p2l1427t1369r1653b1409],
25	ycQpr0te1	NN	O	ycqpr0te1	rcmod	21	SENT_19	[p2l1427t1369r1653b1409],
26	'n	CC	O	'n	_	0	SENT_19	[p2l1427t1369r1653b1409],
27	|	CD	NUMBER	|	num	29	SENT_19	[p2l1676t1369r1794b1400],
28	|	NN	O	|	nn	29	SENT_19	[p2l1676t1369r1794b1400],
29	b	NN	O	b	conj_'n	25	SENT_19	[p2l1676t1369r1794b1400],
30	/	:	O	/	punct	33	SENT_19	[p2l1676t1369r1794b1400],
31	|	CD	NUMBER	|	num	32	SENT_19	[p2l1676t1369r1794b1400],
32	|	CD	NUMBER	|	nsubj	33	SENT_19	[p2l1676t1369r1794b1400],
33	|	VBD	O	|	dep	29	SENT_19	[p2l1676t1369r1794b1400],
34	a	DT	O	a	nsubjpass	45	SENT_19	[p2l1676t1369r1794b1400],
35	in	IN	O	in	_	0	SENT_19	[p2l1814t1370r1845b1400],
36	the	DT	O	the	det	40	SENT_19	[p2l1866t1369r1925b1400],
37	patho52	NN	O	patho52	nn	40	SENT_19	[p2l1945t1369r2060b1409, p2l98t1409r129b1434],
38	03	NN	NUMBER	03	nn	40	SENT_19	[p2l143t1409r185b1434],
39	'	''	O	'	_	0	SENT_19	[p2l143t1409r185b1434],
40	genesis	NN	O	genesis	prep_in	34	SENT_19	[p2l1119t1420r1250b1458],
41	of	IN	O	of	_	0	SENT_19	[p2l1268t1419r1305b1450],
42	ACS	NN	ORGANIZATION	ac	prep_of	40	SENT_19	[p2l1321t1419r1388b1450],
43	was	VBD	O	be	auxpass	45	SENT_19	[p2l1407t1427r1475b1450],
44	convincingly	RB	O	convincingly	advmod	45	SENT_19	[p2l1494t1419r1720b1458],
45	evidenced	VBN	O	evidence	ccomp	33	SENT_19	[p2l1738t1419r1923b1450],
46	by	IN	O	by	_	0	SENT_19	[p2l1945t1419r1985b1458],
47	the	DT	O	the	det	49	SENT_19	[p2l2004t1419r2063b1450],
48	E-mail	NN	MISC	e-mail	nn	49	SENT_19	[p2l147t1450r240b1475],
49	addresses	NNS	O	address	agent	45	SENT_19	[p2l252t1450r403b1475],
50	:	:	O	:	_	0	SENT_19	[p2l252t1450r403b1475],
51	j.dropinski@chello.pl	NN	O	j.dropinski@chello.pl	dep	29	SENT_19	[p2l419t1450r729b1482],
52	(	CD	NUMBER	(	num	55	SENT_19	[p2l744t1451r777b1482],
53	J.	NNP	PERSON	J.	nn	55	SENT_19	[p2l744t1451r777b1482],
54	Dropinski	NNP	PERSON	Dropinski	nn	55	SENT_19	[p2l794t1450r946b1482],
55	)	NN	O	)	dep	51	SENT_19	[p2l794t1450r946b1482],
56	,	,	O	,	_	0	SENT_19	[p2l794t1450r946b1482],
57	effectiveness	NN	O	effectiveness	dobj	25	SENT_19	[p2l1119t1469r1361b1500],
58	of	IN	O	of	_	0	SENT_19	[p2l1381t1469r1418b1500],
59	GP	NN	O	gp	prep_of	57	SENT_19	[p2l1437t1469r1484b1500],
60	"	''	O	"	punct	57	SENT_19	[p2l1507t1469r1625b1500],
61	b/ma	FW	O	b/ma	nn	62	SENT_19	[p2l1507t1469r1625b1500],
62	anta	FW	O	anta	amod	57	SENT_19	[p2l1645t1472r1725b1500],
63	on	IN	O	on	prep	20	SENT_19	[p2l1748t1469r1801b1500],
64	.	.	O	.	_	0	SENT_19	[p2l1748t1469r1801b1500],

1	t	NN	O	t	nn	4	SENT_20	[p2l1821t1472r1835b1500],
2	1	CD	NUMBER	1	num	4	SENT_20	[p2l1889t1470r1900b1500],
3	Ab	NN	O	ab	nn	4	SENT_20	[p2l1956t1469r2001b1500],
4	t	NN	O	t	dep	16	SENT_20	[p2l2049t1472r2063b1500],
5	mmmusia@cyf-kr.edu.pl	JJ	O	mmmusia@cyf-kr.edu.pl	amod	9	SENT_20	[p2l98t1492r448b1524],
6	(	CD	NUMBER	(	num	9	SENT_20	[p2l461t1492r494b1523],
7	J.	NNP	PERSON	J.	nn	9	SENT_20	[p2l461t1492r494b1523],
8	Musial	NNP	PERSON	Musial	nn	9	SENT_20	[p2l507t1492r617b1523],
9	)	NN	O	)	dep	4	SENT_20	[p2l507t1492r617b1523],
10	,	,	O	,	_	0	SENT_20	[p2l507t1492r617b1523],
11	nfsanak@cyfronet.krakow.pl	NN	O	nfsanak@cyfronet.krakow.pl	appos	9	SENT_20	[p2l630t1492r1042b1524],
12	. . .	CD	NUMBER	. . .	num	13	SENT_20	[p2l1332t1520r1337b1525],[p2l1243t1520r1248b1525],
13	g	NN	O	g	dep	16	SENT_20	[p2l1727t1476r1746b1508],
14	‘	CD	NUMBER	‘	num	16	SENT_20	[p2l1793t1477r1819b1500],
15	S	NN	O	s	nn	16	SENT_20	[p2l1793t1477r1819b1500],
16	S	NN	O	s	dep	45	SENT_20	[p2l1837t1477r1852b1500],
17	[	CD	NUMBER	[	num	18	SENT_20	[p2l1874t1469r1884b1508],
18	R	NN	O	r	dep	16	SENT_20	[p2l1909t1469r1933b1508],
19	+	CC	O	+	_	0	SENT_20	[p2l1909t1469r1933b1508],
20	O	NN	O	o	nn	24	SENT_20	[p2l2004t1477r2045b1500],
21	”	CD	NUMBER	”	num	24	SENT_20	[p2l2004t1477r2045b1500],
22	(	CD	NUMBER	(	num	24	SENT_20	[p2l99t1534r141b1565],
23	M.	NNP	NUMBER	M.	nn	24	SENT_20	[p2l99t1534r141b1565],
24	Sanak	NNP	PERSON	Sanak	dep	16	SENT_20	[p2l168t1533r273b1565],
25	)	NN	O	)	nsubj	45	SENT_20	[p2l168t1533r273b1565],
26	,	,	O	,	_	0	SENT_20	[p2l168t1533r273b1565],
27	wwegrzyn@mp.pl	NN	O	wwegrzyn@mp.pl	dep	39	SENT_20	[p2l296t1533r557b1565],
28	(	CD	NUMBER	(	num	31	SENT_20	[p2l583t1534r627b1565],
29	W.	NNP	PERSON	W.	nn	31	SENT_20	[p2l583t1534r627b1565],
30	Wegrzyn	NNP	PERSON	Wegrzyn	nn	31	SENT_20	[p2l653t1534r798b1565],
31	)	NN	O	)	dep	27	SENT_20	[p2l653t1534r798b1565],
32	,	,	O	,	_	0	SENT_20	[p2l653t1534r798b1565],
33	rtn@wp_p[	NN	O	rtn@wp_p[	appos	31	SENT_20	[p2l824t1533r976b1565],
34	(	CD	NUMBER	(	num	33	SENT_20	[p2l1001t1534r1039b1565],
35	R	NN	O	r	dep	39	SENT_20	[p2l1001t1534r1039b1565],
36	_	CD	PERCENT	_	num	35	SENT_20	[p2l1001t1534r1039b1565],
37	25	CD	PERCENT	25	number	38	SENT_20	[p2l1118t1519r1184b1550],
38	%	NN	PERCENT	%	amod	39	SENT_20	[p2l1118t1519r1184b1550],
39	ofindividuals	NNS	O	ofindividual	dep	25	SENT_20	[p2l1195t1519r1435b1550],
40	of	IN	O	of	_	0	SENT_20	[p2l1445t1519r1482b1550],
41	northern	JJ	O	northern	amod	43	SENT_20	[p2l1492t1519r1648b1550],
42	European	JJ	MISC	european	amod	43	SENT_20	[p2l1661t1520r1828b1558],
43	ancestry	NN	O	ancestry	prep_of	39	SENT_20	[p2l1840t1522r1995b1558],
44	are	VBP	O	be	cop	45	SENT_20	[p2l2005t1527r2063b1550],
45	Nizankowski	NNP	O	Nizankowski	_	0	SENT_20	[p2l98t1574r294b1606],
46	)	CD	NUMBER	)	num	45	SENT_20	[p2l98t1574r294b1606],
47	,	,	O	,	_	0	SENT_20	[p2l98t1574r294b1606],
48	mmszczek@cyf-kr.edu.pl	JJ	O	mmszczek@cyf-kr.edu.pl	amod	50	SENT_20	[p2l308t1574r668b1607],
49	(	NN	O	(	nn	50	SENT_20	[p2l683t1575r720b1606],
50	A.	NN	PERSON	a.	appos	45	SENT_20	[p2l683t1575r720b1606],
51	Szczeklik	NNP	PERSON	Szczeklik	dep	50	SENT_20	[p2l736t1574r888b1606],
52	)	CD	NUMBER	)	num	51	SENT_20	[p2l736t1574r888b1606],
53	.	.	O	.	_	0	SENT_20	[p2l736t1574r888b1606],

1	carrying	VBG	O	carry	_	0	SENT_21	[p2l1118t1569r1266b1608],
2	a	DT	O	a	det	4	SENT_21	[p2l1288t1577r1307b1600],
3	PlA2	NN	O	pla2	nn	4	SENT_21	[p2l1332t1568r1408b1600],
4	allele	NN	O	allele	nsubj	5	SENT_21	[p2l1431t1568r1532b1600],
5	due	JJ	O	due	xcomp	1	SENT_21	[p2l1555t1568r1620b1600],
6	to	TO	O	to	_	0	SENT_21	[p2l1643t1571r1679b1600],
7	a	DT	O	a	det	9	SENT_21	[p2l1701t1577r1720b1600],
8	single	JJ	O	single	amod	9	SENT_21	[p2l1743t1568r1846b1608],
9	nucleotide	NN	O	nucleotide	prep_to	5	SENT_21	[p2l1870t1568r2062b1600],

1	0049-3848	CD	DURATION	0049-3848	nsubj	5	SENT_22	[p2l97t1648r260b1673],
2	/	:	O	/	punct	3	SENT_22	[p2l97t1648r260b1673],
3	S	NN	O	s	dep	1	SENT_22	[p2l265t1646r279b1677],
4	-	:	O	-	_	0	SENT_22	[p2l294t1661r302b1665],
5	see	VB	O	see	_	0	SENT_22	[p2l316t1655r363b1673],
6	front	JJ	O	front	amod	7	SENT_22	[p2l376t1648r448b1673],
7	matter	NN	O	matter	dobj	5	SENT_22	[p2l461t1650r561b1673],
8	©	CD	NUMBER	©	num	11	SENT_22	[p2l573t1650r596b1674],
9	2006	CD	DATE	2006	num	11	SENT_22	[p2l609t1648r676b1674],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	11	SENT_22	[p2l690t1648r803b1673],
11	Ltd.	NNP	ORGANIZATION	Ltd.	dep	7	SENT_22	[p2l816t1648r870b1673],
12	.	.	O	.	_	0	SENT_22	[p2l816t1648r870b1673],

1	All	DT	O	all	det	2	SENT_23	[p2l885t1648r922b1673],
2	rights	NNS	O	rights	nsubj	3	SENT_23	[p2l936t1648r1017b1680],
3	reserved	VBN	O	reserve	_	0	SENT_23	[p2l1030t1648r1164b1673],
4	.	.	O	.	_	0	SENT_23	[p2l1030t1648r1164b1673],

1	do1	NN	O	do1	nsubj	6	SENT_24	[p2l97t1689r633b1721],
2	'	''	O	'	_	0	SENT_24	[p2l97t1689r633b1721],
3	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_24	[p2l97t1689r633b1721],
4	/	:	O	/	punct	5	SENT_24	[p2l97t1689r633b1721],
5	j.	NN	O	j.	dep	1	SENT_24	[p2l97t1689r633b1721],
6	thromres	VBZ	O	thromre	_	0	SENT_24	[p2l97t1689r633b1721],
7	.2006.03.005	CD	NUMBER	.2006.03.005	num	8	SENT_24	[p2l97t1689r633b1721],
8	302	CD	NUMBER	302	dobj	6	SENT_24	[p2l99t1741r159b1773],
9	J.	NNP	PERSON	J.	nn	10	SENT_24	[p2l1731t1742r1760b1773],
10	Dropinski	NNP	PERSON	Dropinski	tmod	6	SENT_24	[p2l1782t1741r1946b1781],
11	et	FW	O	et	nn	12	SENT_24	[p2l1963t1744r2000b1773],
12	al.	FW	O	al.	dep	10	SENT_24	[p2l2017t1741r2059b1773],
13	.	.	O	.	_	0	SENT_24	[p2l2017t1741r2059b1773],

1	transition	NN	O	transition	_	0	SENT_25	[p2l10t1947r403b2017],
2	of	IN	O	of	_	0	SENT_25	[p2l433t1945r515b2017],
3	the	DT	O	the	det	4	SENT_25	[p2l538t1945r671b2017],
4	gene	NN	O	gene	prep_of	1	SENT_25	[p2l698t1963r892b2035],
5	encoding	VBG	O	encode	partmod	1	SENT_25	[p2l918t1945r1288b2035],
6	glycoprotein	NN	O	glycoprotein	nn	8	SENT_25	[p2l1314t1945r1827b2035],
7	Illa	NN	O	illum	nn	8	SENT_25	[p2l1862t1947r1976b2017],
8	[	NN	O	[	dobj	5	SENT_25	[p2l2009t1945r2141b2035],
9	2	CD	NUMBER	2	num	10	SENT_25	[p2l2009t1945r2141b2035],
10	]	NN	O	]	dep	8	SENT_25	[p2l2009t1945r2141b2035],
11	.	.	O	.	_	0	SENT_25	[p2l2009t1945r2141b2035],

1	The	DT	O	the	det	3	SENT_26	[p2l7t2058r161b2129],
2	P1A2	NN	O	p1a2	nn	3	SENT_26	[p2l204t2059r398b2129],
3	variant	NN	O	variant	nsubj	5	SENT_26	[p2l438t2060r730b2129],
4	may	MD	O	may	aux	5	SENT_26	[p2l774t2077r940b2148],
5	confer	VB	O	confer	_	0	SENT_26	[p2l978t2058r1244b2129],
6	an	DT	O	a	det	8	SENT_26	[p2l1283t2077r1374b2129],
7	increased	VBN	O	increase	amod	8	SENT_26	[p2l1417t2058r1808b2129],
8	risk	NN	O	risk	dobj	5	SENT_26	[p2l1856t2058r1996b2129],
9	for	IN	O	for	mark	12	SENT_26	[p2l2033t2058r2151b2129],
10	coronary	JJ	O	coronary	amod	11	SENT_26	[p2l9t2190r372b2259],
11	events	NNS	O	event	nsubj	12	SENT_26	[p2l428t2178r696b2241],
12	[	VBP	O	[	advcl	5	SENT_26	[p2l761t2171r893b2259],
13	3	CD	NUMBER	3	num	14	SENT_26	[p2l761t2171r893b2259],
14	]	NN	O	]	dobj	12	SENT_26	[p2l761t2171r893b2259],
15	.	.	O	.	_	0	SENT_26	[p2l761t2171r893b2259],

1	Aspirin	NN	O	aspirin	nsubj	2	SENT_27	[p2l958t2172r1237b2259],
2	reduces	VBZ	O	reduce	_	0	SENT_27	[p2l1302t2171r1618b2241],
3	the	DT	O	the	det	4	SENT_27	[p2l1677t2171r1811b2241],
4	risk	NN	O	risk	dobj	2	SENT_27	[p2l1873t2171r2014b2241],
5	of	IN	O	of	_	0	SENT_27	[p2l2069t2171r2152b2241],
6	myocardial	JJ	O	myocardial	amod	7	SENT_27	[p2l12t2283r464b2373],
7	infarction	NN	O	infarction	prep_of	4	SENT_27	[p2l499t2283r928b2370],
8	,	,	O	,	_	0	SENT_27	[p2l499t2283r928b2370],
9	stroke	NN	O	stroke	prep_of	4	SENT_27	[p2l970t2283r1223b2355],
10	and	CC	O	and	_	0	SENT_27	[p2l1258t2283r1401b2355],
11	death	NN	O	death	prep_of	4	SENT_27	[p2l1438t2283r1670b2355],
12	in	IN	O	in	_	0	SENT_27	[p2l1708t2285r1776b2354],
13	patients	NNS	O	patient	prep_in	2	SENT_27	[p2l1816t2285r2150b2373],
14	with	IN	O	with	_	0	SENT_27	[p2l7t2396r186b2467],
15	cardiovascular	JJ	O	cardiovascular	amod	16	SENT_27	[p2l218t2396r818b2466],
16	disease	NN	O	disease	prep_with	13	SENT_27	[p2l845t2396r1169b2467],
17	.	.	O	.	_	0	SENT_27	[p2l845t2396r1169b2467],

1	However	RB	O	however	advmod	6	SENT_28	[p2l1210t2398r1580b2482],
2	,	,	O	,	_	0	SENT_28	[p2l1210t2398r1580b2482],
3	its	PRP$	O	its	poss	4	SENT_28	[p2l1618t2398r1714b2466],
4	effectiveness	NN	O	effectiveness	nsubjpass	6	SENT_28	[p2l1742t2396r2145b2467, p2l12t2527r182b2578],
5	is	VBZ	O	be	auxpass	6	SENT_28	[p2l222t2509r281b2578],
6	limited	VBN	O	limit	_	0	SENT_28	[p2l325t2508r640b2594],
7	,	,	O	,	_	0	SENT_28	[p2l325t2508r640b2594],
8	as	IN	O	as	mark	16	SENT_28	[p2l690t2527r771b2578],
9	10-20	CD	PERCENT	10-20	num	10	SENT_28	[p2l817t2508r1127b2578],
10	%	NN	PERCENT	%	nsubj	16	SENT_28	[p2l817t2508r1127b2578],
11	of	IN	O	of	_	0	SENT_28	[p2l1168t2508r1251b2578],
12	the	DT	O	the	det	14	SENT_28	[p2l1288t2508r1422b2578],
13	treated	JJ	O	treated	amod	14	SENT_28	[p2l1463t2508r1769b2578],
14	patients	NNS	O	patient	prep_of	10	SENT_28	[p2l1815t2509r2150b2596],
15	still	RB	O	still	advmod	16	SENT_28	[p2l9t2620r160b2692],
16	experience	VBP	O	experience	advcl	6	SENT_28	[p2l197t2622r655b2710],
17	a	DT	O	a	det	23	SENT_28	[p2l693t2640r736b2692],
18	recurrent	JJ	O	recurrent	amod	23	SENT_28	[p2l777t2627r1165b2692],
19	vascular	JJ	O	vascular	amod	23	SENT_28	[p2l1199t2620r1540b2692],
20	event	NN	O	event	nn	23	SENT_28	[p2l1575t2628r1807b2692],
21	[	NN	O	[	nn	23	SENT_28	[p2l1850t2620r1982b2710],
22	4	CD	NUMBER	4	num	23	SENT_28	[p2l1850t2620r1982b2710],
23	]	NN	O	]	dobj	16	SENT_28	[p2l1850t2620r1982b2710],
24	.	.	O	.	_	0	SENT_28	[p2l1850t2620r1982b2710],

1	We	PRP	O	we	nsubj	4	SENT_29	[p2l2025t2622r2149b2692],
2	have	VBP	O	have	aux	4	SENT_29	[p2l12t2733r202b2803],
3	previously	RB	DATE	previously	advmod	4	SENT_29	[p2l234t2733r652b2821],
4	reported	VBN	O	report	_	0	SENT_29	[p2l683t2733r1037b2821],
5	that	IN	O	that	complm	9	SENT_29	[p2l1071t2733r1239b2803],
6	healthy	JJ	O	healthy	amod	8	SENT_29	[p2l1271t2733r1579b2821],
7	P1A2	NN	O	p1a2	nn	8	SENT_29	[p2l1610t2733r1804b2802],
8	carriers	NNS	O	carrier	nsubj	9	SENT_29	[p2l1835t2734r2149b2803],
9	appear	VBP	O	appear	ccomp	4	SENT_29	[p2l10t2865r302b2935],
10	to	TO	O	to	aux	13	SENT_29	[p2l361t2853r444b2917],
11	be	VB	O	be	cop	13	SENT_29	[p2l508t2845r604b2917],
12	more	RBR	O	more	advmod	13	SENT_29	[p2l668t2865r878b2917],
13	resistant	JJ	O	resistant	xcomp	9	SENT_29	[p2l943t2847r1307b2917],
14	to	TO	O	to	_	0	SENT_29	[p2l1368t2853r1450b2917],
15	antithrombotic	JJ	O	antithrombotic	amod	16	SENT_29	[p2l1512t2845r2149b2917],
16	action	NN	O	action	prep_to	13	SENT_29	[p2l10t2960r262b3029],
17	of	IN	O	of	_	0	SENT_29	[p2l301t2958r384b3029],
18	aspirin	NN	O	aspirin	prep_of	16	SENT_29	[p2l418t2959r688b3048],
19	than	IN	O	than	mark	22	SENT_29	[p2l729t2958r908b3029],
20	P1A1	NN	O	p1a1	nn	21	SENT_29	[p2l953t2959r1135b3029],
21	homozygotes	NNS	O	homozygote	nsubj	22	SENT_29	[p2l1190t2958r1723b3048],
22	[	VBP	O	[	advcl	13	SENT_29	[p2l1767t2958r1982b3048],
23	5,6	CD	NUMBER	5,6	number	24	SENT_29	[p2l1767t2958r1982b3048],
24	]	CD	NUMBER	]	dobj	22	SENT_29	[p2l1767t2958r1982b3048],
25	.	.	O	.	_	0	SENT_29	[p2l1767t2958r1982b3048],

1	We	PRP	O	we	nsubj	2	SENT_30	[p2l2025t2960r2150b3029],
2	wondered	VBD	O	wonder	_	0	SENT_30	[p2l7t3071r414b3141],
3	whether	IN	O	whether	complm	9	SENT_30	[p2l449t3071r796b3141],
4	this	DT	O	this	nsubj	9	SENT_30	[p2l828t3071r975b3141],
5	could	MD	O	could	aux	9	SENT_30	[p2l1009t3071r1228b3141],
6	be	VB	O	be	cop	9	SENT_30	[p2l1268t3071r1362b3141],
7	also	RB	O	also	advmod	9	SENT_30	[p2l1397t3071r1555b3141],
8	the	DT	O	the	det	9	SENT_30	[p2l1590t3071r1723b3141],
9	case	NN	O	case	ccomp	2	SENT_30	[p2l1757t3090r1935b3141],
10	with	IN	O	with	_	0	SENT_30	[p2l1968t3071r2146b3141],
11	patients	NNS	O	patient	prep_with	9	SENT_30	[p2l12t3185r346b3273],
12	suffering	VBG	O	suffer	partmod	11	SENT_30	[p2l393t3183r757b3273],
13	from	IN	O	from	_	0	SENT_30	[p2l804t3183r994b3255],
14	clinically	RB	O	clinically	advmod	17	SENT_30	[p2l1045t3183r1416b3273],
15	proven	VBN	O	prove	amod	17	SENT_30	[p2l1464t3203r1738b3273],
16	coronary	JJ	O	coronary	amod	17	SENT_30	[p2l1789t3203r2151b3273],
17	artery	NN	O	artery	prep_from	12	SENT_30	[p2l10t3303r263b3386],
18	disease	NN	O	disease	nn	21	SENT_30	[p2l292t3296r590b3367],
19	(	CD	NUMBER	(	num	21	SENT_30	[p2l627t3297r878b3386],
20	CAD	NN	O	cad	nn	21	SENT_30	[p2l627t3297r878b3386],
21	)	NN	O	)	dep	17	SENT_30	[p2l627t3297r878b3386],
22	.	.	O	.	_	0	SENT_30	[p2l627t3297r878b3386],

1	From	IN	O	from	_	0	SENT_31	[p2l126t3411r327b3479],
2	consecutive	JJ	O	consecutive	amod	4	SENT_31	[p2l389t3410r877b3479],
3	500	CD	NUMBER	500	num	4	SENT_31	[p2l938t3410r1078b3479],
4	survivors	NNS	O	survivor	prep_from	26	SENT_31	[p2l1137t3410r1498b3479],
5	of	IN	O	of	_	0	SENT_31	[p2l1556t3409r1639b3479],
6	myocardial	JJ	O	myocardial	amod	7	SENT_31	[p2l1697t3409r2148b3497],
7	infarction	NN	O	infarction	prep_of	4	SENT_31	[p2l10t3521r431b3593],
8	(	CD	NUMBER	(	num	10	SENT_31	[p2l503t3523r689b3611],
9	MI	NNP	O	MI	nn	10	SENT_31	[p2l503t3523r689b3611],
10	)	NNP	O	)	dep	7	SENT_31	[p2l503t3523r689b3611],
11	,	,	O	,	_	0	SENT_31	[p2l503t3523r689b3611],
12	treated	VBN	O	treat	partmod	7	SENT_31	[p2l761t3521r1080b3593],
13	in	IN	O	in	_	0	SENT_31	[p2l1148t3523r1219b3592],
14	the	DT	O	the	det	15	SENT_31	[p2l1286t3521r1424b3593],
15	Department	NNP	O	Department	prep_in	12	SENT_31	[p2l1492t3523r2004b3611],
16	of	IN	O	of	_	0	SENT_31	[p2l2068t3521r2152b3593],
17	Medicine	NNP	O	Medicine	prep_of	15	SENT_31	[p2l7t3634r375b3704],
18	between	IN	O	between	_	0	SENT_31	[p2l401t3634r753b3704],
19	1999	CD	DATE	1999	prep_between	17	SENT_31	[p2l785t3634r968b3704],
20	and	CC	DATE	and	_	0	SENT_31	[p2l994t3634r1137b3704],
21	2002	CD	DATE	2002	prep_between	17	SENT_31	[p2l1163t3634r1380b3720],
22	,	,	O	,	_	0	SENT_31	[p2l1163t3634r1380b3720],
23	we	PRP	O	we	nsubj	26	SENT_31	[p2l1410t3653r1527b3704],
24	have	VBP	O	have	aux	26	SENT_31	[p2l1552t3634r1742b3704],
25	randomly	RB	O	randomly	advmod	26	SENT_31	[p2l1769t3634r2151b3722],
26	chosen	VBN	O	choose	_	0	SENT_31	[p3l9t19r288b91],
27	100	CD	NUMBER	100	num	28	SENT_31	[p3l323t20r458b91],
28	subjects	NNS	O	subject	dobj	26	SENT_31	[p3l484t19r850b109],
29	.	.	O	.	_	0	SENT_31	[p3l484t19r850b109],

1	Out	IN	O	out	_	0	SENT_32	[p3l886t20r1031b91],
2	of	IN	O	of	prepc_out_of	8	SENT_32	[p3l1056t19r1139b91],
3	this	DT	O	this	det	4	SENT_32	[p3l1162t19r1309b91],
4	number	NN	O	number	pobj	8	SENT_32	[p3l1337t19r1661b106],
5	,	,	O	,	_	0	SENT_32	[p3l1337t19r1661b106],
6	28	CD	NUMBER	28	num	7	SENT_32	[p3l1694t20r1786b91],
7	patients	NNS	O	patient	nsubj	8	SENT_32	[p3l1816t21r2150b109],
8	met	VBD	O	meet	_	0	SENT_32	[p3l12t139r171b203],
9	the	DT	O	the	det	11	SENT_32	[p3l193t132r327b203],
10	entry	NN	O	entry	nn	11	SENT_32	[p3l350t139r568b222],
11	criteria	NNS	O	criterion	dobj	8	SENT_32	[p3l589t134r893b203],
12	of	IN	O	of	_	0	SENT_32	[p3l916t132r998b203],
13	the	DT	O	the	det	14	SENT_32	[p3l1019t132r1152b203],
14	study	NN	O	study	prep_of	11	SENT_32	[p3l1175t132r1409b222],
15	,	,	O	,	_	0	SENT_32	[p3l1175t132r1409b222],
16	i	FW	O	i	appos	14	SENT_32	[p3l1440t134r1458b202],
17	.	.	O	.	_	0	SENT_32	[p3l1473t151r1606b203],

1	e.	NN	O	e.	_	0	SENT_33	[p3l1473t151r1606b203],
2	:	:	O	:	_	0	SENT_33	[p3l1473t151r1606b203],
3	MI	NNP	O	MI	dep	1	SENT_33	[p3l1636t134r1719b203],
4	(	CD	NUMBER	(	num	3	SENT_33	[p3l1753t134r1863b221],
5	at	IN	DURATION	at	quantmod	7	SENT_33	[p3l1753t134r1863b221],
6	least	JJS	DURATION	least	mwe	5	SENT_33	[p3l1889t132r2083b203],
7	6	CD	DURATION	6	num	8	SENT_33	[p3l2106t133r2148b203],
8	months	NNS	NUMBER	month	npadvmod	9	SENT_33	[p3l12t245r309b315],
9	before	IN	O	before	advmod	10	SENT_33	[p3l350t245r617b315],
10	entering	VBG	O	enter	partmod	3	SENT_33	[p3l656t246r1003b333],
11	the	DT	O	the	det	13	SENT_33	[p3l1042t245r1176b315],
12	study	NN	O	study	nn	13	SENT_33	[p3l1215t245r1464b333],
13	)	NN	O	)	dobj	10	SENT_33	[p3l1215t245r1464b333],
14	and	CC	O	and	_	0	SENT_33	[p3l1508t245r1651b315],
15	lack	NN	O	lack	dobj	10	SENT_33	[p3l1696t245r1860b315],
16	of	IN	O	of	_	0	SENT_33	[p3l1897t245r1980b315],
17	the	DT	O	the	det	19	SENT_33	[p3l2016t245r2149b315],
18	exclusion	NN	O	exclusion	nn	19	SENT_33	[p3l9t357r389b429],
19	criteria	NNS	O	criterion	prep_of	13	SENT_33	[p3l425t359r728b429],
20	(	JJ	O	(	amod	21	SENT_33	[p3l767t359r938b447],
21	age	NN	O	age	conj_or	21	SENT_33	[p3l767t359r938b447],
22	over	IN	O	over	_	0	SENT_33	[p3l971t377r1152b429],
23	65	CD	NUMBER	65	prep_over	21	SENT_33	[p3l1182t358r1272b429],
24	or	CC	O	or	_	0	SENT_33	[p3l1308t377r1391b429],
25	under	IN	O	under	_	0	SENT_33	[p3l1423t357r1660b429],
26	30	CD	NUMBER	30	prep_under	21	SENT_33	[p3l1692t358r1809b444],
27	,	,	O	,	_	0	SENT_33	[p3l1692t358r1809b444],
28	contraindications	NNS	O	contraindication	prep_under	21	SENT_33	[p3l1849t364r2144b429, p3l10t470r458b541],
29	for	IN	O	for	_	0	SENT_33	[p3l517t470r635b541],
30	aspirin	NN	O	aspirin	nn	31	SENT_33	[p3l692t471r961b560],
31	intake	NN	O	intake	prep_for	28	SENT_33	[p3l1024t470r1307b557],
32	,	,	O	,	_	0	SENT_33	[p3l1024t470r1307b557],
33	diabetes	NN	O	diabetes	nn	34	SENT_33	[p3l1374t470r1725b541],
34	mellitus	NN	O	mellitus	prep_under	21	SENT_33	[p3l1787t470r2141b557],
35	,	,	O	,	_	0	SENT_33	[p3l1787t470r2141b557],
36	autoimmune	JJ	O	autoimmune	amod	37	SENT_33	[p3l10t584r526b653],
37	diseases	NNS	O	disease	prep_under	21	SENT_33	[p3l572t583r933b669],
38	,	,	O	,	_	0	SENT_33	[p3l572t583r933b669],
39	antiphospholipid	JJ	O	antiphospholipid	amod	40	SENT_33	[p3l987t583r1671b671],
40	syndrome	NN	O	syndrome	prep_under	21	SENT_33	[p3l1719t583r2141b671],
41	,	,	O	,	_	0	SENT_33	[p3l1719t583r2141b671],
42	renal	JJ	O	renal	amod	45	SENT_33	[p3l13t695r218b767],
43	and	CC	O	and	_	0	SENT_33	[p3l265t695r408b767],
44	hepatic	JJ	O	hepatic	amod	45	SENT_33	[p3l459t695r764b785],
45	insufficiency	NN	O	insufficiency	prep_under	21	SENT_33	[p3l810t695r1349b785],
46	,	,	O	,	_	0	SENT_33	[p3l810t695r1349b785],
47	endocrinopathies	NNS	O	endocrinopathy	prep_under	21	SENT_33	[p3l1401t695r2141b785],
48	,	,	O	,	_	0	SENT_33	[p3l1401t695r2141b785],
49	cancer	NN	O	cancer	prep_under	21	SENT_33	[p3l9t827r287b878],
50	and	CC	O	and	_	0	SENT_33	[p3l331t808r474b878],
51	hypercholesterolemia	NN	O	hypercholesterolemia	prep_under	21	SENT_33	[p3l527t808r1425b896],
52	(	CD	NUMBER	(	dep	53	SENT_33	[p3l1477t809r1693b896],
53	>	JJR	O	>	dep	57	SENT_33	[p3l1477t809r1693b896],
54	5.5	CD	NUMBER	5.5	num	55	SENT_33	[p3l1477t809r1693b896],
55	mmol/l	NN	O	mmol/l	dep	53	SENT_33	[p3l1745t808r2141b896],
56	)	CD	NUMBER	)	num	57	SENT_33	[p3l1745t808r2141b896],
57	)	NN	O	)	dep	13	SENT_33	[p3l1745t808r2141b896],
58	.	.	O	.	_	0	SENT_33	[p3l1745t808r2141b896],

1	All	DT	O	all	nsubj	2	SENT_34	[p3l7t920r113b992],
2	abstained	VBD	O	abstain	_	0	SENT_34	[p3l162t920r559b992],
3	from	IN	O	from	_	0	SENT_34	[p3l610t920r800b992],
4	aspirin	NN	O	aspirin	prep_from	2	SENT_34	[p3l851t922r1121b1010],
5	and	CC	O	and	_	0	SENT_34	[p3l1173t920r1316b992],
6	other	JJ	O	other	amod	9	SENT_34	[p3l1367t920r1589b992],
7	nonsteroidal	JJ	O	nonsteroidal	amod	9	SENT_34	[p3l1638t920r2148b992],
8	anti-inflammatory	JJ	O	anti-inflammatory	amod	9	SENT_34	[p3l10t1033r767b1123],
9	drugs	NNS	O	drug	prep_from	2	SENT_34	[p3l805t1033r1025b1123],
10	for	IN	O	for	_	0	SENT_34	[p3l1063t1033r1181b1104],
11	at	IN	DURATION	at	quantmod	13	SENT_34	[p3l1219t1040r1300b1104],
12	least	JJS	DURATION	least	mwe	11	SENT_34	[p3l1343t1033r1537b1104],
13	3	CD	DURATION	3	num	14	SENT_34	[p3l1579t1034r1617b1104],
14	weeks	NNS	NUMBER	week	prep_for	2	SENT_34	[p3l1658t1033r1938b1104],
15	.	.	O	.	_	0	SENT_34	[p3l1658t1033r1938b1104],

1	This	DT	O	this	nsubjpass	3	SENT_35	[p3l1983t1033r2150b1104],
2	was	VBD	O	be	auxpass	3	SENT_35	[p3l7t1165r161b1216],
3	ascertained	VBN	O	ascertain	_	0	SENT_35	[p3l213t1146r690b1216],
4	by	IN	O	by	_	0	SENT_35	[p3l749t1146r841b1234],
5	the	DT	O	the	det	12	SENT_35	[p3l892t1146r1025b1216],
6	normal	JJ	O	normal	amod	12	SENT_35	[p3l1080t1146r1362b1216],
7	arachidonic	JJ	O	arachidonic	amod	12	SENT_35	[p3l1416t1146r1894b1216],
8	acidinduced	JJ	O	acidinduced	amod	12	SENT_35	[p3l1947t1146r2144b1216, p3l10t1258r331b1330],
9	(	NN	O	(	nn	12	SENT_35	[p3l362t1259r532b1348],
10	600	CD	NUMBER	600	num	12	SENT_35	[p3l362t1259r532b1348],
11	umoll	NN	O	umoll	nn	12	SENT_35	[p3l553t1258r796b1347],
12	l	NN	O	l	agent	3	SENT_35	[p3l811t1258r860b1348],
13	)	CD	NUMBER	)	num	15	SENT_35	[p3l811t1258r860b1348],
14	platelet	NN	O	platelet	nn	15	SENT_35	[p3l888t1258r1213b1348],
15	aggregation	NN	O	aggregation	dep	12	SENT_35	[p3l1235t1260r1746b1348],
16	.	.	O	.	_	0	SENT_35	[p3l1235t1260r1746b1348],

1	Informed	JJ	O	informed	amod	2	SENT_36	[p3l1782t1258r2146b1330],
2	consent	NN	O	consent	nsubjpass	4	SENT_36	[p3l9t1379r329b1443],
3	was	VBD	O	be	auxpass	4	SENT_36	[p3l377t1391r531b1443],
4	obtained	VBN	O	obtain	_	0	SENT_36	[p3l581t1372r942b1443],
5	from	IN	O	from	_	0	SENT_36	[p3l996t1372r1187b1443],
6	all	DT	O	all	predet	8	SENT_36	[p3l1242t1372r1339b1443],
7	the	DT	O	the	det	8	SENT_36	[p3l1391t1372r1525b1443],
8	patients	NNS	O	patient	prep_from	4	SENT_36	[p3l1579t1373r1938b1462],
9	.	.	O	.	_	0	SENT_36	[p3l1579t1373r1938b1462],

1	The	DT	O	the	det	2	SENT_37	[p3l1996t1372r2149b1443],
2	study	NN	O	study	nsubjpass	4	SENT_37	[p3l9t1484r229b1572],
3	was	VBD	O	be	auxpass	4	SENT_37	[p3l281t1503r434b1554],
4	accepted	VBN	O	accept	_	0	SENT_37	[p3l488t1484r864b1572],
5	by	IN	O	by	_	0	SENT_37	[p3l925t1484r1017b1572],
6	the	DT	O	the	det	8	SENT_37	[p3l1071t1484r1204b1554],
7	Ethics	NNPS	ORGANIZATION	Ethics	nn	8	SENT_37	[p3l1262t1484r1502b1554],
8	Committee	NNP	ORGANIZATION	Committee	agent	4	SENT_37	[p3l1557t1485r2015b1554],
9	of	IN	ORGANIZATION	of	_	0	SENT_37	[p3l2069t1484r2152b1554],
10	Jagiellonian	NNP	ORGANIZATION	Jagiellonian	nn	12	SENT_37	[p3l8t1596r502b1686],
11	University	NNP	ORGANIZATION	University	nn	12	SENT_37	[p3l539t1598r952b1686],
12	School	NNP	ORGANIZATION	School	prep_of	8	SENT_37	[p3l981t1596r1243b1668],
13	of	IN	ORGANIZATION	of	_	0	SENT_37	[p3l1276t1596r1359b1668],
14	Medicine	NNP	ORGANIZATION	Medicine	nn	16	SENT_37	[p3l1384t1596r1778b1683],
15	,	,	O	,	_	0	SENT_37	[p3l1384t1596r1778b1683],
16	Krakow	NNP	LOCATION	Krakow	prep_of	12	SENT_37	[p3l1820t1596r2134b1668],
17	.	.	O	.	_	0	SENT_37	[p3l1820t1596r2134b1668],

1	PVWA2	NN	O	pvwa2	nn	2	SENT_38	[p3l126t1691r389b1780],
2	polymorphism	NN	O	polymorphism	nsubjpass	4	SENT_38	[p3l433t1709r1006b1798],
3	was	VBD	O	be	auxpass	4	SENT_38	[p3l1047t1728r1200b1780],
4	analyzed	VBN	O	analyze	_	0	SENT_38	[p3l1241t1709r1603b1798],
5	by	IN	O	by	_	0	SENT_38	[p3l1649t1709r1741b1798],
6	polymerase	NN	O	polymerase	nn	8	SENT_38	[p3l1782t1709r2144b1798, p3l10t1842r141b1894],
7	chain	NN	O	chain	nn	8	SENT_38	[p3l180t1822r395b1894],
8	reaction	NN	O	reaction	agent	4	SENT_38	[p3l441t1824r777b1894],
9	and	CC	O	and	_	0	SENT_38	[p3l818t1822r961b1894],
10	restriction	NN	O	restriction	nn	18	SENT_38	[p3l1007t1824r1431b1894],
11	fragment	NN	O	fragment	nn	18	SENT_38	[p3l1472t1822r1851b1912],
12	length	NN	O	length	nn	18	SENT_38	[p3l1893t1822r2145b1912],
13	polymorphism	NN	O	polymorphism	nn	18	SENT_38	[p3l12t1935r586b2025],
14	(	NN	O	(	nn	18	SENT_38	[p3l623t1935r839b2025],
15	Mspl	NN	O	mspl	nn	18	SENT_38	[p3l623t1935r839b2025],
16	restriction	NN	O	restriction	nn	18	SENT_38	[p3l872t1936r1296b2006],
17	enouclease	NN	O	enouclease	nn	18	SENT_38	[p3l1328t1935r1847b2024],
18	)	NN	O	)	agent	4	SENT_38	[p3l1328t1935r1847b2024],
19	.	.	O	.	_	0	SENT_38	[p3l1328t1935r1847b2024],

1	Bleeding	VBG	O	bleed	amod	5	SENT_39	[p3l1889t1935r2144b2006, p3l10t2049r134b2136],
2	time	NN	O	time	nn	5	SENT_39	[p3l204t2049r398b2118],
3	(	CD	NUMBER	(	num	5	SENT_39	[p3l473t2049r642b2136],
4	BT	NNP	O	BT	nn	5	SENT_39	[p3l473t2049r642b2136],
5	)	NN	O	)	nsubjpass	10	SENT_39	[p3l473t2049r642b2136],
6	and	CC	O	and	_	0	SENT_39	[p3l716t2048r864b2118],
7	thrombin	NN	O	thrombin	nn	8	SENT_39	[p3l937t2048r1328b2118],
8	generation	NN	O	generation	conj_and	5	SENT_39	[p3l1402t2049r1866b2136],
9	were	VBD	O	be	auxpass	10	SENT_39	[p3l1937t2067r2149b2118],
10	measured	VBN	O	measure	conj_and	10	SENT_39	[p3l12t2160r406b2232],
11	at	IN	O	at	_	0	SENT_39	[p3l453t2167r534b2232],
12	the	DT	O	the	det	13	SENT_39	[p3l577t2160r711b2232],
13	beginning	NN	O	beginning	prep_at	10	SENT_39	[p3l757t2160r1152b2250],
14	of	IN	O	of	_	0	SENT_39	[p3l1195t2160r1278b2232],
15	the	DT	O	the	det	16	SENT_39	[p3l1318t2160r1452b2232],
16	study	NN	O	study	prep_of	13	SENT_39	[p3l1495t2160r1715b2250],
17	and	CC	O	and	_	0	SENT_39	[p3l1757t2160r1901b2232],
18	after	IN	O	after	_	0	SENT_39	[p3l1947t2160r2151b2232],
19	14	CD	DURATION	14	num	20	SENT_39	[p3l15t2275r103b2344],
20	days	NNS	NUMBER	day	prep_after	10	SENT_39	[p3l139t2273r319b2363],
21	of	IN	O	of	_	0	SENT_39	[p3l355t2273r438b2344],
22	aspirin	NN	O	aspirin	nn	24	SENT_39	[p3l471t2275r742b2363],
23	administration	NN	O	administration	nn	24	SENT_39	[p3l782t2273r1380b2344],
24	(	NN	O	(	prep_of	20	SENT_39	[p3l1426t2274r1596b2363],
25	300	CD	NUMBER	300	num	27	SENT_39	[p3l1426t2274r1596b2363],
26	mg/day	JJ	O	mg/day	amod	27	SENT_39	[p3l1636t2273r2009b2363],
27	)	NN	O	)	dep	10	SENT_39	[p3l1636t2273r2009b2363],
28	.	.	O	.	_	0	SENT_39	[p3l1636t2273r2009b2363],

1	For	IN	O	for	_	0	SENT_40	[p3l126t2388r255b2456],
2	measurement	NN	O	measurement	prep_for	10	SENT_40	[p3l290t2392r851b2456],
3	of	IN	O	of	_	0	SENT_40	[p3l885t2386r968b2456],
4	thrombin	NN	O	thrombin	nn	5	SENT_40	[p3l999t2386r1372b2456],
5	generation	NN	O	generation	prep_of	2	SENT_40	[p3l1410t2387r1880b2474],
6	,	,	O	,	_	0	SENT_40	[p3l1410t2387r1880b2474],
7	blood	NN	O	blood	nn	8	SENT_40	[p3l1925t2386r2146b2456],
8	samples	NNS	O	sample	nsubjpass	10	SENT_40	[p3l9t2498r337b2588],
9	were	VBD	O	be	auxpass	10	SENT_40	[p3l365t2518r570b2570],
10	collected	VBN	O	collect	_	0	SENT_40	[p3l601t2498r981b2570],
11	every	DT	O	every	det	13	SENT_40	[p3l1015t2518r1242b2588],
12	30	CD	NUMBER	30	num	13	SENT_40	[p3l1274t2499r1365b2570],
13	s	NNS	O	s	dobj	10	SENT_40	[p3l1396t2518r1428b2570],
14	up	IN	DURATION	up	advmod	10	SENT_40	[p3l1461t2518r1556b2588],
15	to	TO	DURATION	to	_	0	SENT_40	[p3l1588t2506r1670b2570],
16	3	CD	DURATION	3	num	17	SENT_40	[p3l1702t2499r1741b2570],
17	min	NN	DURATION	min	prep_to	14	SENT_40	[p3l1778t2500r1922b2569],
18	from	IN	O	from	_	0	SENT_40	[p3l1956t2498r2146b2570],
19	two	CD	NUMBER	two	num	23	SENT_40	[p3l10t2618r161b2681],
20	linear	JJ	O	linear	amod	23	SENT_40	[p3l202t2611r437b2681],
21	standardized	JJ	O	standardized	amod	23	SENT_40	[p3l472t2611r1001b2681],
22	skin	NN	O	skin	nn	23	SENT_40	[p3l1042t2611r1196b2681],
23	incisions	NNS	O	incision	prep_from	10	SENT_40	[p3l1236t2612r1583b2681],
24	made	VBN	O	make	partmod	23	SENT_40	[p3l1623t2611r1844b2681],
25	on	IN	O	on	_	0	SENT_40	[p3l1882t2630r1975b2681],
26	the	DT	O	the	det	27	SENT_40	[p3l2016t2611r2149b2681],
27	forearm	NN	O	forearm	prep_on	24	SENT_40	[p3l9t2723r358b2795],
28	with	IN	O	with	_	0	SENT_40	[p3l431t2723r619b2795],
29	a	DT	O	a	det	32	SENT_40	[p3l695t2743r738b2795],
30	Simplate	NNP	O	Simplate	nn	32	SENT_40	[p3l811t2723r1197b2813],
31	II	NNP	O	II	nn	32	SENT_40	[p3l1274t2725r1313b2794],
32	device	NN	O	device	prep_with	27	SENT_40	[p3l1391t2723r1676b2795],
33	(	CD	NUMBER	(	num	36	SENT_40	[p3l1753t2724r2146b2813],
34	Organon	NNP	ORGANIZATION	Organon	nn	36	SENT_40	[p3l1753t2724r2146b2813],
35	Teknika	NNP	ORGANIZATION	Teknika	nn	36	SENT_40	[p3l7t2836r381b2925],
36	)	NN	O	)	dep	32	SENT_40	[p3l7t2836r381b2925],
37	.	.	O	.	_	0	SENT_40	[p3l7t2836r381b2925],

1	Thrombin	NN	O	thrombin	nn	2	SENT_41	[p3l452t2836r846b2907],
2	generation	NN	O	generation	nsubjpass	4	SENT_41	[p3l915t2837r1358b2926],
3	was	VBD	O	be	auxpass	4	SENT_41	[p3l1424t2855r1578b2907],
4	assessed	VBN	O	assess	_	0	SENT_41	[p3l1643t2836r1988b2907],
5	by	IN	O	by	_	0	SENT_41	[p3l2059t2836r2151b2926],
6	F1	NN	O	f1	nn	9	SENT_41	[p3l13t2950r88b3018],
7	+2	CD	NUMBER	+2	num	9	SENT_41	[p3l110t2950r199b3018],
8	prothrombin	NN	O	prothrombin	nn	9	SENT_41	[p3l247t2949r756b3037],
9	fragment	NN	O	fragment	agent	4	SENT_41	[p3l803t2949r1182b3037],
10	concentration	NN	O	concentration	nn	12	SENT_41	[p3l1225t2950r1800b3019],
11	(	CD	NUMBER	(	num	12	SENT_41	[p3l1853t2951r2144b3037, p3l12t3068r207b3148],
12	Enzygnost	NNP	O	Enzygnost	dep	9	SENT_41	[p3l1853t2951r2144b3037, p3l12t3068r207b3148],
13	,	,	O	,	_	0	SENT_41	[p3l1853t2951r2144b3037, p3l12t3068r207b3148],
14	Behring	NNP	PERSON	Behring	nn	18	SENT_41	[p3l263t3061r596b3151],
15	,	,	O	,	_	0	SENT_41	[p3l263t3061r596b3151],
16	Marburg	NNP	LOCATION	Marburg	appos	18	SENT_41	[p3l647t3061r1009b3151],
17	,	,	O	,	_	0	SENT_41	[p3l647t3061r1009b3151],
18	Germany	NNP	LOCATION	Germany	appos	9	SENT_41	[p3l1062t3062r1461b3151],
19	)	CD	NUMBER	)	num	18	SENT_41	[p3l1062t3062r1461b3151],
20	[	CD	NUMBER	[	number	21	SENT_41	[p3l1515t3061r1648b3151],
21	7	CD	NUMBER	7	num	22	SENT_41	[p3l1515t3061r1648b3151],
22	]	NN	O	]	dep	18	SENT_41	[p3l1515t3061r1648b3151],
23	.	.	O	.	_	0	SENT_41	[p3l1515t3061r1648b3151],

1	Analysis	NN	O	analysis	nsubjpass	8	SENT_42	[p3l1699t3061r2025b3151],
2	of	IN	O	of	_	0	SENT_42	[p3l2069t3061r2152b3133],
3	samples	NNS	O	sample	prep_of	1	SENT_42	[p3l9t3174r337b3264],
4	and	CC	O	and	_	0	SENT_42	[p3l378t3174r521b3245],
5	thrombin	NN	O	thrombin	nn	6	SENT_42	[p3l566t3174r939b3246],
6	generation	NN	O	generation	prep_of	1	SENT_42	[p3l984t3176r1426b3264],
7	were	VBD	O	be	auxpass	8	SENT_42	[p3l1467t3193r1672b3246],
8	performed	VBN	O	perform	_	0	SENT_42	[p3l1717t3174r2146b3264],
9	without	IN	O	without	_	0	SENT_42	[p3l7t3287r328b3357],
10	knowledge	NN	O	knowledge	prep_without	8	SENT_42	[p3l365t3287r803b3375],
11	of	IN	O	of	_	0	SENT_42	[p3l837t3287r919b3357],
12	the	DT	O	the	det	13	SENT_42	[p3l951t3287r1085b3357],
13	genotype	NN	O	genotype	prep_of	10	SENT_42	[p3l1119t3294r1525b3375],
14	.	.	O	.	_	0	SENT_42	[p3l1119t3294r1525b3375],

1	As	IN	O	as	_	0	SENT_43	[p3l1565t3288r1655b3357],
2	a	DT	O	a	det	4	SENT_43	[p3l1689t3306r1732b3357],
3	quantitative	JJ	O	quantitative	amod	4	SENT_43	[p3l1767t3288r2144b3375, p3l10t3401r166b3471],
4	measure	NN	O	measure	prep_as	10	SENT_43	[p3l206t3419r551b3471],
5	of	IN	O	of	_	0	SENT_43	[p3l589t3399r671b3471],
6	thrombin	NN	O	thrombin	nn	7	SENT_43	[p3l706t3399r1079b3471],
7	generation	NN	O	generation	prep_of	4	SENT_43	[p3l1121t3401r1592b3489],
8	,	,	O	,	_	0	SENT_43	[p3l1121t3401r1592b3489],
9	we	PRP	O	we	nsubj	10	SENT_43	[p3l1636t3419r1753b3471],
10	used	VBD	O	use	_	0	SENT_43	[p3l1794t3399r1974b3471],
11	the	DT	O	the	det	12	SENT_43	[p3l2016t3399r2149b3471],
12	mean	NN	O	mean	dobj	10	SENT_43	[p3l12t3531r230b3582],
13	integral	JJ	O	integral	amod	14	SENT_43	[p3l298t3512r617b3600],
14	5	CD	NUMBER	5	npadvmod	10	SENT_43	[p3l684t3512r724b3582],
15	of	IN	O	of	_	0	SENT_43	[p3l792t3512r874b3582],
16	F1	NN	O	f1	nn	20	SENT_43	[p3l939t3513r1014b3581],
17	+2	CD	NUMBER	+2	num	20	SENT_43	[p3l1036t3512r1124b3581],
18	prothrombin	NN	O	prothrombin	nn	20	SENT_43	[p3l1194t3512r1702b3600],
19	fragment	NN	O	fragment	nn	20	SENT_43	[p3l1770t3512r2150b3600],
20	concentration	NN	O	concentration	prep_of	10	SENT_43	[p3l9t3626r584b3696],
21	c	NN	O	c	nn	24	SENT_43	[p3l652t3626r803b3714],
22	(	CD	NUMBER	(	num	24	SENT_43	[p3l652t3626r803b3714],
23	t	NN	O	t	nn	24	SENT_43	[p3l652t3626r803b3714],
24	)	NN	O	)	npadvmod	10	SENT_43	[p3l652t3626r803b3714],
25	over	IN	O	over	_	0	SENT_43	[p3l869t3644r1051b3696],
26	the	DT	O	the	det	29	SENT_43	[p3l1112t3624r1246b3696],
27	fixed	JJ	O	fixed	amod	29	SENT_43	[p3l1310t3624r1512b3696],
28	time	NN	O	time	nn	29	SENT_43	[p3l1580t3626r1766b3696],
29	interval	NN	O	interval	prep_over	10	SENT_43	[p3l1830t3624r2149b3696],

1	[	NN	O	[	_	0	SENT_44	[p4l16t18r244b108],
2	a	DT	O	a	dep	1	SENT_44	[p4l16t18r244b108],
3	,	,	O	,	_	0	SENT_44	[p4l16t18r244b108],
4	b	NN	O	b	nn	5	SENT_44	[p4l16t18r244b108],
5	]	NN	O	]	appos	1	SENT_44	[p4l16t18r244b108],
6	.	.	O	.	_	0	SENT_44	[p4l16t18r244b108],

1	S	NN	O	s	nsubjpass	3	SENT_45	[p4l290t19r330b89],
2	is	VBZ	O	be	auxpass	3	SENT_45	[p4l371t20r429b89],
3	defined	VBN	O	define	_	0	SENT_45	[p4l466t18r774b89],
4	as	IN	O	as	prep	3	SENT_45	[p4l816t37r897b89],

1	Bleeding	VBG	O	bleed	amod	2	SENT_46	[p4l126t582r476b670],
2	time	NN	O	time	nsubjpass	4	SENT_46	[p4l518t583r704b652],
3	was	VBD	O	be	auxpass	4	SENT_46	[p4l742t601r896b652],
4	calculated	VBN	O	calculate	_	0	SENT_46	[p4l936t582r1364b652],
5	as	IN	O	as	_	0	SENT_46	[p4l1409t601r1490b652],
6	a	DT	O	a	det	7	SENT_46	[p4l1530t601r1573b652],
7	mean	NN	O	mean	prep_as	4	SENT_46	[p4l1617t601r1834b652],
8	of	IN	O	of	_	0	SENT_46	[p4l1878t582r1960b652],
9	two	CD	NUMBER	two	num	11	SENT_46	[p4l1998t588r2149b652],
10	bleeding	JJ	O	bleeding	amod	11	SENT_46	[p4l12t694r363b784],
11	times	NNS	O	time	prep_of	7	SENT_46	[p4l423t696r647b765],
12	measured	VBN	O	measure	partmod	11	SENT_46	[p4l709t694r1103b765],
13	with	IN	O	with	_	0	SENT_46	[p4l1164t694r1342b766],
14	two	CD	NUMBER	two	num	16	SENT_46	[p4l1405t701r1556b766],
15	standardized	JJ	O	standardized	amod	16	SENT_46	[p4l1617t694r2145b765],
16	incisions	NNS	O	incision	prep_with	12	SENT_46	[p4l9t809r357b879],
17	of	IN	O	of	_	0	SENT_46	[p4l389t807r472b879],
18	the	DT	O	the	det	19	SENT_46	[p4l501t807r635b879],
19	skin	NN	O	skin	prep_of	16	SENT_46	[p4l668t807r821b879],
20	performed	VBN	O	perform	partmod	19	SENT_46	[p4l861t807r1290b897],
21	as	IN	O	as	mark	22	SENT_46	[p4l1326t827r1407b879],
22	described	VBN	O	describe	advcl	20	SENT_46	[p4l1440t807r1836b879],
23	above	IN	O	above	prep	22	SENT_46	[p4l1873t807r2141b894],
24	,	,	O	,	_	0	SENT_46	[p4l1873t807r2141b894],
25	using	VBG	O	use	dep	22	SENT_46	[p4l11t922r216b1010],
26	a	DT	O	a	det	29	SENT_46	[p4l254t939r297b991],
27	Simplate	NNP	O	Simplate	nn	29	SENT_46	[p4l335t920r695b1010],
28	II	NNP	O	II	nn	29	SENT_46	[p4l737t922r772b991],
29	device	NN	O	device	dobj	25	SENT_46	[p4l814t920r1108b991],
30	.	.	O	.	_	0	SENT_46	[p4l814t920r1108b991],

1	For	IN	O	for	_	0	SENT_47	[p4l125t1035r254b1104],
2	statistical	JJ	O	statistical	amod	3	SENT_47	[p4l295t1033r700b1104],
3	evaluation	NN	O	evaluation	prep_for	5	SENT_47	[p4l745t1033r1176b1104],
4	we	PRP	O	we	nsubj	5	SENT_47	[p4l1220t1053r1338b1104],
5	used	VBD	O	use	_	0	SENT_47	[p4l1383t1033r1564b1104],
6	STATISTICATM	NN	O	statisticatm	dobj	5	SENT_47	[p4l1611t1029r2134b1104],

1	software	NN	O	software	_	0	SENT_48	[p4l9t1146r369b1218],
2	(	SYM	O	(	dep	5	SENT_48	[p4l405t1146r757b1236],
3	Statsoft	FW	O	statsoft	nn	5	SENT_48	[p4l405t1146r757b1236],
4	|	FW	O	|	nn	5	SENT_48	[p4l792t1148r964b1233],
5	nc.	FW	O	nc.	rcmod	1	SENT_48	[p4l792t1148r964b1233],
6	,	,	O	,	_	0	SENT_48	[p4l792t1148r964b1233],
7	Tulsa	NNP	LOCATION	Tulsa	amod	11	SENT_48	[p4l1000t1146r1230b1233],
8	,	,	O	,	_	0	SENT_48	[p4l1000t1146r1230b1233],
9	OK	UH	O	ok	dep	7	SENT_48	[p4l1270t1147r1407b1233],
10	,	,	O	,	_	0	SENT_48	[p4l1270t1147r1407b1233],
11	USA	NNP	LOCATION	USA	appos	1	SENT_48	[p4l1449t1147r1661b1236],
12	)	CD	NUMBER	)	dep	11	SENT_48	[p4l1449t1147r1661b1236],
13	.	.	O	.	_	0	SENT_48	[p4l1449t1147r1661b1236],

1	The	DT	O	the	det	2	SENT_49	[p4l1697t1146r1851b1218],
2	groups	NNS	O	group	nsubjpass	5	SENT_49	[p4l1881t1164r2150b1236],
3	studied	VBN	O	study	partmod	2	SENT_49	[p4l9t1259r308b1330],
4	were	VBD	O	be	auxpass	5	SENT_49	[p4l350t1278r555b1330],
5	compared	VBN	O	compare	_	0	SENT_49	[p4l597t1259r1002b1349],
6	by	IN	O	by	_	0	SENT_49	[p4l1050t1259r1142b1349],
7	a	DT	O	a	det	9	SENT_49	[p4l1182t1278r1225b1330],
8	multiway	JJ	O	multiway	amod	9	SENT_49	[p4l1269t1259r1648b1349],
9	ANOVA	NNP	ORGANIZATION	ANOVA	agent	5	SENT_49	[p4l1685t1260r1964b1331],
10	and	CC	O	and	_	0	SENT_49	[p4l2003t1259r2146b1330],
11	Tukey	NNP	PERSON	Tukey	poss	19	SENT_49	[p4l6t1372r313b1460],
12	’s	POS	O	’s	_	0	SENT_49	[p4l6t1372r313b1460],
13	honest	JJ	O	honest	amod	19	SENT_49	[p4l359t1372r629b1442],
14	significant	JJ	O	significant	amod	19	SENT_49	[p4l672t1372r1100b1460],
15	difference	NN	O	difference	nn	19	SENT_49	[p4l1143t1372r1572b1442],
16	(	NN	O	(	nn	19	SENT_49	[p4l1620t1373r1838b1460],
17	HSD	NN	O	hsd	nn	19	SENT_49	[p4l1620t1373r1838b1460],
18	)	CD	NUMBER	)	num	19	SENT_49	[p4l1620t1373r1838b1460],
19	procedure	NN	O	procedure	nsubj	20	SENT_49	[p4l1888t1391r2144b1460, p4l9t1484r195b1556],
20	served	VBD	O	serve	conj_and	5	SENT_49	[p4l255t1484r521b1556],
21	for	IN	O	for	_	0	SENT_49	[p4l583t1484r702b1556],
22	multiple	JJ	O	multiple	amod	23	SENT_49	[p4l762t1484r1106b1574],
23	comparisons	NNS	O	comparison	prep_for	20	SENT_49	[p4l1165t1486r1702b1574],
24	.	.	O	.	_	0	SENT_49	[p4l1165t1486r1702b1574],

1	Summary	NN	O	summary	nn	2	SENT_50	[p4l1771t1485r2152b1574],
2	statistics	NNS	O	statistics	nsubjpass	4	SENT_50	[p4l9t1598r376b1667],
3	was	VBD	O	be	auxpass	4	SENT_50	[p4l426t1616r579b1667],
4	expressed	VBN	O	express	_	0	SENT_50	[p4l630t1597r1038b1685],
5	by	IN	O	by	_	0	SENT_50	[p4l1095t1597r1187b1685],
6	meaniS	NN	O	meani	agent	4	SENT_50	[p4l1241t1597r1758b1683],
7	.	.	O	.	_	0	SENT_50	[p4l1241t1597r1758b1683],

1	D.	NNP	O	D.	dep	6	SENT_51	[p4l1241t1597r1758b1683],
2	;	:	O	;	_	0	SENT_51	[p4l1241t1597r1758b1683],
3	fourfold	RB	O	fourfold	advmod	6	SENT_51	[p4l1818t1597r2145b1667],
4	tables	NNS	O	table	nsubjpass	6	SENT_51	[p4l9t1709r259b1781],
5	were	VBD	O	be	auxpass	6	SENT_51	[p4l281t1729r486b1781],
6	analyzed	VBN	O	analyze	_	0	SENT_51	[p4l511t1709r872b1799],
7	using	VBG	O	use	xcomp	6	SENT_51	[p4l903t1711r1108b1799],
8	Fischer	NNP	PERSON	Fischer	poss	11	SENT_51	[p4l1136t1709r1497b1781],
9	's	POS	O	's	_	0	SENT_51	[p4l1136t1709r1497b1781],
10	exact	JJ	O	exact	amod	11	SENT_51	[p4l1521t1717r1748b1781],
11	test	NN	O	test	dobj	7	SENT_51	[p4l1773t1716r1956b1781],
12	.	.	O	.	_	0	SENT_51	[p4l1773t1716r1956b1781],

1	A	DT	O	a	det	2	SENT_52	[p4l1986t1710r2042b1780],
2	pvalue	NN	O	pvalue	nsubj	4	SENT_52	[p4l2060t1729r2145b1799, p4l7t1822r229b1893],
3	s	VBZ	O	s	cop	4	SENT_52	[p4l252t1838r307b1892],
4	0.05	CD	NUMBER	0.05	_	0	SENT_52	[p4l330t1823r504b1893],
5	was	VBD	O	be	auxpass	6	SENT_52	[p4l530t1841r683b1893],
6	considered	VBN	O	consider	rcmod	4	SENT_52	[p4l708t1822r1153b1893],
7	statistically	RB	O	statistically	advmod	8	SENT_52	[p4l1182t1822r1664b1912],
8	significant	JJ	O	significant	acomp	6	SENT_52	[p4l1687t1822r2141b1912],
9	.	.	O	.	_	0	SENT_52	[p4l1687t1822r2141b1912],

1	Out	IN	O	out	_	0	SENT_53	[p4l122t1936r268b2005],
2	of	IN	O	of	prepc_out_of	20	SENT_53	[p4l306t1935r388b2005],
3	28	CD	NUMBER	28	num	4	SENT_53	[p4l424t1936r516b2005],
4	patients	NNS	O	patient	pobj	20	SENT_53	[p4l558t1936r918b2023],
5	,	,	O	,	_	0	SENT_53	[p4l558t1936r918b2023],
6	19	CD	NUMBER	19	nsubj	9	SENT_53	[p4l970t1936r1056b2005],
7	were	VBD	O	be	cop	9	SENT_53	[p4l1093t1954r1298b2005],
8	A1A1	NN	O	a1a1	nn	9	SENT_53	[p4l1334t1936r1525b2004],
9	homozygotes	NNS	O	homozygote	parataxis	20	SENT_53	[p4l1581t1935r2142b2023],
10	,	,	O	,	_	0	SENT_53	[p4l1581t1935r2142b2023],
11	8	CD	NUMBER	8	num	13	SENT_53	[p4l10t2048r52b2119],
12	A1A2	NN	O	a1a2	nn	13	SENT_53	[p4l97t2048r300b2118],
13	heterozygotes	NNS	O	heterozygote	nsubj	20	SENT_53	[p4l352t2047r934b2137],
14	and	CC	O	and	_	0	SENT_53	[p4l981t2047r1123b2119],
15	one	CD	NUMBER	one	num	16	SENT_53	[p4l1173t2067r1320b2119],
16	patient	NN	O	patient	conj_and	13	SENT_53	[p4l1369t2049r1666b2137],
17	was	VBD	O	be	cop	20	SENT_53	[p4l1710t2067r1864b2119],
18	an	DT	O	a	det	20	SENT_53	[p4l1910t2067r2001b2119],
19	A2	NN	O	a2	nn	20	SENT_53	[p4l2048t2048r2148b2118],
20	homozygote	NN	O	homozygote	_	0	SENT_53	[p4l12t2160r534b2250],
21	.	.	O	.	_	0	SENT_53	[p4l12t2160r534b2250],

1	There	EX	O	there	expl	2	SENT_54	[p4l590t2160r830b2231],
2	were	VBD	O	be	_	0	SENT_54	[p4l877t2179r1082b2232],
3	no	DT	O	no	det	4	SENT_54	[p4l1134t2179r1227b2231],
4	differences	NNS	O	difference	nsubj	2	SENT_54	[p4l1276t2160r1742b2231],
5	between	IN	O	between	_	0	SENT_54	[p4l1794t2160r2146b2232],
6	groups	NNS	O	group	prep_between	4	SENT_54	[p4l9t2290r282b2361],
7	in	IN	O	in	_	0	SENT_54	[p4l348t2274r417b2342],
8	respect	NN	O	respect	prep_in	6	SENT_54	[p4l491t2280r797b2361],
9	to	TO	O	to	_	0	SENT_54	[p4l864t2280r946b2343],
10	a	DT	O	a	det	13	SENT_54	[p4l1013t2292r1056b2343],
11	positive	JJ	O	positive	amod	13	SENT_54	[p4l1126t2274r1449b2361],
12	family	NN	O	family	nn	13	SENT_54	[p4l1515t2273r1777b2361],
13	history	NN	O	history	prep_to	2	SENT_54	[p4l1844t2273r2142b2361],
14	,	,	O	,	_	0	SENT_54	[p4l1844t2273r2142b2361],
15	hypertension	NN	O	hypertension	prep_to	2	SENT_54	[p4l12t2385r607b2475],
16	,	,	O	,	_	0	SENT_54	[p4l12t2385r607b2475],
17	smoking	NN	O	smoking	prep_to	2	SENT_54	[p4l686t2385r1064b2475],
18	,	,	O	,	_	0	SENT_54	[p4l686t2385r1064b2475],
19	age	NN	O	age	prep_to	2	SENT_54	[p4l1143t2403r1321b2475],
20	,	,	O	,	_	0	SENT_54	[p4l1143t2403r1321b2475],
21	weight	NN	O	weight	prep_to	2	SENT_54	[p4l1397t2385r1722b2475],
22	,	,	O	,	_	0	SENT_54	[p4l1397t2385r1722b2475],
23	platelet	NN	O	platelet	nn	24	SENT_54	[p4l1804t2385r2150b2475],
24	count	NN	O	count	prep_to	2	SENT_54	[p4l8t2504r266b2583],
25	,	,	O	,	_	0	SENT_54	[p4l8t2504r266b2583],
26	lipid	NN	O	lipid	nn	27	SENT_54	[p4l314t2498r486b2586],
27	profile	NN	O	profile	prep_to	2	SENT_54	[p4l530t2498r799b2586],
28	and	CC	O	and	_	0	SENT_54	[p4l836t2498r979b2568],
29	fibrinogen	NN	O	fibrinogen	nn	30	SENT_54	[p4l1019t2498r1437b2586],
30	concentration	NN	O	concentration	prep_to	2	SENT_54	[p4l1477t2499r2080b2568],
31	.	.	O	.	_	0	SENT_54	[p4l1477t2499r2080b2568],

1	At	IN	O	at	_	0	SENT_55	[p4l119t2611r209b2682],
2	baseline	NN	O	baseline	pobj	1	SENT_55	[p4l270t2610r634b2697],
3	,	,	O	,	_	0	SENT_55	[p4l270t2610r634b2697],
4	bleeding	VBG	O	bleed	partmod	2	SENT_55	[p4l703t2610r1052b2700],
5	time	NN	O	time	dobj	4	SENT_55	[p4l1111t2612r1298b2682],
6	did	VBD	O	do	aux	8	SENT_55	[p4l1356t2610r1478b2682],
7	not	RB	O	not	neg	8	SENT_55	[p4l1542t2617r1672b2682],
8	differ	VB	O	differ	rcmod	5	SENT_55	[p4l1730t2610r1962b2682],
9	between	IN	O	between	_	0	SENT_55	[p4l2020t2610r2144b2682, p4l9t2729r261b2792],
10	the	DT	O	the	det	11	SENT_55	[p4l304t2722r438b2792],
11	carriers	NNS	O	carrier	prep_between	8	SENT_55	[p4l477t2724r792b2792],
12	of	IN	O	of	_	0	SENT_55	[p4l831t2722r914b2792],
13	the	DT	O	the	det	15	SENT_55	[p4l951t2722r1084b2792],
14	PlA2	NN	O	pla2	nn	15	SENT_55	[p4l1128t2722r1301b2792],
15	allele	NN	O	allele	prep_of	11	SENT_55	[p4l1343t2722r1570b2792],
16	and	CC	O	and	_	0	SENT_55	[p4l1611t2722r1754b2792],
17	the	DT	O	the	det	18	SENT_55	[p4l1797t2722r1931b2792],
18	PlA1	NN	O	pla1	prep_of	11	SENT_55	[p4l1975t2722r2135b2792],

1	group	NN	O	group	_	0	SENT_56	[p4l9t2853r240b2925],
2	(	CD	NUMBER	(	num	3	SENT_56	[p4l291t2837r700b2926],
3	p	NN	O	p	dep	1	SENT_56	[p4l291t2837r700b2926],
4	=	JJ	O	=	amod	6	SENT_56	[p4l291t2837r700b2926],
5	0.13	CD	NUMBER	0.13	tmod	4	SENT_56	[p4l291t2837r700b2926],
6	)	NN	O	)	dep	3	SENT_56	[p4l291t2837r700b2926],
7	.	.	O	.	_	0	SENT_56	[p4l291t2837r700b2926],

1	It	PRP	O	it	nsubjpass	4	SENT_57	[p4l759t2838r811b2907],
2	was	VBD	O	be	auxpass	4	SENT_57	[p4l854t2855r1007b2907],
3	significantly	RB	O	significantly	advmod	4	SENT_57	[p4l1052t2836r1555b2925],
4	prolonged	VBN	O	prolong	_	0	SENT_57	[p4l1602t2836r2008b2925],
5	by	IN	O	by	_	0	SENT_57	[p4l2060t2836r2152b2925],
6	aspirin	NN	O	aspirin	agent	4	SENT_57	[p4l9t2950r279b3038],
7	in	IN	O	in	_	0	SENT_57	[p4l322t2950r391b3019],
8	the	DT	O	the	det	35	SENT_57	[p4l433t2948r566b3020],
9	A1	NN	O	a1	nn	35	SENT_57	[p4l603t2949r690b3019],
10	/	:	O	/	punct	12	SENT_57	[p4l715t2949r843b3019],
11	A1	NN	O	a1	nn	12	SENT_57	[p4l715t2949r843b3019],
12	group	NN	O	group	dep	35	SENT_57	[p4l897t2966r1127b3038],
13	(	CD	NUMBER	(	dep	12	SENT_57	[p4l1172t2948r1470b3038],
14	before	IN	O	before	_	0	SENT_57	[p4l1172t2948r1470b3038],
15	472.31	CD	NUMBER	472.31	prep_before	13	SENT_57	[p4l1508t2949r1769b3020],
16	i	FW	O	i	dep	13	SENT_57	[p4l1808t2958r1864b3023],
17	32.00	CD	NUMBER	32.00	dep	16	SENT_57	[p4l1892t2949r2141b3035],
18	,	,	O	,	_	0	SENT_57	[p4l1892t2949r2141b3035],
19	after	IN	O	after	prep	16	SENT_57	[p4l9t3061r214b3132],
20	560.00	CD	NUMBER	560.00	num	23	SENT_57	[p4l272t3062r875b3136],
21	i33	NN	O	i33	nn	23	SENT_57	[p4l272t3062r875b3136],
22	.60	CD	NUMBER	.60	num	23	SENT_57	[p4l272t3062r875b3136],
23	s	NNS	O	s	pobj	19	SENT_57	[p4l933t3080r991b3148],
24	,	,	O	,	_	0	SENT_57	[p4l933t3080r991b3148],
25	p	NN	O	p	appos	23	SENT_57	[p4l1053t3062r1422b3151],
26	=	JJ	O	=	amod	28	SENT_57	[p4l1053t3062r1422b3151],
27	0.02	CD	NUMBER	0.02	tmod	26	SENT_57	[p4l1053t3062r1422b3151],
28	)	NN	O	)	dep	25	SENT_57	[p4l1053t3062r1422b3151],
29	,	,	O	,	_	0	SENT_57	[p4l1053t3062r1422b3151],
30	but	CC	O	but	_	0	SENT_57	[p4l1491t3061r1623b3132],
31	not	RB	O	not	conj_but	19	SENT_57	[p4l1684t3068r1814b3132],
32	in	IN	O	in	dep	19	SENT_57	[p4l1872t3063r1940b3132],
33	A1	NN	O	a1	pobj	32	SENT_57	[p4l1999t3062r2143b3132],
34	/	:	O	/	punct	12	SENT_57	[p4l1999t3062r2143b3132],
35	A2	NN	O	a2	prep_in	6	SENT_57	[p4l6t3175r448b3243],
36	+	CC	O	+	_	0	SENT_57	[p4l6t3175r448b3243],
37	A2/A2	NN	O	a2/a2	nn	38	SENT_57	[p4l6t3175r448b3243],
38	group	NN	O	group	conj_+	4	SENT_57	[p4l519t3191r757b3262],
39	(	CD	NUMBER	(	num	38	SENT_57	[p4l832t3174r1142b3262],
40	before	IN	O	before	_	0	SENT_57	[p4l832t3174r1142b3262],
41	409.05	CD	NUMBER	409.05	num	42	SENT_57	[p4l1208t3175r1491b3244],
42	J_r28	NN	O	j_r28	prep_before	38	SENT_57	[p4l1520t3175r1863b3260],
43	.22	CD	NUMBER	.22	dep	42	SENT_57	[p4l1520t3175r1863b3260],
44	,	,	O	,	_	0	SENT_57	[p4l1520t3175r1863b3260],
45	after	IN	O	after	_	0	SENT_57	[p4l1940t3174r2152b3244],
46	497.66	CD	NUMBER	497.66	num	49	SENT_57	[p4l7t3286r612b3360],
47	i22	NN	O	i22	nn	49	SENT_57	[p4l7t3286r612b3360],
48	.22	CD	NUMBER	.22	num	49	SENT_57	[p4l7t3286r612b3360],
49	s	NNS	O	s	prep_after	38	SENT_57	[p4l652t3304r710b3371],
50	,	,	O	,	_	0	SENT_57	[p4l652t3304r710b3371],
51	p	NN	O	p	appos	49	SENT_57	[p4l751t3286r1120b3374],
52	=	JJ	O	=	amod	54	SENT_57	[p4l751t3286r1120b3374],
53	0.10	CD	NUMBER	0.10	tmod	52	SENT_57	[p4l751t3286r1120b3374],
54	)	NN	O	)	dep	51	SENT_57	[p4l751t3286r1120b3374],
55	.	.	O	.	_	0	SENT_57	[p4l751t3286r1120b3374],

1	Baseline	NN	O	baseline	nn	3	SENT_58	[p4l126t3398r463b3468],
2	thrombin	NN	O	thrombin	nn	3	SENT_58	[p4l495t3398r868b3468],
3	generation	NN	O	generation	nsubj	5	SENT_58	[p4l903t3399r1345b3486],
4	was	VBD	O	be	cop	5	SENT_58	[p4l1377t3417r1530b3468],
5	comparable	JJ	O	comparable	_	0	SENT_58	[p4l1560t3398r2046b3486],
6	in	IN	O	in	_	0	SENT_58	[p4l2078t3399r2146b3467],
7	carriers	NNS	O	carrier	prep_in	5	SENT_58	[p4l9t3512r324b3582],
8	of	IN	O	of	_	0	SENT_58	[p4l372t3510r454b3582],
9	the	DT	O	the	det	11	SENT_58	[p4l501t3510r634b3582],
10	PlA2	NN	O	pla2	nn	11	SENT_58	[p4l688t3510r861b3582],
11	allele	NN	O	allele	prep_of	7	SENT_58	[p4l913t3510r1140b3582],
12	and	CC	O	and	_	0	SENT_58	[p4l1189t3510r1333b3582],
13	in	IN	O	in	_	0	SENT_58	[p4l1386t3512r1455b3581],
14	the	DT	O	the	det	18	SENT_58	[p4l1507t3510r1641b3582],
15	PlA1	NN	O	pla1	nn	18	SENT_58	[p4l1694t3510r1854b3582],
16	group	NN	O	group	nn	18	SENT_58	[p4l1918t3528r2149b3600],
17	(	CD	NUMBER	(	num	18	SENT_58	[p4l15t3624r422b3713],
18	p	NN	O	p	conj_and	7	SENT_58	[p4l15t3624r422b3713],
19	=	JJ	O	=	amod	21	SENT_58	[p4l15t3624r422b3713],
20	0.15	CD	NUMBER	0.15	num	21	SENT_58	[p4l15t3624r422b3713],
21	)	NN	O	)	dep	5	SENT_58	[p4l15t3624r422b3713],
22	.	.	O	.	_	0	SENT_58	[p4l15t3624r422b3713],

1	Aspirin	NN	O	aspirin	nsubj	2	SENT_59	[p4l479t3624r758b3713],
2	depressed	VBD	O	depress	dep	18	SENT_59	[p4l812t3623r1223b3713],
3	thrombin	NN	O	thrombin	nn	4	SENT_59	[p4l1278t3623r1651b3694],
4	generation	NN	O	generation	nsubj	8	SENT_59	[p4l1704t3625r2146b3713],
5	in	IN	O	in	_	0	SENT_59	[p5l9t20r78b89],
6	A1	NN	O	a1	nn	7	SENT_59	[p5l115t20r202b89],
7	homozygotes	NNS	O	homozygote	prep_in	4	SENT_59	[p5l256t19r790b108],
8	(	VBP	O	(	ccomp	2	SENT_59	[p5l832t20r1210b109],
9	p	NN	O	p	dobj	8	SENT_59	[p5l832t20r1210b109],
10	=	JJ	O	=	amod	9	SENT_59	[p5l832t20r1210b109],
11	0.04	CD	NUMBER	0.04	num	12	SENT_59	[p5l832t20r1210b109],
12	)	NN	O	)	dep	10	SENT_59	[p5l832t20r1210b109],
13	but	CC	O	but	dep	14	SENT_59	[p5l1253t19r1386b90],
14	not	RB	O	not	dep	8	SENT_59	[p5l1425t26r1556b90],
15	in	IN	O	in	dep	14	SENT_59	[p5l1592t20r1660b89],
16	A2	NN	O	a2	nn	17	SENT_59	[p5l1697t20r1797b89],
17	carriers	NNS	O	carrier	pobj	15	SENT_59	[p5l1835t20r2149b90],
18	(	VBP	O	(	_	0	SENT_59	[p5l15t131r393b219],
19	p	NN	O	p	nsubj	20	SENT_59	[p5l15t131r393b219],
20	=	JJ	O	=	ccomp	18	SENT_59	[p5l15t131r393b219],
21	O.	NNP	O	O.	iobj	20	SENT_59	[p5l15t131r393b219],
22	69	CD	NUMBER	69	num	23	SENT_59	[p5l15t131r393b219],
23	)	CD	NUMBER	)	dobj	20	SENT_59	[p5l15t131r393b219],
24	(	CD	NUMBER	(	num	25	SENT_59	[p5l439t132r611b219],
25	Fig	NN	O	fig	nsubj	18	SENT_59	[p5l439t132r611b219],
26	.	.	O	.	_	0	SENT_59	[p5l439t132r611b219],

1	1	CD	NUMBER	1	_	0	SENT_60	[p5l662t132r760b219],
2	)	NN	O	)	dep	1	SENT_60	[p5l662t132r760b219],
3	.	.	O	.	_	0	SENT_60	[p5l662t132r760b219],

1	Our	PRP$	O	we	poss	2	SENT_61	[p5l123t244r269b315],
2	study	NN	O	study	nsubj	3	SENT_61	[p5l315t243r534b333],
3	demonstrates	VBZ	O	demonstrate	_	0	SENT_61	[p5l582t243r1140b314],
4	that	IN	O	that	complm	7	SENT_61	[p5l1188t243r1356b314],
5	PlA1/A2	NN	O	pla1/a2	nn	6	SENT_61	[p5l1409t243r1733b314],
6	polymorphism	NN	O	polymorphism	nsubj	7	SENT_61	[p5l1787t243r2146b333, p5l12t356r244b444],
7	affects	VBZ	O	affect	ccomp	3	SENT_61	[p5l278t356r561b426],
8	blood	NN	O	blood	nn	9	SENT_61	[p5l593t356r812b426],
9	clotting	NN	O	clotting	dobj	7	SENT_61	[p5l846t356r1161b444],
10	at	IN	O	at	_	0	SENT_61	[p5l1193t363r1273b426],
11	the	DT	O	the	det	12	SENT_61	[p5l1304t356r1438b426],
12	site	NN	O	site	prep_at	7	SENT_61	[p5l1468t357r1614b426],
13	of	IN	O	of	_	0	SENT_61	[p5l1645t356r1727b426],
14	microvascular	JJ	O	microvascular	amod	15	SENT_61	[p5l1758t357r2145b426, p5l9t468r214b540],
15	injury	NN	O	injury	prep_of	12	SENT_61	[p5l241t470r481b558],
16	in	IN	O	in	_	0	SENT_61	[p5l508t470r576b539],
17	patients	NNS	O	patient	prep_in	15	SENT_61	[p5l611t470r941b558],
18	with	IN	O	with	_	0	SENT_61	[p5l968t468r1146b540],
19	CAD	NN	O	cad	prep_with	17	SENT_61	[p5l1177t469r1364b540],
20	.	.	O	.	_	0	SENT_61	[p5l1177t469r1364b540],

1	Only	RB	O	only	advmod	7	SENT_62	[p5l1402t468r1585b558],
2	in	IN	O	in	_	0	SENT_62	[p5l1612t470r1680b539],
3	A2	NN	O	a2	nn	4	SENT_62	[p5l1709t469r1809b539],
4	carriers	NNS	O	carrier	prep_in	7	SENT_62	[p5l1839t470r2150b540],
5	aspirin	NN	O	aspirin	nsubj	7	SENT_62	[p5l9t582r276b669],
6	was	VBD	O	be	cop	7	SENT_62	[p5l329t600r482b651],
7	able	JJ	O	able	_	0	SENT_62	[p5l533t581r706b651],
8	to	TO	O	to	aux	9	SENT_62	[p5l757t588r838b651],
9	depress	VB	O	depress	xcomp	7	SENT_62	[p5l890t581r1199b669],
10	thrombin	NN	O	thrombin	nn	11	SENT_62	[p5l1250t581r1620b651],
11	generation	NN	O	generation	dobj	9	SENT_62	[p5l1675t582r2141b669],
12	.	.	O	.	_	0	SENT_62	[p5l1675t582r2141b669],

1	This	DT	O	this	nsubj	12	SENT_63	[p5l6t693r172b765],
2	is	VBZ	O	be	cop	12	SENT_63	[p5l217t695r276b765],
3	in	IN	O	in	_	0	SENT_63	[p5l321t695r390b764],
4	agreement	NN	O	agreement	prep_in	12	SENT_63	[p5l439t701r882b783],
5	with	IN	O	with	_	0	SENT_63	[p5l924t693r1102b765],
6	our	PRP$	O	we	poss	8	SENT_63	[p5l1150t713r1285b765],
7	previous	JJ	O	previous	amod	8	SENT_63	[p5l1330t695r1670b783],
8	findings	NNS	O	finding	prep_with	4	SENT_63	[p5l1714t693r2033b783],
9	in	IN	O	in	_	0	SENT_63	[p5l2078t695r2147b764],
10	healthy	JJ	O	healthy	amod	11	SENT_63	[p5l12t806r317b896],
11	subjects	NNS	O	subject	prep_in	8	SENT_63	[p5l365t806r704b896],
12	[	JJ	O	[	_	0	SENT_63	[p5l761t806r1106b896],
13	5,9,10	CD	NUMBER	5,9,10	num	14	SENT_63	[p5l761t806r1106b896],
14	]	NN	O	]	dep	12	SENT_63	[p5l761t806r1106b896],
15	.	.	O	.	_	0	SENT_63	[p5l761t806r1106b896],

1	These	DT	O	these	det	2	SENT_64	[p5l1162t806r1403b877],
2	results	NNS	O	result	nsubj	5	SENT_64	[p5l1457t806r1724b877],
3	may	MD	O	may	aux	5	SENT_64	[p5l1778t825r1944b896],
4	also	RB	O	also	advmod	5	SENT_64	[p5l1992t806r2149b877],
5	explain	VB	O	explain	_	0	SENT_64	[p5l8t919r302b1007],
6	why	WRB	O	why	advmod	22	SENT_64	[p5l333t919r497b1007],
7	in	IN	O	in	_	0	SENT_64	[p5l525t920r594b988],
8	patients	NNS	O	patient	prep_in	22	SENT_64	[p5l628t920r960b1007],
9	after	IN	O	after	_	0	SENT_64	[p5l989t919r1192b989],
10	coronary	JJ	O	coronary	amod	13	SENT_64	[p5l1219t938r1578b1007],
11	artery	NN	O	artery	nn	13	SENT_64	[p5l1606t926r1857b1007],
12	bypass	NN	O	bypass	nn	13	SENT_64	[p5l1886t919r2150b1007],
13	surgery	NN	O	surgery	prep_after	8	SENT_64	[p5l9t1049r321b1121],
14	,	,	O	,	_	0	SENT_64	[p5l9t1049r321b1121],
15	treated	VBN	O	treat	partmod	8	SENT_64	[p5l358t1031r660b1103],
16	with	IN	O	with	_	0	SENT_64	[p5l689t1031r868b1103],
17	aspirin	NN	O	aspirin	prep_with	15	SENT_64	[p5l898t1033r1195b1121],
18	,	,	O	,	_	0	SENT_64	[p5l898t1033r1195b1121],
19	the	DT	O	the	det	21	SENT_64	[p5l1231t1031r1364b1103],
20	PlA2	NN	O	pla2	nn	21	SENT_64	[p5l1396t1031r1567b1103],
21	allele	NN	O	allele	nsubj	22	SENT_64	[p5l1598t1031r1823b1103],
22	confers	VBZ	O	confer	advcl	5	SENT_64	[p5l1851t1031r2151b1103],
23	risk	NN	O	risk	dobj	22	SENT_64	[p5l13t1144r153b1215],
24	for	IN	O	for	_	0	SENT_64	[p5l185t1144r303b1215],
25	bypass	NN	O	bypass	nn	26	SENT_64	[p5l338t1144r601b1234],
26	occlusion	NN	O	occlusion	prep_for	23	SENT_64	[p5l636t1144r1040b1231],
27	,	,	O	,	_	0	SENT_64	[p5l636t1144r1040b1231],
28	myocardial	JJ	O	myocardial	amod	29	SENT_64	[p5l1085t1144r1534b1234],
29	infarction	NN	O	infarction	prep_for	23	SENT_64	[p5l1569t1144r1966b1215],
30	and	CC	O	and	_	0	SENT_64	[p5l2004t1144r2147b1215],
31	death	NN	O	death	prep_for	23	SENT_64	[p5l9t1257r240b1327],
32	[	CD	NUMBER	[	number	33	SENT_64	[p5l270t1257r402b1345],
33	8	CD	NUMBER	8	num	34	SENT_64	[p5l270t1257r402b1345],
34	]	NN	O	]	dep	31	SENT_64	[p5l270t1257r402b1345],
35	.	.	O	.	_	0	SENT_64	[p5l270t1257r402b1345],

1	Glycoprotein	NN	O	glycoprotein	nn	3	SENT_65	[p5l432t1257r956b1345],
2	Illa	NN	O	illum	nn	3	SENT_65	[p5l985t1259r1100b1327],
3	polymorphism	NN	O	polymorphism	nsubj	4	SENT_65	[p5l1124t1257r1693b1345],
4	influenced	VBD	O	influence	_	0	SENT_65	[p5l1718t1257r2147b1327],
5	also	RB	O	also	advmod	4	SENT_65	[p5l9t1369r166b1441],
6	BT	NNP	O	BT	nn	7	SENT_65	[p5l206t1371r307b1440],
7	changes	NNS	O	change	dobj	4	SENT_65	[p5l329t1369r656b1459],
8	after	IN	O	after	_	0	SENT_65	[p5l692t1369r895b1441],
9	aspirin	NN	O	aspirin	prep_after	4	SENT_65	[p5l929t1371r1225b1459],
10	.	.	O	.	_	0	SENT_65	[p5l929t1371r1225b1459],

1	The	DT	O	the	det	2	SENT_66	[p5l1267t1369r1420b1441],
2	drug	NN	O	drug	nsubj	4	SENT_66	[p5l1456t1369r1635b1459],
3	was	VBD	O	be	cop	4	SENT_66	[p5l1670t1389r1823b1441],
4	able	JJ	O	able	_	0	SENT_66	[p5l1859t1369r2031b1441],
5	to	TO	O	to	aux	6	SENT_66	[p5l2069t1377r2150b1441],
6	prolong	VB	O	prolong	xcomp	4	SENT_66	[p5l12t1482r316b1570],
7	BT	NNP	O	BT	dobj	6	SENT_66	[p5l350t1483r451b1551],
8	only	RB	O	only	advmod	6	SENT_66	[p5l468t1482r640b1570],
9	in	IN	O	in	_	0	SENT_66	[p5l669t1483r737b1551],
10	PlA1-positive	JJ	O	pla1-positive	amod	11	SENT_66	[p5l775t1482r1305b1570],
11	patients	NNS	O	patient	prep_in	6	SENT_66	[p5l1340t1483r1696b1570],
12	.	.	O	.	_	0	SENT_66	[p5l1340t1483r1696b1570],

1	It	PRP	O	it	nsubj	4	SENT_67	[p5l1741t1483r1793b1552],
2	must	MD	O	must	aux	4	SENT_67	[p5l1826t1488r2022b1552],
3	be	VB	O	be	cop	4	SENT_67	[p5l2055t1482r2150b1552],
4	stressed	JJ	O	stressed	_	0	SENT_67	[p5l9t1594r367b1681],
5	,	,	O	,	_	0	SENT_67	[p5l9t1594r367b1681],
6	however	RB	O	however	advmod	4	SENT_67	[p5l406t1594r764b1681],
7	,	,	O	,	_	0	SENT_67	[p5l406t1594r764b1681],
8	that	IN	O	that	complm	16	SENT_67	[p5l802t1594r970b1666],
9	the	DT	O	the	det	10	SENT_67	[p5l999t1594r1133b1666],
10	number	NN	O	number	nsubj	16	SENT_67	[p5l1164t1594r1475b1666],
11	of	IN	O	of	_	0	SENT_67	[p5l1502t1594r1584b1666],
12	PlA2	NN	O	pla2	nn	13	SENT_67	[p5l1614t1594r1785b1666],
13	patients	NNS	O	patient	prep_of	10	SENT_67	[p5l1819t1596r2150b1684],
14	was	VBD	O	be	cop	16	SENT_67	[p5l7t1725r160b1776],
15	low	JJ	O	low	advmod	16	SENT_67	[p5l188t1706r328b1776],
16	due	JJ	O	due	conj_and	16	SENT_67	[p5l349t1706r498b1776],
17	to	TO	O	to	_	0	SENT_67	[p5l523t1713r605b1776],
18	the	DT	O	the	det	19	SENT_67	[p5l629t1706r763b1776],
19	randomization	NN	O	randomization	prep_to	16	SENT_67	[p5l790t1706r1374b1776],
20	and	CC	O	and	_	0	SENT_67	[p5l1402t1706r1546b1776],
21	for	IN	O	for	_	0	SENT_67	[p5l1572t1706r1691b1776],
22	this	DT	O	this	det	23	SENT_67	[p5l1712t1706r1858b1776],
23	reason	NN	O	reason	prep_for	16	SENT_67	[p5l1886t1725r2147b1776],
24	the	DT	O	the	det	25	SENT_67	[p5l9t1819r143b1889],
25	result	NN	O	result	nsubjpass	28	SENT_67	[p5l190t1819r420b1889],
26	should	MD	O	should	aux	28	SENT_67	[p5l464t1819r723b1889],
27	be	VB	O	be	auxpass	28	SENT_67	[p5l772t1819r867b1889],
28	taken	VBN	O	take	rcmod	23	SENT_67	[p5l911t1819r1136b1889],
29	with	IN	O	with	_	0	SENT_67	[p5l1181t1819r1358b1889],
30	caution	NN	O	caution	prep_with	28	SENT_67	[p5l1405t1820r1734b1889],
31	.	.	O	.	_	0	SENT_67	[p5l1405t1820r1734b1889],

1	Yet	RB	O	yet	advmod	22	SENT_68	[p5l1784t1821r1939b1905],
2	,	,	O	,	_	0	SENT_68	[p5l1784t1821r1939b1905],
3	in	IN	O	in	_	0	SENT_68	[p5l1991t1820r2059b1888],
4	a	DT	O	a	det	6	SENT_68	[p5l2106t1838r2149b1889],
5	larger	JJR	O	larger	amod	6	SENT_68	[p5l13t1931r252b2021],
6	group	NN	O	group	prep_in	22	SENT_68	[p5l280t1949r509b2021],
7	of	IN	O	of	_	0	SENT_68	[p5l541t1931r623b2003],
8	healthy	JJ	O	healthy	amod	9	SENT_68	[p5l653t1931r957b2021],
9	subjects	NNS	O	subject	prep_of	6	SENT_68	[p5l986t1931r1351b2021],
10	,	,	O	,	_	0	SENT_68	[p5l986t1931r1351b2021],
11	prolongation	NN	O	prolongation	nsubj	22	SENT_68	[p5l1392t1931r1905b2021],
12	of	IN	O	of	_	0	SENT_68	[p5l1938t1931r2021b2003],
13	BT	NNP	O	BT	prep_of	11	SENT_68	[p5l2052t1933r2152b2002],
14	after	IN	O	after	mark	18	SENT_68	[p5l9t2044r213b2115],
15	aspirin	NN	O	aspirin	nsubj	18	SENT_68	[p5l234t2046r501b2134],
16	was	VBD	O	be	cop	18	SENT_68	[p5l525t2063r678b2116],
17	less	RBR	O	less	advmod	18	SENT_68	[p5l704t2044r847b2115],
18	pronounced	JJ	O	pronounced	dep	13	SENT_68	[p5l873t2044r1349b2134],
19	in	IN	O	in	_	0	SENT_68	[p5l1375t2046r1444b2115],
20	PlA2	NN	O	pla2	nn	21	SENT_68	[p5l1474t2044r1646b2115],
21	carriers	NNS	O	carrier	prep_in	18	SENT_68	[p5l1670t2046r1981b2115],
22	[	VBP	O	[	_	0	SENT_68	[p5l2010t2044r2141b2134],
23	6	CD	NUMBER	6	num	24	SENT_68	[p5l2010t2044r2141b2134],
24	]	NN	O	]	dobj	22	SENT_68	[p5l2010t2044r2141b2134],
25	.	.	O	.	_	0	SENT_68	[p5l2010t2044r2141b2134],

1	Initiation	NN	O	initiation	nsubjpass	11	SENT_69	[p5l127t2158r494b2227],
2	of	IN	O	of	_	0	SENT_69	[p5l538t2157r620b2227],
3	the	DT	O	the	det	5	SENT_69	[p5l657t2157r791b2227],
4	coagulation	NN	O	coagulation	nn	5	SENT_69	[p5l831t2157r1307b2245],
5	cascade	NN	O	cascade	prep_of	1	SENT_69	[p5l1351t2157r1676b2227],
6	and	CC	O	and	_	0	SENT_69	[p5l1717t2157r1861b2227],
7	platelet	NN	O	platelet	nn	8	SENT_69	[p5l1906t2157r2145b2245, p5l13t2269r119b2341],
8	activation	NN	O	activation	conj_and	5	SENT_69	[p5l162t2271r572b2341],
9	are	VBP	O	be	auxpass	11	SENT_69	[p5l617t2289r748b2341],
10	closely	RB	O	closely	advmod	11	SENT_69	[p5l789t2269r1073b2359],
11	linked	VBN	O	link	_	0	SENT_69	[p5l1115t2269r1359b2341],
12	events	NNS	O	event	dobj	11	SENT_69	[p5l1403t2276r1699b2356],
13	,	,	O	,	_	0	SENT_69	[p5l1403t2276r1699b2356],
14	cooperating	VBG	O	cooperate	partmod	11	SENT_69	[p5l1748t2277r2145b2359, p5l9t2383r128b2470],
15	in	IN	O	in	_	0	SENT_69	[p5l171t2383r240b2451],
16	the	DT	O	the	det	17	SENT_69	[p5l286t2382r420b2452],
17	formation	NN	O	formation	prep_in	14	SENT_69	[p5l462t2382r866b2452],
18	of	IN	O	of	_	0	SENT_69	[p5l912t2382r995b2452],
19	thrombin	NN	O	thrombin	prep_of	17	SENT_69	[p5l1035t2382r1437b2452],
20	.	.	O	.	_	0	SENT_69	[p5l1035t2382r1437b2452],

1	Replacement	NN	O	replacement	nsubj	6	SENT_70	[p5l1492t2382r2027b2470],
2	of	IN	O	of	_	0	SENT_70	[p5l2070t2382r2153b2452],
3	leucine	NN	O	leucine	prep_of	1	SENT_70	[p5l13t2494r308b2566],
4	with	IN	O	with	_	0	SENT_70	[p5l345t2494r524b2566],
5	proline	NN	O	proline	prep_with	3	SENT_70	[p5l569t2494r856b2584],
6	alters	VBZ	O	alter	_	0	SENT_70	[p5l896t2494r1128b2566],
7	conformation	NN	O	conformation	dobj	6	SENT_70	[p5l1168t2494r1719b2566],
8	of	IN	O	of	_	0	SENT_70	[p5l1762t2494r1844b2566],
9	GP	NN	O	gp	nn	10	SENT_70	[p5l1881t2495r1989b2566],
10	Illa	NN	PERSON	illum	prep_of	7	SENT_70	[p5l2034t2496r2149b2566],
11	and	CC	O	and	_	0	SENT_70	[p5l9t2608r152b2679],
12	spatial	JJ	O	spatial	amod	13	SENT_70	[p5l213t2608r485b2698],
13	orientation	NN	O	orientation	dobj	6	SENT_70	[p5l542t2610r1000b2679],
14	of	IN	O	of	_	0	SENT_70	[p5l1061t2608r1143b2679],
15	the	DT	O	the	det	17	SENT_70	[p5l1197t2608r1330b2679],
16	fibrinogen-binding	JJ	O	fibrinogen-binding	amod	17	SENT_70	[p5l1388t2608r2149b2698],
17	region	NN	O	region	prep_of	13	SENT_70	[p5l13t2721r283b2808],
18	[	CD	NUMBER	[	number	19	SENT_70	[p5l365t2720r562b2808],
19	11	CD	NUMBER	11	num	20	SENT_70	[p5l365t2720r562b2808],
20	]	NN	O	]	dep	13	SENT_70	[p5l365t2720r562b2808],
21	.	.	O	.	_	0	SENT_70	[p5l365t2720r562b2808],

1	Thus	RB	O	thus	advmod	6	SENT_71	[p5l642t2720r875b2806],
2	,	,	O	,	_	0	SENT_71	[p5l642t2720r875b2806],
3	the	DT	O	the	det	5	SENT_71	[p5l956t2720r1098b2790],
4	PlA2-expressing	JJ	O	pla2-expressing	amod	5	SENT_71	[p5l1174t2720r1877b2808],
5	cells	NNS	O	cell	nsubj	10	SENT_71	[p5l1949t2720r2150b2790],
6	exhibited	VBD	O	exhibit	_	0	SENT_71	[p5l9t2832r395b2904],
7	increased	VBN	O	increase	amod	8	SENT_71	[p5l440t2832r832b2904],
8	adhesion	NN	O	adhesion	dobj	6	SENT_71	[p5l876t2832r1264b2919],
9	,	,	O	,	_	0	SENT_71	[p5l876t2832r1264b2919],
10	enhanced	VBD	O	enhance	conj_and	6	SENT_71	[p5l1314t2832r1709b2904],
11	spreading	VBG	O	spread	xcomp	10	SENT_71	[p5l1752t2832r2150b2922],
12	more	RBR	O	more	advmod	13	SENT_71	[p5l12t2964r219b3016],
13	extensive	JJ	O	extensive	amod	15	SENT_71	[p5l252t2947r646b3017],
14	actin	NN	O	actin	nn	15	SENT_71	[p5l680t2947r880b3016],
15	polymerization	NN	O	polymerization	dobj	11	SENT_71	[p5l921t2945r1534b3035],
16	and	CC	O	and	_	0	SENT_71	[p5l1572t2945r1715b3016],
17	enhanced	VBD	O	enhance	conj_and	6	SENT_71	[p5l1752t2945r2146b3016],
18	fibrin	JJ	O	fibrin	amod	20	SENT_71	[p5l8t3058r227b3128],
19	clot	NNS	O	clot	nn	20	SENT_71	[p5l281t3058r437b3128],
20	retraction	NN	O	retraction	dobj	17	SENT_71	[p5l490t3059r929b3144],
21	,	,	O	,	_	0	SENT_71	[p5l490t3059r929b3144],
22	reflecting	VBG	O	reflect	conj_and	6	SENT_71	[p5l990t3058r1390b3146],
23	PlA2-related	JJ	O	pla2-related	amod	24	SENT_71	[p5l1444t3058r1954b3128],
24	differences	NNS	O	difference	dobj	22	SENT_71	[p5l2008t3058r2145b3128, p5l8t3170r362b3242],
25	in	IN	O	in	_	0	SENT_71	[p5l416t3172r485b3241],
26	outside-in	JJ	O	outside-in	amod	27	SENT_71	[p5l541t3170r950b3242],
27	signaling	NN	O	signaling	prep_in	22	SENT_71	[p5l1006t3170r1363b3260],
28	[	CD	NUMBER	[	number	29	SENT_71	[p5l1423t3170r1604b3260],
29	12	CD	NUMBER	12	num	30	SENT_71	[p5l1423t3170r1604b3260],
30	]	NN	O	]	dep	22	SENT_71	[p5l1423t3170r1604b3260],
31	.	.	O	.	_	0	SENT_71	[p5l1423t3170r1604b3260],

1	Aspirin	NN	O	aspirin	nsubjpass	3	SENT_72	[p5l1663t3171r1942b3260],
2	was	VBD	O	be	auxpass	3	SENT_72	[p5l1996t3190r2150b3242],
3	found	VBN	O	find	_	0	SENT_72	[p5l8t3283r240b3353],
4	to	TO	O	to	aux	5	SENT_72	[p5l275t3290r356b3353],
5	decrease	VB	O	decrease	xcomp	3	SENT_72	[p5l389t3283r757b3353],
6	thrombin	NN	O	thrombin	nn	7	SENT_72	[p5l789t3283r1162b3353],
7	generation	NN	O	generation	dobj	5	SENT_72	[p5l1198t3284r1640b3371],
8	in	FW	O	in	nn	9	SENT_72	[p5l1676t3284r1745b3352],
9	vitro	FW	O	vitro	advmod	5	SENT_72	[p5l1777t3284r1971b3353],
10	and	CC	O	and	advmod	5	SENT_72	[p5l2003t3283r2146b3353],

1	Antithrombotic	JJ	O	antithrombotic	amod	2	SENT_73	[p5l96t3446r375b3478],
2	effects	NNS	O	effect	_	0	SENT_73	[p5l391t3446r518b3478],
3	of	IN	O	of	_	0	SENT_73	[p5l534t3446r570b3478],
4	aspirin	NN	O	aspirin	prep_of	2	SENT_73	[p5l585t3447r704b3486],
5	based	VBN	O	base	_	0	SENT_73	[p5l723t3446r824b3478],
6	on	IN	O	on	prepc_based_on	2	SENT_73	[p5l842t3455r883b3478],
7	PLA1/A2	NN	O	pla1/a2	nn	10	SENT_73	[p5l902t3446r1055b3478],
8	glycoprotein	NN	O	glycoprotein	nn	10	SENT_73	[p5l1072t3446r1298b3486],
9	Illa	NN	PERSON	illum	nn	10	SENT_73	[p5l1318t3447r1368b3478],
10	polymorphism	NN	O	polymorphism	pobj	2	SENT_73	[p5l1386t3446r1639b3486],
11	in	IN	O	in	_	0	SENT_73	[p5l1657t3447r1687b3478],
12	patients	NNS	O	patient	prep_in	10	SENT_73	[p5l1706t3447r1853b3486],
13	303	CD	NUMBER	303	dep	12	SENT_73	[p5l2001t3446r2061b3478],

1	Mean	NN	O	mean	_	0	SENT_74	[p5l924t3544r999b3567],
2	+	CC	O	+	_	0	SENT_74	[p5l1011t3548r1026b3564],
3	95	CD	PERCENT	95	num	4	SENT_74	[p5l1037t3544r1096b3568],
4	%	NN	PERCENT	%	conj_+	1	SENT_74	[p5l1037t3544r1096b3568],
5	CI	NN	O	ci	dep	1	SENT_74	[p5l1108t3544r1136b3567],

1	Aspirin	NN	O	aspirin	_	0	SENT_75	[p5l976t3588r1080b3617],

1	A1IA2	NN	O	a1ia2	_	0	SENT_76	[p6l1101t75r1195b103],
2	,	,	O	,	_	0	SENT_76	[p6l1101t75r1195b103],
3	A2lA2	NN	O	a2la2	appos	1	SENT_76	[p6l1205t75r1291b98],

1	F1	NN	O	f1	_	0	SENT_77	[p6l488t322r511b389],
2	+2	CD	NUMBER	+2	number	3	SENT_77	[p6l488t322r511b389],
3	[	CD	NUMBER	[	num	4	SENT_77	[p6l488t228r517b301],
4	nmol	NN	O	nmol	dep	1	SENT_77	[p6l488t228r517b301],
5	I	PRP	O	I	dep	1	SENT_77	[p6l488t209r511b218],
6	I	PRP	O	I	nsubj	7	SENT_77	[p6l488t187r517b199],
7	]	VBP	O	]	rcmod	1	SENT_77	[p6l488t187r517b199],
8	l	NN	O	l	tmod	7	SENT_77	[p6l538t367r552b390],
9	\	CD	NUMBER	\	number	10	SENT_77	[p6l538t367r552b390],
10	)	CD	NUMBER	)	num	11	SENT_77	[p6l538t367r552b390],
11	(	NN	O	(	dobj	7	SENT_77	[p6l538t280r553b302],
12	.	.	O	.	_	0	SENT_77	[p6l538t280r553b302],

1	o	NN	O	o	_	0	SENT_78	[p6l538t280r553b302],
2	-	:	O	-	_	0	SENT_78	[p6l537t192r553b216],
3	h	NN	O	h	nn	6	SENT_78	[p6l537t192r553b216],
4	C	NN	O	c	nn	6	SENT_78	[p6l555t367r570b390],
5	O	NN	O	o	nn	6	SENT_78	[p6l555t280r570b302],
6	O	NN	O	o	dep	1	SENT_78	[p6l555t193r570b216],
7	_	CD	NUMBER	_	number	8	SENT_78	[p6l540t454r549b476],
8	\	CD	NUMBER	\	num	10	SENT_78	[p6l540t454r549b476],
9	O	NN	O	o	nn	10	SENT_78	[p6l556t541r571b564],
10	O	NN	O	o	dep	6	SENT_78	[p6l555t454r570b477],

1	-	:	O	-	_	0	SENT_79	[p6l1524t513r1564b532],
2	o	NN	O	o	npadvmod	6	SENT_79	[p6l1524t513r1564b532],
3	--	:	O	--	_	0	SENT_79	[p6l1524t513r1564b532],
4	Before	IN	O	before	dep	2	SENT_79	[p6l1584t510r1672b533],
5	30	CD	NUMBER	30	pobj	4	SENT_79	[p6l604t566r636b589],
6	so	RB	O	so	dep	7	SENT_79	[p6l675t566r708b589],
7	90 120150180	CD	NUMBER	90 120150180	_	0	SENT_79	[p6l814t566r1006b589],[p6l748t566r780b589],
8	30	CD	NUMBER	30	number	9	SENT_79	[p6l1059t566r1091b589],
9	60 90 120150180	CD	NUMBER	60 90 120150180	num	11	SENT_79	[p6l1269t566r1462b589],[p6l1131t566r1164b589],
10	*	NN	O	*	nn	11	SENT_79	[p6l1523t557r1647b580],
11	Aﬂer	NN	O	aﬂer	dep	7	SENT_79	[p6l1523t557r1647b580],

1	Time	NNP	O	Time	_	0	SENT_80	[p6l920t622r990b646],
2	[	JJ	O	[	amod	3	SENT_80	[p6l1002t622r1144b651],
3	seconds	NNS	DURATION	seconds	dep	1	SENT_80	[p6l1002t622r1144b651],
4	]	IN	O	]	amod	3	SENT_80	[p6l1002t622r1144b651],

1	Figure	NNP	O	Figure	nsubj	11	SENT_81	[p6l99t692r206b727],
2	1	CD	NUMBER	1	num	4	SENT_81	[p6l221t692r231b720],
3	Thrombin	NN	O	thrombin	nn	4	SENT_81	[p6l288t691r443b720],
4	generation	NN	O	generation	npadvmod	5	SENT_81	[p6l456t692r631b727],
5	before	IN	O	before	advmod	11	SENT_81	[p6l645t691r751b720],
6	and	CC	O	and	_	0	SENT_81	[p6l762t691r819b720],
7	after	IN	O	after	advmod	11	SENT_81	[p6l832t691r913b720],
8	aspirin	NN	O	aspirin	pobj	7	SENT_81	[p6l923t692r1042b727],
9	,	,	O	,	_	0	SENT_81	[p6l923t692r1042b727],
10	as	RB	O	as	advmod	8	SENT_81	[p6l1057t699r1089b720],
11	expressed	VBN	O	express	_	0	SENT_81	[p6l1100t691r1262b727],
12	by	IN	O	by	_	0	SENT_81	[p6l1275t691r1312b727],
13	the	DT	O	the	det	15	SENT_81	[p6l1322t691r1375b720],
14	increasing	VBG	O	increase	amod	15	SENT_81	[p6l1387t692r1552b727],
15	concentrations	NNS	O	concentration	prep_by	11	SENT_81	[p6l1563t692r1807b720],
16	of	IN	O	of	_	0	SENT_81	[p6l1819t691r1851b720],
17	F1	NN	O	f1	prep_of	15	SENT_81	[p6l1863t692r1893b719],
18	+2	CD	NUMBER	+2	num	17	SENT_81	[p6l1906t691r1946b719],
19	in	IN	O	in	_	0	SENT_81	[p6l1958t692r1985b719],
20	30-5	CD	NUMBER	30-5	prep_in	17	SENT_81	[p6l1999t691r2063b720],

1	intervals	NNS	O	interval	_	0	SENT_82	[p6l7t749r351b814],
2	.	.	O	.	_	0	SENT_82	[p6l7t749r351b814],

1	in	FW	O	in	dep	5	SENT_83	[p6l7t970r76b1039],
2	vivo	FW	O	vivo	nn	3	SENT_83	[p6l138t970r304b1040],
3	[	FW	O	[	pobj	1	SENT_83	[p6l371t969r471b1058],
4	7	CD	NUMBER	7	num	5	SENT_83	[p6l371t969r471b1058],
5	]	NN	O	]	csubj	17	SENT_83	[p6l371t969r471b1058],
6	and	CC	O	and	_	0	SENT_83	[p6l540t969r684b1040],
7	inhibit	VBP	O	inhibit	csubj	17	SENT_83	[p6l748t969r1015b1040],
8	GP	NN	O	gp	nn	10	SENT_83	[p6l1076t970r1184b1040],
9	Ilb/Illa	NN	O	ilb/illa	nn	10	SENT_83	[p6l1252t969r1519b1040],
10	activation	NN	O	activation	dobj	7	SENT_83	[p6l1581t970r1991b1040],
11	by	IN	O	by	_	0	SENT_83	[p6l2060t969r2152b1058],
12	interfering	VBG	O	interfere	prepc_by	7	SENT_83	[p6l7t1081r451b1171],
13	with	IN	O	with	_	0	SENT_83	[p6l486t1081r664b1153],
14	intracellular	JJ	O	intracellular	amod	16	SENT_83	[p6l705t1081r1218b1153],
15	signaling	NN	O	signaling	nn	16	SENT_83	[p6l1252t1081r1611b1171],
16	events	NNS	O	event	prep_with	12	SENT_83	[p6l1647t1089r1917b1153],
17	[	VBP	O	[	_	0	SENT_83	[p6l1960t1081r2141b1171],
18	13	CD	NUMBER	13	num	19	SENT_83	[p6l1960t1081r2141b1171],
19	]	CD	NUMBER	]	dobj	17	SENT_83	[p6l1960t1081r2141b1171],
20	.	.	O	.	_	0	SENT_83	[p6l1960t1081r2141b1171],

1	All	DT	O	all	det	2	SENT_84	[p6l117t1194r224b1265],
2	observations	NNS	O	observation	nsubj	19	SENT_84	[p6l254t1194r774b1265],
3	suggesting	VBG	O	suggest	partmod	2	SENT_84	[p6l803t1196r1232b1284],
4	that	IN	O	that	complm	11	SENT_84	[p6l1262t1194r1431b1265],
5	the	DT	O	the	det	7	SENT_84	[p6l1461t1194r1595b1265],
6	PlA2	NN	O	pla2	nn	7	SENT_84	[p6l1629t1194r1801b1265],
7	allele	NN	O	allele	nsubj	11	SENT_84	[p6l1833t1194r2061b1265],
8	is	VBZ	O	be	cop	11	SENT_84	[p6l2091t1196r2150b1265],
9	a	DT	O	a	det	11	SENT_84	[p6l7t1326r50b1377],
10	risk	NN	O	risk	nn	11	SENT_84	[p6l90t1307r230b1377],
11	factor	NN	O	factor	ccomp	3	SENT_84	[p6l262t1307r513b1377],
12	for	IN	O	for	_	0	SENT_84	[p6l546t1307r663b1377],
13	arterial	JJ	O	arterial	amod	14	SENT_84	[p6l696t1307r1003b1377],
14	thrombosis	NN	O	thrombosis	prep_for	11	SENT_84	[p6l1040t1307r1491b1377],
15	rather	RB	O	rather	_	0	SENT_84	[p6l1529t1307r1783b1377],
16	than	IN	O	than	_	0	SENT_84	[p6l1816t1307r1996b1377],
17	for	IN	O	for	_	0	SENT_84	[p6l2034t1307r2152b1377],
18	atherosclerosis	NN	O	atherosclerosis	prep_for	11	SENT_84	[p6l7t1419r648b1491],
19	led	VBD	O	lead	_	0	SENT_84	[p6l719t1419r841b1491],
20	to	TO	O	to	_	0	SENT_84	[p6l912t1426r996b1491],
21	the	DT	O	the	det	22	SENT_84	[p6l1063t1419r1201b1491],
22	concept	NN	O	concept	prep_to	19	SENT_84	[p6l1268t1426r1606b1509],
23	that	IN	O	that	complm	30	SENT_84	[p6l1675t1419r1849b1491],
24	Pro33	NN	O	pro33	nn	25	SENT_84	[p6l1920t1420r2147b1491],
25	substitution	NN	O	substitution	nsubj	30	SENT_84	[p6l7t1533r494b1604],
26	in	IN	O	in	_	0	SENT_84	[p6l537t1534r605b1603],
27	beta3	NN	O	beta3	nn	28	SENT_84	[p6l650t1533r879b1604],
28	integrin	NN	O	integrin	prep_in	25	SENT_84	[p6l921t1534r1240b1622],
29	may	MD	O	may	aux	30	SENT_84	[p6l1285t1552r1451b1622],
30	induce	VB	O	induce	ccomp	19	SENT_84	[p6l1489t1533r1761b1604],
31	a	DT	O	a	det	33	SENT_84	[p6l1801t1552r1844b1604],
32	hypercoagulable	JJ	O	hypercoagulable	amod	33	SENT_84	[p6l1886t1533r2145b1622, p6l7t1645r466b1735],
33	state	NN	O	state	dobj	30	SENT_84	[p6l534t1652r774b1732],
34	,	,	O	,	_	0	SENT_84	[p6l534t1652r774b1732],
35	most	RBS	O	most	advmod	36	SENT_84	[p6l853t1653r1052b1717],
36	likely	RB	O	likely	rcmod	33	SENT_84	[p6l1124t1645r1350b1735],
37	through	IN	O	through	dep	36	SENT_84	[p6l1416t1645r1740b1735],
38	platelet	NN	O	platelet	nn	39	SENT_84	[p6l1815t1645r2150b1735],
39	hyperaggregability	NN	O	hyperaggregability	pobj	37	SENT_84	[p6l10t1759r797b1849],
40	.	.	O	.	_	0	SENT_84	[p6l10t1759r797b1849],

1	However	RB	O	however	advmod	19	SENT_85	[p6l844t1761r1215b1846],
2	,	,	O	,	_	0	SENT_85	[p6l844t1761r1215b1846],
3	the	DT	O	the	det	5	SENT_85	[p6l1258t1759r1392b1830],
4	exact	JJ	O	exact	amod	5	SENT_85	[p6l1427t1766r1653b1830],
5	mechanism	NN	O	mechanism	nsubj	19	SENT_85	[p6l1690t1759r2147b1830],
6	by	IN	O	by	_	0	SENT_85	[p6l10t1872r102b1961],
7	which	WDT	O	which	rel	10	SENT_85	[p6l148t1872r387b1943],
8	PlA1A2	NN	O	pla1a2	nn	9	SENT_85	[p6l444t1872r720b1943],
9	polymorphism	NN	O	polymorphism	nsubj	10	SENT_85	[p6l776t1872r1350b1961],
10	influences	VBZ	O	influence	rcmod	5	SENT_85	[p6l1404t1872r1825b1943],
11	aspirin	NN	O	aspirin	nn	12	SENT_85	[p6l1876t1873r2146b1961],
12	effect	NN	O	effect	dobj	10	SENT_85	[p6l7t1984r262b2056],
13	of	IN	O	of	_	0	SENT_85	[p6l329t1984r412b2056],
14	thrombin-generation	NN	O	thrombin-generation	nn	15	SENT_85	[p6l477t1984r1356b2074],
15	markers	NNS	O	marker	prep_of	12	SENT_85	[p6l1430t1984r1764b2056],
16	and	CC	O	and	_	0	SENT_85	[p6l1831t1984r1976b2056],
17	BT	NNP	O	BT	prep_of	12	SENT_85	[p6l2051t1986r2152b2055],
18	remains	VBZ	O	remain	cop	19	SENT_85	[p6l10t2099r336b2168],
19	unknown	JJ	O	unknown	_	0	SENT_85	[p6l404t2097r799b2168],
20	.	.	O	.	_	0	SENT_85	[p6l404t2097r799b2168],

1	It	PRP	O	it	nsubjpass	4	SENT_86	[p6l880t2099r933b2168],
2	could	MD	O	could	aux	4	SENT_86	[p6l999t2097r1220b2168],
3	be	VB	O	be	auxpass	4	SENT_86	[p6l1293t2097r1387b2168],
4	speculated	VBN	O	speculate	_	0	SENT_86	[p6l1455t2097r1908b2187],
5	that	IN	O	that	complm	9	SENT_86	[p6l1978t2097r2150b2168],
6	PlA2	NN	O	pla2	nn	7	SENT_86	[p6l10t2211r187b2282],
7	allele	NN	O	allele	nsubj	9	SENT_86	[p6l256t2211r490b2282],
8	might	MD	O	might	aux	9	SENT_86	[p6l559t2211r796b2300],
9	affect	VB	O	affect	ccomp	4	SENT_86	[p6l863t2211r1115b2282],
10	the	DT	O	the	det	11	SENT_86	[p6l1182t2211r1318b2282],
11	formation	NN	O	formation	dobj	9	SENT_86	[p6l1385t2211r1797b2282],
12	of	IN	O	of	_	0	SENT_86	[p6l1867t2211r1950b2282],
13	the	DT	O	the	det	15	SENT_86	[p6l2014t2211r2151b2282],
14	prothrombinase	NN	O	prothrombinase	nn	15	SENT_86	[p6l10t2323r660b2413],
15	complex	NN	O	complex	prep_of	11	SENT_86	[p6l707t2323r1056b2413],
16	on	IN	O	on	_	0	SENT_86	[p6l1101t2343r1194b2395],
17	platelets	NNS	O	platelet	prep_on	9	SENT_86	[p6l1246t2323r1610b2413],
18	and	CC	O	and	_	0	SENT_86	[p6l1657t2323r1829b2410],
19	,	,	O	,	_	0	SENT_86	[p6l1657t2323r1829b2410],
20	consequently	RB	O	consequently	dep	17	SENT_86	[p6l1884t2343r2144b2395, p6l7t2437r334b2526],
21	,	,	O	,	_	0	SENT_86	[p6l1884t2343r2144b2395, p6l7t2437r334b2526],
22	thrombin-mediated	JJ	O	thrombin-mediated	amod	24	SENT_86	[p6l377t2437r1182b2508],
23	coagulation	NN	O	coagulation	nn	24	SENT_86	[p6l1220t2437r1697b2526],
24	reactions	NNS	O	reaction	prep_on	9	SENT_86	[p6l1739t2438r2140b2508],
25	.	.	O	.	_	0	SENT_86	[p6l1739t2438r2140b2508],

1	Platelet	NN	O	platelet	nn	2	SENT_87	[p6l10t2549r335b2621],
2	GP	NN	O	gp	nsubjpass	8	SENT_87	[p6l375t2550r483b2621],
3	Illa	NN	PERSON	illum	nn	4	SENT_87	[p6l529t2551r644b2621],
4	polymorphism	NN	O	polymorphism	dep	2	SENT_87	[p6l687t2549r1260b2639],
5	could	MD	O	could	aux	8	SENT_87	[p6l1303t2549r1521b2621],
6	be	VB	O	be	auxpass	8	SENT_87	[p6l1567t2549r1662b2621],
7	also	RB	O	also	advmod	8	SENT_87	[p6l1701t2549r1860b2621],
8	linked	VBN	O	link	_	0	SENT_87	[p6l1903t2549r2146b2621],
9	to	TO	O	to	_	0	SENT_87	[p6l7t2669r89b2733],
10	a	DT	O	a	det	14	SENT_87	[p6l131t2681r174b2733],
11	yet	RB	O	yet	advmod	12	SENT_87	[p6l213t2669r345b2752],
12	unknown	JJ	O	unknown	amod	14	SENT_87	[p6l389t2662r749b2733],
13	allelic	JJ	O	allelic	amod	14	SENT_87	[p6l795t2662r1044b2733],
14	variant	NN	O	variant	prep_to	8	SENT_87	[p6l1084t2664r1377b2733],
15	that	WDT	O	that	nsubj	16	SENT_87	[p6l1419t2662r1588b2733],
16	accounts	VBZ	O	account	rcmod	14	SENT_87	[p6l1630t2669r1993b2733],
17	for	IN	O	for	_	0	SENT_87	[p6l2034t2662r2152b2733],
18	the	DT	O	the	det	19	SENT_87	[p6l7t2776r141b2847],
19	alterations	NNS	O	alteration	prep_for	16	SENT_87	[p6l182t2776r629b2847],
20	in	IN	O	in	_	0	SENT_87	[p6l670t2777r738b2846],
21	blood	NN	O	blood	nn	22	SENT_87	[p6l784t2776r1005b2847],
22	coagulation	NN	O	coagulation	prep_in	19	SENT_87	[p6l1048t2776r1553b2865],
23	.	.	O	.	_	0	SENT_87	[p6l1048t2776r1553b2865],

1	Limited	JJ	O	limited	amod	3	SENT_88	[p6l1606t2776r1912b2847],
2	aspirin	NN	O	aspirin	nn	3	SENT_88	[p6l1956t2777r2144b2865, p6l10t2890r112b2959],
3	effectiveness	NN	O	effectiveness	nsubj	12	SENT_88	[p6l149t2888r700b2960],
4	in	IN	O	in	_	0	SENT_88	[p6l734t2890r803b2959],
5	patients	NNS	O	patient	prep_in	3	SENT_88	[p6l842t2890r1177b2978],
6	with	IN	O	with	_	0	SENT_88	[p6l1208t2888r1387b2960],
7	arterial	JJ	O	arterial	amod	8	SENT_88	[p6l1424t2888r1731b2960],
8	thrombosis	NN	O	thrombosis	prep_with	5	SENT_88	[p6l1766t2888r2145b2960, p6l7t3003r103b3072],
9	is	VBZ	O	be	cop	12	SENT_88	[p6l133t3003r192b3072],
10	certainly	RB	O	certainly	advmod	12	SENT_88	[p6l221t3001r589b3091],
11	multifactorial	JJ	O	multifactorial	amod	12	SENT_88	[p6l621t3001r1189b3072],
12	[	NN	O	[	_	0	SENT_88	[p6l1226t3001r1408b3091],
13	14	CD	NUMBER	14	num	14	SENT_88	[p6l1226t3001r1408b3091],
14	]	NN	O	]	dep	12	SENT_88	[p6l1226t3001r1408b3091],
15	.	.	O	.	_	0	SENT_88	[p6l1226t3001r1408b3091],

1	Perhaps	RB	O	perhaps	advmod	6	SENT_89	[p6l1449t3001r1766b3091],
2	P1A1/A2	NN	O	p1a1/a2	nn	3	SENT_89	[p6l1800t3002r2148b3072],
3	polymorphism	NN	O	polymorphism	nsubj	6	SENT_89	[p6l10t3115r583b3204],
4	may	MD	O	may	aux	6	SENT_89	[p6l626t3134r793b3204],
5	be	VB	O	be	cop	6	SENT_89	[p6l831t3115r926b3186],
6	one	CD	NUMBER	one	_	0	SENT_89	[p6l963t3134r1110b3186],
7	of	IN	O	of	_	0	SENT_89	[p6l1147t3115r1230b3186],
8	such	JJ	O	such	amod	9	SENT_89	[p6l1264t3115r1441b3186],
9	factors	NNS	O	factor	prep_of	6	SENT_89	[p6l1481t3115r1767b3186],
10	involved	VBN	O	involve	partmod	9	SENT_89	[p6l1805t3115r2146b3186],
11	in	IN	O	in	_	0	SENT_89	[p6l7t3228r76b3296],
12	aspirin	NN	O	aspirin	nn	13	SENT_89	[p6l116t3228r387b3315],
13	resistance	NN	O	resistance	prep_in	10	SENT_89	[p6l430t3228r871b3297],
14	.	.	O	.	_	0	SENT_89	[p6l430t3228r871b3297],

1	In	IN	O	in	_	0	SENT_90	[p6l125t3341r188b3410],
2	conclusion	NN	O	conclusion	prep_in	5	SENT_90	[p6l243t3340r702b3427],
3	,	,	O	,	_	0	SENT_90	[p6l243t3340r702b3427],
4	we	PRP	O	we	nsubj	5	SENT_90	[p6l759t3359r877b3411],
5	hypothesize	VBP	O	hypothesize	_	0	SENT_90	[p6l931t3340r1421b3429],
6	that	IN	O	that	complm	13	SENT_90	[p6l1473t3340r1643b3411],
7	genotyping	VBG	O	genotype	csubj	13	SENT_90	[p6l1695t3341r2149b3429],
8	for	IN	O	for	_	0	SENT_90	[p6l7t3452r125b3524],
9	glycoprotein	NN	O	glycoprotein	nn	11	SENT_90	[p6l177t3452r690b3542],
10	Illa	NN	PERSON	illum	nn	11	SENT_90	[p6l754t3454r868b3524],
11	polymorphism	NN	O	polymorphism	prep_for	7	SENT_90	[p6l926t3452r1500b3542],
12	might	MD	O	might	aux	13	SENT_90	[p6l1560t3452r1792b3542],
13	help	VB	O	help	ccomp	5	SENT_90	[p6l1849t3452r2022b3542],
14	in	IN	O	in	_	0	SENT_90	[p6l2078t3454r2147b3523],
15	predicting	VBG	O	predict	prepc_in	13	SENT_90	[p6l10t3566r428b3656],
16	antithrombotic	JJ	O	antithrombotic	amod	17	SENT_90	[p6l477t3566r1101b3637],
17	effectiveness	NN	O	effectiveness	dobj	15	SENT_90	[p6l1149t3566r1700b3637],
18	of	IN	O	of	_	0	SENT_90	[p6l1748t3566r1831b3637],
19	aspirin	NN	O	aspirin	prep_of	17	SENT_90	[p6l1876t3567r2146b3656],
20	in	IN	O	in	_	0	SENT_90	[p6l7t3680r76b3749],
21	secondary	JJ	O	secondary	amod	22	SENT_90	[p6l116t3679r532b3768],
22	prevention	NN	O	prevention	prep_in	15	SENT_90	[p6l570t3680r1012b3768],
23	of	IN	O	of	_	0	SENT_90	[p6l1052t3679r1134b3750],
24	CAD	NN	O	cad	prep_of	22	SENT_90	[p6l1169t3680r1357b3750],
25	.	.	O	.	_	0	SENT_90	[p6l1169t3680r1357b3750],

1	References	NNS	O	reference	_	0	SENT_91	[p7l12t144r589b229],

1	[	NN	O	[	nn	5	SENT_92	[p7l49t378r130b450],
2	1	CD	NUMBER	1	num	5	SENT_92	[p7l49t378r130b450],
3	]	CD	NUMBER	]	num	5	SENT_92	[p7l49t378r130b450],
4	Reginelli	NNP	PERSON	Reginelli	nn	5	SENT_92	[p7l181t378r463b450],
5	JP	NNP	O	JP	_	0	SENT_92	[p7l519t379r601b448],
6	,	,	O	,	_	0	SENT_92	[p7l519t379r601b448],
7	Topol	NNP	PERSON	Topol	nn	8	SENT_92	[p7l658t378r836b450],
8	EJ	NNP	O	EJ	appos	5	SENT_92	[p7l893t379r983b435],
9	.	.	O	.	_	0	SENT_92	[p7l893t379r983b435],

1	Glycoprotein	NN	O	glycoprotein	nn	3	SENT_93	[p7l1043t378r1473b450],
2	llb/Illa	NN	O	llb/illa	nn	3	SENT_93	[p7l1533t378r1751b435],
3	inhibitors	NNS	O	inhibitor	_	0	SENT_93	[p7l1806t378r2143b435],
4	:	:	O	:	_	0	SENT_93	[p7l1806t378r2143b435],
5	current	JJ	DATE	current	amod	6	SENT_93	[p7l178t477r429b528],
6	indications	NNS	O	indication	dep	3	SENT_93	[p7l484t471r857b528],
7	and	CC	O	and	_	0	SENT_93	[p7l912t471r1030b528],
8	future	JJ	DATE	future	amod	9	SENT_93	[p7l1086t471r1299b528],
9	prospects	NNS	O	prospects	dep	3	SENT_93	[p7l1355t477r1702b543],
10	.	.	O	.	_	0	SENT_93	[p7l1355t477r1702b543],

1	Am	VBP	O	be	_	0	SENT_94	[p7l1759t472r1868b528],
2	J	NN	O	j	nsubj	3	SENT_94	[p7l1919t473r1956b528],
3	Med	VBD	O	med	ccomp	1	SENT_94	[p7l2006t471r2150b528],
4	2000	CD	DATE	2000	dobj	3	SENT_94	[p7l178t566r740b634],
5	;	:	O	;	_	0	SENT_94	[p7l178t566r740b634],
6	109:252	CD	NUMBER	109:252	number	7	SENT_94	[p7l178t566r740b634],
7	—	CD	NUMBER	—	dep	4	SENT_94	[p7l178t566r740b634],
8	4	CD	NUMBER	4	dep	7	SENT_94	[p7l178t566r740b634],
9	.	.	O	.	_	0	SENT_94	[p7l178t566r740b634],

1	[	NN	O	[	nn	5	SENT_95	[p7l49t659r129b731],
2	2	CD	NUMBER	2	num	5	SENT_95	[p7l49t659r129b731],
3	]	CD	NUMBER	]	num	5	SENT_95	[p7l49t659r129b731],
4	Newman	NNP	ORGANIZATION	Newman	nn	5	SENT_95	[p7l178t660r456b716],
5	PJ	NNP	ORGANIZATION	PJ	_	0	SENT_95	[p7l507t660r599b729],
6	,	,	O	,	_	0	SENT_95	[p7l507t660r599b729],
7	Derbes	NNP	ORGANIZATION	Derbes	nn	8	SENT_95	[p7l656t659r877b716],
8	RS	NN	ORGANIZATION	r	appos	5	SENT_95	[p7l927t660r1021b729],
9	,	,	O	,	_	0	SENT_95	[p7l927t660r1021b729],
10	Aster	NN	O	aster	nn	11	SENT_95	[p7l1072t660r1246b716],
11	RH	NN	O	rh	appos	8	SENT_95	[p7l1294t660r1399b716],
12	.	.	O	.	_	0	SENT_95	[p7l1294t660r1399b716],

1	The	DT	O	the	det	4	SENT_96	[p7l1452t659r1574b716],
2	human	JJ	O	human	amod	4	SENT_96	[p7l1624t659r1839b716],
3	platelet	NN	O	platelet	nn	4	SENT_96	[p7l1892t659r2151b731],
4	alloantigens	NNS	O	alloantigen	nsubjpass	11	SENT_96	[p7l176t752r595b824],
5	,	,	O	,	_	0	SENT_96	[p7l176t752r595b824],
6	P1A1	NN	O	p1a1	appos	4	SENT_96	[p7l648t753r794b809],
7	and	CC	O	and	_	0	SENT_96	[p7l848t752r963b809],
8	PlA2	NN	O	pla2	conj_and	6	SENT_96	[p7l1012t752r1173b822],
9	,	,	O	,	_	0	SENT_96	[p7l1012t752r1173b822],
10	are	VBP	O	be	auxpass	11	SENT_96	[p7l1223t768r1328b809],
11	associated	VBN	O	associate	_	0	SENT_96	[p7l1371t752r1713b809],
12	with	IN	O	with	_	0	SENT_96	[p7l1757t752r1899b809],
13	a	DT	O	a	det	17	SENT_96	[p7l1945t768r1980b809],
14	leucine33/proline33	NN	O	leucine33/proline33	nn	17	SENT_96	[p7l2027t752r2147b809, p7l175t846r739b918],
15	amino	NN	O	amino	nn	17	SENT_96	[p7l773t847r972b903],
16	acid	NN	O	acid	nn	17	SENT_96	[p7l1015t846r1147b903],
17	polymorphism	NN	O	polymorphism	prep_with	11	SENT_96	[p7l1195t846r1652b918],
18	in	IN	O	in	_	0	SENT_96	[p7l1698t847r1754b903],
19	membrane	NN	O	membrane	nn	21	SENT_96	[p7l1801t846r2151b903],
20	glycoprotein	NN	O	glycoprotein	nn	21	SENT_96	[p7l176t940r585b1012],
21	Illa	NN	O	illum	prep_in	17	SENT_96	[p7l632t942r745b1010],
22	,	,	O	,	_	0	SENT_96	[p7l632t942r745b1010],
23	and	CC	O	and	_	0	SENT_96	[p7l793t940r908b997],
24	are	VBP	O	be	cop	25	SENT_96	[p7l951t956r1056b997],
25	distinguishable	JJ	O	distinguishable	conj_and	11	SENT_96	[p7l1097t940r1590b1012],
26	by	IN	O	by	_	0	SENT_96	[p7l1633t940r1707b1012],
27	DNA	NN	O	dna	nn	28	SENT_96	[p7l1748t941r1881b998],
28	typing	NN	O	typing	prep_by	25	SENT_96	[p7l1920t942r2144b1012],
29	.	.	O	.	_	0	SENT_96	[p7l1920t942r2144b1012],

1	J	NNP	O	J	nn	2	SENT_97	[p7l173t1036r209b1091],
2	Clin	NNP	O	Clin	nsubj	3	SENT_97	[p7l251t1034r376b1091],
3	Invest	VB	O	invest	_	0	SENT_97	[p7l418t1036r614b1091],
4	1989	CD	DATE	1989	dobj	3	SENT_97	[p7l663t1035r1256b1103],
5	;	:	O	;	_	0	SENT_97	[p7l663t1035r1256b1103],
6	83:1778	CD	NUMBER	83:1778	number	7	SENT_97	[p7l663t1035r1256b1103],
7	—	CD	NUMBER	—	dep	4	SENT_97	[p7l663t1035r1256b1103],
8	81	CD	NUMBER	81	dep	7	SENT_97	[p7l663t1035r1256b1103],
9	.	.	O	.	_	0	SENT_97	[p7l663t1035r1256b1103],

1	[	NN	O	[	nn	4	SENT_98	[p7l49t1127r129b1199],
2	3	CD	NUMBER	3	num	4	SENT_98	[p7l49t1127r129b1199],
3	]	NN	O	]	nn	4	SENT_98	[p7l49t1127r129b1199],
4	Mikkelsson	NN	O	mikkelsson	_	0	SENT_98	[p7l174t1127r521b1184],
5	J	NN	O	j	dep	4	SENT_98	[p7l558t1129r612b1197],
6	,	,	O	,	_	0	SENT_98	[p7l558t1129r612b1197],
7	Perola	NN	O	perolum	nn	8	SENT_98	[p7l657t1127r859b1184],
8	M	NN	O	m	appos	5	SENT_98	[p7l893t1129r965b1197],
9	,	,	O	,	_	0	SENT_98	[p7l893t1129r965b1197],
10	Penttila	NNP	PERSON	Penttila	nn	11	SENT_98	[p7l1010t1127r1265b1184],
11	A	NNP	O	A	appos	5	SENT_98	[p7l1298t1128r1361b1197],
12	,	,	O	,	_	0	SENT_98	[p7l1298t1128r1361b1197],
13	Goldschmidt-Clermont	NNP	O	Goldschmidt-Clermont	nn	14	SENT_98	[p7l1404t1127r2151b1184],
14	PJ	NNP	O	PJ	appos	5	SENT_98	[p7l178t1223r269b1291],
15	,	,	O	,	_	0	SENT_98	[p7l178t1223r269b1291],
16	Karhunen	NNP	PERSON	Karhunen	nn	17	SENT_98	[p7l311t1221r617b1278],
17	PJ	NNP	PERSON	PJ	appos	5	SENT_98	[p7l654t1223r745b1278],
18	.	.	O	.	_	0	SENT_98	[p7l654t1223r745b1278],

1	The	DT	O	the	det	3	SENT_99	[p7l782t1221r905b1278],
2	GP	NN	O	gp	nn	3	SENT_99	[p7l937t1222r1125b1279],
3	|	NN	O	|	nsubj	5	SENT_99	[p7l937t1222r1125b1279],
4	|	CD	NUMBER	|	dep	3	SENT_99	[p7l937t1222r1125b1279],
5	|	VBD	O	|	_	0	SENT_99	[p7l937t1222r1125b1279],
6	a	DT	O	a	det	12	SENT_99	[p7l937t1222r1125b1279],
7	(	JJ	O	(	amod	12	SENT_99	[p7l1162t1221r1369b1293],
8	beta3	NN	O	beta3	nn	12	SENT_99	[p7l1162t1221r1369b1293],
9	integrin	NN	O	integrin	nn	12	SENT_99	[p7l1404t1223r1686b1293],
10	)	CD	NUMBER	)	num	12	SENT_99	[p7l1404t1223r1686b1293],
11	PlA	NN	O	plum	nn	12	SENT_99	[p7l1723t1221r1826b1278],
12	polymorphism	NN	O	polymorphism	dobj	5	SENT_99	[p7l1858t1221r2147b1293, p7l174t1315r361b1387],
13	in	IN	O	in	_	0	SENT_99	[p7l385t1317r440b1372],
14	the	DT	O	the	det	16	SENT_99	[p7l464t1315r571b1372],
15	early	JJ	O	early	amod	16	SENT_99	[p7l593t1315r759b1387],
16	development	NN	O	development	prep_in	12	SENT_99	[p7l779t1315r1212b1387],
17	of	IN	O	of	_	0	SENT_99	[p7l1233t1315r1299b1372],
18	coronary	JJ	O	coronary	amod	19	SENT_99	[p7l1318t1331r1608b1387],
19	atherosclerosis	NN	O	atherosclerosis	prep_of	16	SENT_99	[p7l1628t1315r2143b1373],
20	.	.	O	.	_	0	SENT_99	[p7l1628t1315r2143b1373],

1	Atherosclerosis	NNP	O	Atherosclerosis	_	0	SENT_100	[p7l168t1410r680b1466],
2	2001	CD	DATE	2001	num	1	SENT_100	[p7l711t1410r853b1466],
3	;	:	O	;	_	0	SENT_100	[p7l873t1410r1157b1478],
4	154:721	CD	NUMBER	154:721	num	5	SENT_100	[p7l873t1410r1157b1478],
5	—	NN	O	—	dep	1	SENT_100	[p7l1182t1442r1203b1446],
6	7	CD	NUMBER	7	dep	5	SENT_100	[p7l1219t1411r1275b1466],
7	.	.	O	.	_	0	SENT_100	[p7l1219t1411r1275b1466],

1	[	NN	O	[	_	0	SENT_101	[p7l44t1502r125b1574],
2	4	CD	NUMBER	4	num	1	SENT_101	[p7l44t1502r125b1574],
3	]	CD	NUMBER	]	num	5	SENT_101	[p7l44t1502r125b1574],
4	Patrono	NN	O	patrono	nn	5	SENT_101	[p7l175t1503r425b1559],
5	C	NN	O	c	dep	1	SENT_101	[p7l468t1503r530b1572],
6	,	,	O	,	_	0	SENT_101	[p7l468t1503r530b1572],
7	Coller	NNP	PERSON	Coller	nn	8	SENT_101	[p7l580t1502r777b1559],
8	B	NNP	O	B	appos	5	SENT_101	[p7l820t1503r877b1572],
9	,	,	O	,	_	0	SENT_101	[p7l820t1503r877b1572],
10	Dalen	NNP	PERSON	Dalen	nn	11	SENT_101	[p7l930t1502r1109b1559],
11	JE	NNP	O	JE	appos	5	SENT_101	[p7l1153t1504r1246b1572],
12	,	,	O	,	_	0	SENT_101	[p7l1153t1504r1246b1572],
13	FitzGerald	NNP	ORGANIZATION	FitzGerald	nn	14	SENT_101	[p7l1299t1502r1638b1559],
14	GA	NNP	ORGANIZATION	GA	appos	5	SENT_101	[p7l1684t1503r1795b1572],
15	,	,	O	,	_	0	SENT_101	[p7l1684t1503r1795b1572],
16	Fuster	NNP	PERSON	Fuster	nn	17	SENT_101	[p7l1847t1504r2052b1559],
17	V	NNP	PERSON	V	appos	5	SENT_101	[p7l2092t1504r2143b1572],
18	,	,	O	,	_	0	SENT_101	[p7l2092t1504r2143b1572],
19	Gent	NNP	O	Gent	nn	20	SENT_101	[p7l172t1597r330b1654],
20	M	NNP	O	M	appos	5	SENT_101	[p7l380t1598r452b1666],
21	,	,	O	,	_	0	SENT_101	[p7l380t1598r452b1666],
22	et	FW	O	et	nn	23	SENT_101	[p7l510t1602r578b1653],
23	al.	FW	O	al.	appos	5	SENT_101	[p7l630t1596r707b1653],
24	.	.	O	.	_	0	SENT_101	[p7l630t1596r707b1653],

1	Platelet-active	JJ	O	platelet-active	amod	2	SENT_102	[p7l770t1596r1261b1654],
2	drugs	NNS	O	drug	_	0	SENT_102	[p7l1314t1596r1509b1668],
3	:	:	O	:	_	0	SENT_102	[p7l1314t1596r1509b1668],
4	the	DT	O	the	det	5	SENT_102	[p7l1569t1596r1676b1653],
5	relationships	NNS	O	relationship	dep	2	SENT_102	[p7l1731t1596r2150b1668],
6	among	IN	O	among	_	0	SENT_102	[p7l172t1705r394b1762],
7	dose	NN	O	dose	prep_among	5	SENT_102	[p7l455t1690r631b1760],
8	,	,	O	,	_	0	SENT_102	[p7l455t1690r631b1760],
9	effectiveness	NN	O	effectiveness	prep_among	5	SENT_102	[p7l698t1690r1180b1760],
10	,	,	O	,	_	0	SENT_102	[p7l698t1690r1180b1760],
11	and	CC	O	and	_	0	SENT_102	[p7l1248t1690r1367b1747],
12	side	JJ	O	side	amod	13	SENT_102	[p7l1430t1690r1564b1747],
13	effects	NNS	O	effect	prep_among	5	SENT_102	[p7l1624t1690r1886b1747],
14	.	.	O	.	_	0	SENT_102	[p7l1624t1690r1886b1747],

1	Chest	NN	O	chest	_	0	SENT_103	[p7l1957t1690r2146b1748],
2	2001	CD	DATE	2001	num	1	SENT_103	[p7l172t1785r807b1853],
3	;	:	O	;	_	0	SENT_103	[p7l172t1785r807b1853],
4	119:39	CD	NUMBER	119:39	num	5	SENT_103	[p7l172t1785r807b1853],
5	S	NN	O	s	dep	1	SENT_103	[p7l172t1785r807b1853],
6	—	CD	NUMBER	—	num	7	SENT_103	[p7l172t1785r807b1853],
7	63S	NN	O	63	dep	5	SENT_103	[p7l172t1785r807b1853],
8	.	.	O	.	_	0	SENT_103	[p7l172t1785r807b1853],

1	[	NN	O	[	nn	5	SENT_104	[p7l44t1877r125b1949],
2	5	CD	NUMBER	5	num	5	SENT_104	[p7l44t1877r125b1949],
3	]	CD	NUMBER	]	num	5	SENT_104	[p7l44t1877r125b1949],
4	Undas	NNP	O	Undas	nn	5	SENT_104	[p7l175t1877r369b1935],
5	A	NNP	O	A	dep	18	SENT_104	[p7l393t1878r457b1947],
6	,	,	O	,	_	0	SENT_104	[p7l393t1878r457b1947],
7	Sanak	NNP	O	Sanak	nn	8	SENT_104	[p7l492t1877r683b1935],
8	M	NNP	O	M	appos	5	SENT_104	[p7l707t1879r779b1947],
9	,	,	O	,	_	0	SENT_104	[p7l707t1879r779b1947],
10	Musial	NNP	PERSON	Musial	nn	11	SENT_104	[p7l813t1877r1017b1935],
11	J	NNP	PERSON	J	appos	5	SENT_104	[p7l1041t1879r1095b1947],
12	,	,	O	,	_	0	SENT_104	[p7l1041t1879r1095b1947],
13	Szczeklik	NNP	O	Szczeklik	nn	14	SENT_104	[p7l1130t1877r1431b1935],
14	A.	NNP	O	A.	appos	5	SENT_104	[p7l1454t1878r1517b1934],
15	Platelet	NN	O	platelet	nn	18	SENT_104	[p7l1555t1877r1815b1935],
16	glycoprotein	NN	O	glycoprotein	nn	18	SENT_104	[p7l1843t1877r2147b1949, p7l172t1973r298b2028],
17	Illa	NN	PERSON	illum	nn	18	SENT_104	[p7l340t1973r432b2028],
18	polymorphism	NN	O	polymorphism	_	0	SENT_104	[p7l471t1971r952b2043],
19	,	,	O	,	_	0	SENT_104	[p7l471t1971r952b2043],
20	aspirin	NN	O	aspirin	conj_and	18	SENT_104	[p7l994t1973r1234b2043],
21	,	,	O	,	_	0	SENT_104	[p7l994t1973r1234b2043],
22	and	CC	O	and	_	0	SENT_104	[p7l1276t1971r1391b2028],
23	thrombin	NN	O	thrombin	nn	24	SENT_104	[p7l1430t1971r1728b2029],
24	generation	NN	O	generation	conj_and	18	SENT_104	[p7l1767t1973r2143b2043],
25	.	.	O	.	_	0	SENT_104	[p7l1767t1973r2143b2043],

1	Lancet	NNP	O	Lancet	_	0	SENT_105	[p7l173t2067r393b2122],
2	1999	CD	DATE	1999	num	1	SENT_105	[p7l430t2066r988b2135],
3	;	:	O	;	_	0	SENT_105	[p7l430t2066r988b2135],
4	353:982	CD	NUMBER	353:982	number	5	SENT_105	[p7l430t2066r988b2135],
5	—	CD	NUMBER	—	dep	1	SENT_105	[p7l430t2066r988b2135],
6	3	CD	NUMBER	3	dep	5	SENT_105	[p7l430t2066r988b2135],
7	.	.	O	.	_	0	SENT_105	[p7l430t2066r988b2135],

1	[	NN	O	[	nn	3	SENT_106	[p7l44t2158r125b2230],
2	6	CD	NUMBER	6	num	3	SENT_106	[p7l44t2158r125b2230],
3	]	NN	O	]	_	0	SENT_106	[p7l44t2158r125b2230],
4	Szczeklik	NNP	MISC	Szczeklik	nn	5	SENT_106	[p7l172t2158r473b2216],
5	A	NNP	MISC	A	dep	3	SENT_106	[p7l515t2159r579b2228],
6	,	,	O	,	_	0	SENT_106	[p7l515t2159r579b2228],
7	Undas	NNP	O	Undas	nn	8	SENT_106	[p7l635t2158r829b2216],
8	A	NNP	O	A	appos	5	SENT_106	[p7l874t2159r937b2228],
9	,	,	O	,	_	0	SENT_106	[p7l874t2159r937b2228],
10	Sanak	NNP	O	Sanak	nn	11	SENT_106	[p7l991t2158r1182b2216],
11	M	NNP	O	M	appos	5	SENT_106	[p7l1225t2160r1297b2228],
12	,	,	O	,	_	0	SENT_106	[p7l1225t2160r1297b2228],
13	Frolow	NNP	O	Frolow	nn	14	SENT_106	[p7l1354t2158r1575b2216],
14	M	NNP	O	M	appos	5	SENT_106	[p7l1619t2160r1691b2228],
15	,	,	O	,	_	0	SENT_106	[p7l1619t2160r1691b2228],
16	Wegrzyn	NNP	PERSON	Wegrzyn	nn	18	SENT_106	[p7l1743t2160r2019b2230],
17	W.	NNP	O	W.	nn	18	SENT_106	[p7l2067t2160r2143b2216],
18	Relationship	NN	O	relationship	appos	5	SENT_106	[p7l175t2252r575b2324],
19	between	IN	O	between	prep	18	SENT_106	[p7l603t2252r885b2310],
20	bleeding	JJ	O	bleeding	amod	21	SENT_106	[p7l914t2252r1195b2324],
21	time	NN	O	time	dep	19	SENT_106	[p7l1219t2254r1390b2322],
22	,	,	O	,	_	0	SENT_106	[p7l1219t2254r1390b2322],
23	aspirin	NN	O	aspirin	conj_and	21	SENT_106	[p7l1422t2254r1661b2324],
24	,	,	O	,	_	0	SENT_106	[p7l1422t2254r1661b2324],
25	and	CC	O	and	_	0	SENT_106	[p7l1693t2252r1808b2309],
26	the	DT	O	the	det	27	SENT_106	[p7l1836t2252r1943b2309],
27	PlA1	NN	O	pla1	dep	19	SENT_106	[p7l1971t2252r2145b2309],
28	/	:	O	/	punct	21	SENT_106	[p7l1971t2252r2145b2309],
29	A2	NN	O	a2	nn	30	SENT_106	[p7l169t2347r250b2403],
30	polymorphism	NN	O	polymorphism	dep	21	SENT_106	[p7l281t2347r739b2419],
31	of	IN	O	of	_	0	SENT_106	[p7l769t2347r835b2404],
32	platelet	NN	O	platelet	nn	34	SENT_106	[p7l863t2347r1122b2419],
33	glycoprotein	NN	O	glycoprotein	nn	34	SENT_106	[p7l1150t2347r1560b2419],
34	Illa	NN	PERSON	illum	prep_of	30	SENT_106	[p7l1594t2348r1707b2404],
35	.	.	O	.	_	0	SENT_106	[p7l1594t2348r1707b2404],

1	Br	NN	O	br	nn	3	SENT_107	[p7l1742t2347r1815b2403],
2	J	NN	O	j	nn	3	SENT_107	[p7l1835t2348r1872b2404],
3	Haematol	NN	O	haematol	_	0	SENT_107	[p7l1897t2348r2147b2404, p7l176t2441r263b2498],
4	2000	CD	DATE	2000	dep	3	SENT_107	[p7l296t2441r860b2510],
5	;	:	O	;	_	0	SENT_107	[p7l296t2441r860b2510],
6	110:965	CD	NUMBER	110:965	num	7	SENT_107	[p7l296t2441r860b2510],
7	—	NN	O	—	dep	3	SENT_107	[p7l296t2441r860b2510],
8	7	CD	NUMBER	7	dep	7	SENT_107	[p7l296t2441r860b2510],
9	.	.	O	.	_	0	SENT_107	[p7l296t2441r860b2510],

1	[	NN	O	[	nn	5	SENT_108	[p7l44t2533r125b2604],
2	7	CD	NUMBER	7	num	5	SENT_108	[p7l44t2533r125b2604],
3	]	CD	NUMBER	]	num	5	SENT_108	[p7l44t2533r125b2604],
4	Szczeklik	NNP	O	Szczeklik	nn	5	SENT_108	[p7l172t2533r473b2590],
5	A	NNP	O	A	_	0	SENT_108	[p7l499t2533r563b2602],
6	,	,	O	,	_	0	SENT_108	[p7l499t2533r563b2602],
7	Krzanowski	NNP	PERSON	Krzanowski	nn	8	SENT_108	[p7l603t2533r966b2590],
8	M	NNP	PERSON	M	appos	5	SENT_108	[p7l998t2534r1070b2602],
9	,	,	O	,	_	0	SENT_108	[p7l998t2534r1070b2602],
10	Gora	NNP	PERSON	Gora	nn	16	SENT_108	[p7l1108t2529r1262b2590],
11	P	NN	PERSON	p	nn	16	SENT_108	[p7l1296t2534r1337b2602],
12	,	,	O	,	_	0	SENT_108	[p7l1296t2534r1337b2602],
13	Radwan	NNP	PERSON	Radwan	dep	16	SENT_108	[p7l1379t2533r1629b2590],
14	J.	NNP	PERSON	J.	nn	16	SENT_108	[p7l1661t2534r1714b2590],
15	Antiplatelet	NNP	PERSON	Antiplatelet	nn	16	SENT_108	[p7l1750t2533r2150b2604],
16	drugs	NNS	O	drug	appos	5	SENT_108	[p7l172t2627r347b2699],
17	and	CC	O	and	_	0	SENT_108	[p7l379t2627r494b2684],
18	generation	NN	O	generation	appos	5	SENT_108	[p7l529t2628r881b2699],
19	of	IN	O	of	_	0	SENT_108	[p7l916t2627r982b2684],
20	thrombin	NN	O	thrombin	prep_of	18	SENT_108	[p7l1012t2627r1311b2684],
21	in	IN	O	in	_	0	SENT_108	[p7l1345t2628r1400b2683],
22	clotting	VBG	O	clot	amod	23	SENT_108	[p7l1435t2627r1689b2699],
23	blood	NN	O	blood	prep_in	20	SENT_108	[p7l1723t2627r1923b2684],
24	.	.	O	.	_	0	SENT_108	[p7l1723t2627r1923b2684],

1	Blood	NN	O	blood	_	0	SENT_109	[p7l1962t2627r2150b2684],
2	1992	CD	DATE	1992	num	1	SENT_109	[p7l176t2721r770b2790],
3	;	:	O	;	_	0	SENT_109	[p7l176t2721r770b2790],
4	80:2006	CD	NUMBER	80:2006	number	5	SENT_109	[p7l176t2721r770b2790],
5	—	CD	NUMBER	—	dep	1	SENT_109	[p7l176t2721r770b2790],
6	11	CD	NUMBER	11	dep	5	SENT_109	[p7l176t2721r770b2790],
7	.	.	O	.	_	0	SENT_109	[p7l176t2721r770b2790],

1	[	NN	O	[	nn	3	SENT_110	[p7l44t2814r124b2886],
2	8	CD	NUMBER	8	num	3	SENT_110	[p7l44t2814r124b2886],
3	]	NN	O	]	_	0	SENT_110	[p7l44t2814r124b2886],
4	Zotz	NNP	O	Zotz	nn	5	SENT_110	[p7l173t2815r315b2871],
5	RB	NN	O	rb	dep	3	SENT_110	[p7l347t2815r446b2883],
6	,	,	O	,	_	0	SENT_110	[p7l347t2815r446b2883],
7	Klein	NNP	PERSON	Klein	nn	8	SENT_110	[p7l485t2814r644b2871],
8	M	NNP	O	M	appos	5	SENT_110	[p7l675t2815r747b2883],
9	,	,	O	,	_	0	SENT_110	[p7l675t2815r747b2883],
10	Dauben	NNP	PERSON	Dauben	nn	11	SENT_110	[p7l787t2814r1027b2871],
11	HP	NNP	O	HP	appos	5	SENT_110	[p7l1062t2815r1152b2883],
12	,	,	O	,	_	0	SENT_110	[p7l1062t2815r1152b2883],
13	Moser	NNP	PERSON	Moser	nn	14	SENT_110	[p7l1187t2815r1380b2871],
14	C	NNP	O	C	appos	5	SENT_110	[p7l1408t2815r1470b2883],
15	,	,	O	,	_	0	SENT_110	[p7l1408t2815r1470b2883],
16	Gams	NNP	PERSON	Gams	nn	17	SENT_110	[p7l1507t2815r1684b2871],
17	E	NNP	O	E	appos	5	SENT_110	[p7l1716t2815r1770b2883],
18	,	,	O	,	_	0	SENT_110	[p7l1716t2815r1770b2883],
19	Scharf	NNP	PERSON	Scharf	nn	20	SENT_110	[p7l1808t2814r2016b2871],
20	RE	NNP	O	RE	appos	5	SENT_110	[p7l2046t2815r2143b2871],
21	.	.	O	.	_	0	SENT_110	[p7l2046t2815r2143b2871],

1	Prospective	JJ	O	prospective	amod	2	SENT_111	[p7l175t2909r553b2980],
2	analysis	NN	O	analysis	_	0	SENT_111	[p7l585t2908r840b2980],
3	after	IN	O	after	_	0	SENT_111	[p7l871t2908r1036b2965],
4	coronary-artery	JJ	O	coronary-artery	amod	6	SENT_111	[p7l1065t2913r1587b2980],
5	bypass	NN	O	bypass	nn	6	SENT_111	[p7l1619t2908r1833b2980],
6	grafting	NN	O	grafting	prep_after	2	SENT_111	[p7l1864t2908r2143b2980],
7	:	:	O	:	_	0	SENT_111	[p7l1864t2908r2143b2980],
8	platelet	NN	O	platelet	nn	10	SENT_111	[p7l174t3002r435b3074],
9	GP	NN	O	gp	nn	10	SENT_111	[p7l459t3003r547b3059],
10	Illa	NN	O	illum	dep	2	SENT_111	[p7l576t3003r669b3059],
11	polymorphism	NN	O	polymorphism	nn	13	SENT_111	[p7l697t3002r1154b3074],
12	(	NN	O	(	nn	13	SENT_111	[p7l1187t3002r1651b3074],
13	HPA-1b	NN	O	hpa-1b	dep	10	SENT_111	[p7l1187t3002r1651b3074],
14	/	:	O	/	punct	2	SENT_111	[p7l1187t3002r1651b3074],
15	PlA2	NN	O	pla2	nn	16	SENT_111	[p7l1187t3002r1651b3074],
16	)	NN	O	)	nsubj	20	SENT_111	[p7l1187t3002r1651b3074],
17	is	VBZ	O	be	cop	20	SENT_111	[p7l1679t3003r1727b3059],
18	a	DT	O	a	det	20	SENT_111	[p7l1752t3018r1786b3059],
19	risk	NN	O	risk	nn	20	SENT_111	[p7l1815t3002r1928b3059],
20	factor	NN	O	factor	dep	2	SENT_111	[p7l1951t3002r2152b3059],
21	for	IN	O	for	_	0	SENT_111	[p7l172t3096r266b3153],
22	bypass	NN	O	bypass	nn	23	SENT_111	[p7l315t3096r529b3168],
23	occlusion	NN	O	occlusion	prep_for	20	SENT_111	[p7l576t3096r902b3166],
24	,	,	O	,	_	0	SENT_111	[p7l576t3096r902b3166],
25	myocardial	JJ	O	myocardial	amod	26	SENT_111	[p7l959t3096r1320b3168],
26	infarction	NN	O	infarction	prep_for	20	SENT_111	[p7l1370t3096r1713b3166],
27	,	,	O	,	_	0	SENT_111	[p7l1370t3096r1713b3166],
28	and	CC	O	and	_	0	SENT_111	[p7l1768t3096r1883b3153],
29	death	NN	O	death	prep_for	20	SENT_111	[p7l1935t3096r2143b3153],
30	.	.	O	.	_	0	SENT_111	[p7l1935t3096r2143b3153],

1	Thromb	NNP	O	Thromb	nn	2	SENT_112	[p7l175t3190r428b3247],
2	Haemost	NNP	O	Haemost	_	0	SENT_112	[p7l455t3192r744b3247],
3	2000	CD	DATE	2000	num	2	SENT_112	[p7l776t3191r951b3259],
4	;	:	O	;	_	0	SENT_112	[p7l776t3191r951b3259],
5	8	CD	NUMBER	8	number	6	SENT_112	[p7l963t3191r998b3247],
6	3:404	CD	NUMBER	3:404	dep	2	SENT_112	[p7l1008t3191r1191b3248],
7	—	NN	O	—	dep	6	SENT_112	[p7l1204t3222r1224b3226],
8	7	CD	NUMBER	7	num	7	SENT_112	[p7l1240t3191r1296b3247],
9	.	.	O	.	_	0	SENT_112	[p7l1240t3191r1296b3247],

1	[	NN	O	[	nsubjpass	25	SENT_113	[p7l44t3283r125b3355],
2	9	CD	NUMBER	9	num	3	SENT_113	[p7l44t3283r125b3355],
3	]	NN	O	]	dep	1	SENT_113	[p7l44t3283r125b3355],
4	Undas	NNP	O	Undas	nn	5	SENT_113	[p7l175t3283r369b3340],
5	A	NNP	O	A	dep	1	SENT_113	[p7l392t3283r456b3352],
6	,	,	O	,	_	0	SENT_113	[p7l392t3283r456b3352],
7	Brummel	NNP	PERSON	Brummel	nn	8	SENT_113	[p7l492t3283r784b3340],
8	K	NNP	PERSON	K	appos	5	SENT_113	[p7l814t3284r871b3352],
9	,	,	O	,	_	0	SENT_113	[p7l814t3284r871b3352],
10	Musial	NNP	PERSON	Musial	nn	11	SENT_113	[p7l903t3283r1109b3340],
11	J	NNP	PERSON	J	appos	5	SENT_113	[p7l1132t3284r1186b3352],
12	,	,	O	,	_	0	SENT_113	[p7l1132t3284r1186b3352],
13	Mann	NNP	PERSON	Mann	nn	15	SENT_113	[p7l1217t3284r1386b3340],
14	K.	NNP	PERSON	K.	nn	15	SENT_113	[p7l1419t3283r1553b3352],
15	G	NNP	PERSON	G	appos	5	SENT_113	[p7l1419t3283r1553b3352],
16	,	,	O	,	_	0	SENT_113	[p7l1419t3283r1553b3352],
17	Szczeklik	NNP	O	Szczeklik	nn	20	SENT_113	[p7l1587t3283r1888b3340],
18	A.	NNP	O	A.	nn	20	SENT_113	[p7l1911t3283r1974b3340],
19	PlA2	NNP	O	PlA2	nn	20	SENT_113	[p7l2010t3283r2149b3340],
20	polymorphism	NN	O	polymorphism	appos	5	SENT_113	[p7l174t3377r632b3449],
21	of	IN	O	of	_	0	SENT_113	[p7l682t3377r749b3434],
22	beta3	NN	O	beta3	nn	23	SENT_113	[p7l797t3377r979b3434],
23	integrins	NNS	O	integrin	prep_of	20	SENT_113	[p7l1030t3378r1317b3449],
24	is	VBZ	O	be	auxpass	25	SENT_113	[p7l1365t3378r1412b3434],
25	associated	VBN	O	associate	_	0	SENT_113	[p7l1461t3377r1802b3434],
26	with	IN	O	with	_	0	SENT_113	[p7l1851t3377r1994b3434],
27	enhanced	VBN	O	enhance	amod	29	SENT_113	[p7l2045t3392r2146b3434, p7l174t3471r406b3528],
28	thrombin	NN	O	thrombin	nn	29	SENT_113	[p7l443t3471r742b3528],
29	generation	NN	O	generation	prep_with	25	SENT_113	[p7l780t3472r1133b3543],
30	and	CC	O	and	_	0	SENT_113	[p7l1172t3471r1286b3528],
31	impaired	JJ	O	impaired	amod	32	SENT_113	[p7l1324t3471r1615b3543],
32	antithrombotic	JJ	O	antithrombotic	amod	33	SENT_113	[p7l1652t3471r2150b3528],
33	action	NN	O	action	prep_with	25	SENT_113	[p7l172t3566r378b3622],
34	of	IN	O	of	_	0	SENT_113	[p7l434t3565r502b3622],
35	aspirin	NN	O	aspirin	prep_of	33	SENT_113	[p7l554t3566r775b3637],
36	at	IN	O	at	_	0	SENT_113	[p7l832t3570r898b3622],
37	the	DT	O	the	det	38	SENT_113	[p7l951t3565r1061b3622],
38	site	NN	O	site	prep_at	35	SENT_113	[p7l1115t3566r1235b3622],
39	of	IN	O	of	_	0	SENT_113	[p7l1289t3565r1356b3622],
40	microvascular	JJ	O	microvascular	amod	41	SENT_113	[p7l1410t3565r1881b3622],
41	injury	NN	O	injury	prep_of	38	SENT_113	[p7l1933t3566r2142b3637],
42	.	.	O	.	_	0	SENT_113	[p7l1933t3566r2142b3637],

1	Circulation	NN	O	circulation	_	0	SENT_114	[p7l174t3659r539b3716],
2	2001	CD	DATE	2001	num	1	SENT_114	[p7l573t3659r715b3716],
3	;	:	O	;	_	0	SENT_114	[p7l734t3659r1069b3728],
4	104:2666	CD	NUMBER	104:2666	num	6	SENT_114	[p7l734t3659r1069b3728],
5	-	:	O	-	_	0	SENT_114	[p7l1084t3691r1104b3695],
6	72	CD	DATE	72	dep	1	SENT_114	[p7l1120t3659r1215b3716],
7	.	.	O	.	_	0	SENT_114	[p7l1120t3659r1215b3716],

1	[	NN	O	[	nn	5	SENT_115	[p8l7t19r127b91],
2	10	CD	NUMBER	10	num	5	SENT_115	[p8l7t19r127b91],
3	]	CD	NUMBER	]	num	5	SENT_115	[p8l7t19r127b91],
4	Undas	NNP	O	Undas	nn	5	SENT_115	[p8l176t19r370b76],
5	A	NNP	O	A	_	0	SENT_115	[p8l392t20r456b89],
6	,	,	O	,	_	0	SENT_115	[p8l392t20r456b89],
7	Brummel	NNP	ORGANIZATION	Brummel	nn	8	SENT_115	[p8l491t19r782b76],
8	K	NNP	ORGANIZATION	K	appos	5	SENT_115	[p8l812t20r869b89],
9	,	,	O	,	_	0	SENT_115	[p8l812t20r869b89],
10	Musiat	NNP	PERSON	Musiat	nn	11	SENT_115	[p8l899t19r1104b76],
11	J	NNP	PERSON	J	appos	5	SENT_115	[p8l1126t21r1179b89],
12	,	,	O	,	_	0	SENT_115	[p8l1126t21r1179b89],
13	Mann	NNP	PERSON	Mann	nn	14	SENT_115	[p8l1210t21r1380b76],
14	KG	NNP	O	KG	appos	5	SENT_115	[p8l1410t20r1518b89],
15	,	,	O	,	_	0	SENT_115	[p8l1410t20r1518b89],
16	Szczeklik	NNP	O	Szczeklik	nn	19	SENT_115	[p8l1551t19r1852b76],
17	A.	NNP	O	A.	nn	19	SENT_115	[p8l1872t20r1935b76],
18	Blood	NNP	O	Blood	nn	19	SENT_115	[p8l1971t19r2148b76],
19	coagulation	NN	O	coagulation	appos	5	SENT_115	[p8l173t113r554b185],
20	at	IN	O	at	_	0	SENT_115	[p8l590t119r656b170],
21	the	DT	O	the	det	22	SENT_115	[p8l689t113r796b170],
22	site	NN	O	site	prep_at	19	SENT_115	[p8l830t114r947b170],
23	of	IN	O	of	_	0	SENT_115	[p8l981t113r1047b170],
24	microvascular	JJ	O	microvascular	amod	25	SENT_115	[p8l1080t113r1539b170],
25	injury	NN	O	injury	prep_of	22	SENT_115	[p8l1571t114r1784b185],
26	:	:	O	:	_	0	SENT_115	[p8l1571t114r1784b185],
27	effects	NNS	O	effect	dep	5	SENT_115	[p8l1823t113r2053b170],
28	of	IN	O	of	_	0	SENT_115	[p8l2086t113r2152b170],
29	low-dose	JJ	O	low-dose	amod	30	SENT_115	[p8l176t207r466b264],
30	aspirin	NN	O	aspirin	prep_of	27	SENT_115	[p8l496t208r736b279],
31	.	.	O	.	_	0	SENT_115	[p8l496t208r736b279],

1	Blood	NN	O	blood	_	0	SENT_116	[p8l771t207r959b264],
2	2001	CD	DATE	2001	num	1	SENT_116	[p8l988t207r1586b277],
3	;	:	O	;	_	0	SENT_116	[p8l988t207r1586b277],
4	98:2423	CD	NUMBER	98:2423	number	5	SENT_116	[p8l988t207r1586b277],
5	-31	CD	NUMBER	-31	dep	1	SENT_116	[p8l988t207r1586b277],
6	.	.	O	.	_	0	SENT_116	[p8l988t207r1586b277],

1	[	NN	O	[	_	0	SENT_117	[p8l7t301r127b373],
2	11	CD	NUMBER	11	num	1	SENT_117	[p8l7t301r127b373],
3	]	CD	NUMBER	]	num	5	SENT_117	[p8l7t301r127b373],
4	Honda	NNP	ORGANIZATION	Honda	nn	5	SENT_117	[p8l176t301r379b358],
5	S	NN	O	s	dep	1	SENT_117	[p8l398t302r451b371],
6	,	,	O	,	_	0	SENT_117	[p8l398t302r451b371],
7	HondaY	NN	O	honday	appos	5	SENT_117	[p8l479t301r748b371],
8	,	,	O	,	_	0	SENT_117	[p8l479t301r748b371],
9	Bauer	NNP	PERSON	Bauer	nn	10	SENT_117	[p8l776t302r964b358],
10	B	NNP	O	B	appos	5	SENT_117	[p8l983t302r1039b371],
11	,	,	O	,	_	0	SENT_117	[p8l983t302r1039b371],
12	Ruan	NNP	PERSON	Ruan	nn	13	SENT_117	[p8l1067t302r1220b358],
13	C	NNP	O	C	appos	5	SENT_117	[p8l1241t302r1303b371],
14	,	,	O	,	_	0	SENT_117	[p8l1241t302r1303b371],
15	Kunicki	NNP	O	Kunicki	nn	16	SENT_117	[p8l1331t301r1561b358],
16	TJ	NNP	O	TJ	appos	5	SENT_117	[p8l1580t302r1677b358],
17	.	.	O	.	_	0	SENT_117	[p8l1580t302r1677b358],

1	The	DT	O	the	det	2	SENT_118	[p8l1700t301r1823b358],
2	impact	NN	O	impact	_	0	SENT_118	[p8l1842t302r2069b373],
3	of	IN	O	of	_	0	SENT_118	[p8l2086t301r2152b358],
4	three-dimensional	JJ	O	three-dimensional	amod	5	SENT_118	[p8l173t395r776b452],
5	structure	NN	O	structure	prep_of	2	SENT_118	[p8l797t401r1101b452],
6	on	IN	O	on	_	0	SENT_118	[p8l1121t411r1196b452],
7	the	DT	O	the	det	8	SENT_118	[p8l1219t395r1326b452],
8	expression	NN	O	expression	prep_on	2	SENT_118	[p8l1347t396r1692b467],
9	of	IN	O	of	_	0	SENT_118	[p8l1714t395r1781b452],
10	PlA	NN	O	plum	nn	11	SENT_118	[p8l1802t395r1905b452],
11	alloantigens	NNS	O	alloantigen	prep_of	8	SENT_118	[p8l1923t395r2146b452, p8l173t489r370b560],
12	on	IN	O	on	_	0	SENT_118	[p8l393t504r468b545],
13	human	JJ	O	human	amod	15	SENT_118	[p8l497t488r712b545],
14	integrin	NN	O	integrin	nn	15	SENT_118	[p8l739t489r994b560],
15	beta	NN	O	beta	prep_on	2	SENT_118	[p8l1022t488r1167b545],
16	3	CD	NUMBER	3	dep	15	SENT_118	[p8l1194t489r1247b545],
17	.	.	O	.	_	0	SENT_118	[p8l1194t489r1247b545],

1	Blood	NN	O	blood	_	0	SENT_119	[p8l1279t488r1467b545],
2	1995	CD	DATE	1995	num	1	SENT_119	[p8l1496t489r2050b558],
3	;	:	O	;	_	0	SENT_119	[p8l1496t489r2050b558],
4	86:234	CD	NUMBER	86:234	number	5	SENT_119	[p8l1496t489r2050b558],
5	—	CD	NUMBER	—	dep	1	SENT_119	[p8l1496t489r2050b558],
6	42	CD	NUMBER	42	dep	5	SENT_119	[p8l1496t489r2050b558],
7	.	.	O	.	_	0	SENT_119	[p8l1496t489r2050b558],

1	[	NN	O	[	_	0	SENT_120	[p8l7t583r127b655],
2	12	CD	NUMBER	12	num	1	SENT_120	[p8l7t583r127b655],
3	]	CD	NUMBER	]	num	5	SENT_120	[p8l7t583r127b655],
4	Vijayan	NNP	O	Vijayan	nn	5	SENT_120	[p8l171t584r414b655],
5	KV	NN	O	kv	dep	1	SENT_120	[p8l447t584r537b653],
6	,	,	O	,	_	0	SENT_120	[p8l447t584r537b653],
7	Goldschmidt-Clermont	NNP	O	Goldschmidt-Clermont	nn	8	SENT_120	[p8l571t583r1319b640],
8	PJ	NNP	O	PJ	appos	5	SENT_120	[p8l1348t584r1439b653],
9	,	,	O	,	_	0	SENT_120	[p8l1348t584r1439b653],
10	Roos	NNP	PERSON	Roos	nn	11	SENT_120	[p8l1476t584r1620b640],
11	C	NNP	O	C	appos	5	SENT_120	[p8l1646t584r1708b653],
12	,	,	O	,	_	0	SENT_120	[p8l1646t584r1708b653],
13	Bray	NNP	O	Bray	nn	14	SENT_120	[p8l1744t584r1886b655],
14	PF	NNP	O	PF	appos	5	SENT_120	[p8l1914t584r1995b640],
15	.	.	O	.	_	0	SENT_120	[p8l1914t584r1995b640],

1	The	DT	O	the	det	3	SENT_121	[p8l2027t583r2150b640],
2	PlA2	NN	O	pla2	nn	3	SENT_121	[p8l176t677r314b734],
3	polymorphism	NN	O	polymorphism	nsubj	10	SENT_121	[p8l347t677r806b749],
4	of	IN	O	of	_	0	SENT_121	[p8l837t677r903b734],
5	integrin	NN	O	integrin	nn	6	SENT_121	[p8l930t678r1184b749],
6	beta	NN	O	beta	prep_of	3	SENT_121	[p8l1217t677r1454b749],
7	(	CD	NUMBER	(	number	8	SENT_121	[p8l1217t677r1454b749],
8	3	CD	NUMBER	3	num	9	SENT_121	[p8l1217t677r1454b749],
9	)	NN	O	)	dep	6	SENT_121	[p8l1217t677r1454b749],
10	enhances	VBZ	O	enhance	_	0	SENT_121	[p8l1486t677r1792b734],
11	outside-in	JJ	O	outside-in	amod	12	SENT_121	[p8l1820t677r2148b734],
12	signaling	NN	O	signaling	dobj	10	SENT_121	[p8l173t770r467b842],
13	and	CC	O	and	_	0	SENT_121	[p8l521t770r638b827],
14	adhesive	JJ	O	adhesive	amod	15	SENT_121	[p8l695t770r988b827],
15	functions	NNS	O	function	conj_and	12	SENT_121	[p8l1042t770r1375b827],
16	.	.	O	.	_	0	SENT_121	[p8l1042t770r1375b827],

1	J	NNP	O	J	nn	3	SENT_122	[p8l1433t772r1470b827],
2	Clin	NNP	O	Clin	nn	3	SENT_122	[p8l1524t770r1652b827],
3	Invest	NNP	O	Invest	_	0	SENT_122	[p8l1706t772r1907b827],
4	2000	CD	DATE	2000	num	3	SENT_122	[p8l1964t771r2143b840],
5	;	:	O	;	_	0	SENT_122	[p8l1964t771r2143b840],
6	105:793	CD	NUMBER	105:793	num	7	SENT_122	[p8l180t864r630b922],
7	—	NN	O	—	dep	3	SENT_122	[p8l180t864r630b922],
8	802	CD	NUMBER	802	dep	7	SENT_122	[p8l180t864r630b922],
9	.	.	O	.	_	0	SENT_122	[p8l180t864r630b922],

1	[	RB	O	[	dep	5	SENT_123	[p8l7t958r127b1030],
2	13	CD	NUMBER	13	num	5	SENT_123	[p8l7t958r127b1030],
3	]	CD	NUMBER	]	num	5	SENT_123	[p8l7t958r127b1030],
4	Schneider	NNP	O	Schneider	nn	5	SENT_123	[p8l173t958r499b1015],
5	DJ	NNP	O	DJ	_	0	SENT_123	[p8l532t959r627b1028],
6	,	,	O	,	_	0	SENT_123	[p8l532t959r627b1028],
7	Baumann	NNP	ORGANIZATION	Baumann	nn	8	SENT_123	[p8l668t959r964b1015],
8	PQ	NNP	ORGANIZATION	PQ	appos	5	SENT_123	[p8l1001t959r1107b1028],
9	,	,	O	,	_	0	SENT_123	[p8l1001t959r1107b1028],
10	Holmes	NNP	ORGANIZATION	Holmes	nn	11	SENT_123	[p8l1149t958r1386b1015],
11	MB	NNP	ORGANIZATION	MB	appos	5	SENT_123	[p8l1415t959r1530b1028],
12	,	,	O	,	_	0	SENT_123	[p8l1415t959r1530b1028],
13	Taatjes	NNP	O	Taatjes	nn	14	SENT_123	[p8l1566t959r1806b1030],
14	DJ	NNP	O	DJ	appos	11	SENT_123	[p8l1840t959r1935b1028],
15	,	,	O	,	_	0	SENT_123	[p8l1840t959r1935b1028],
16	Sobel	NNP	PERSON	Sobel	nsubj	17	SENT_123	[p8l1974t958r2150b1015],
17	BE	VB	O	be	rcmod	11	SENT_123	[p8l176t1052r272b1108],
18	.	.	O	.	_	0	SENT_123	[p8l176t1052r272b1108],

1	Time	NNP	O	Time	_	0	SENT_124	[p8l313t1052r475b1108],
2	and	CC	O	and	_	0	SENT_124	[p8l512t1051r627b1108],
3	dose	NN	O	dose	conj_and	1	SENT_124	[p8l664t1051r813b1108],
4	dependent	JJ	O	dependent	amod	5	SENT_124	[p8l848t1051r1204b1123],
5	augmentation	NN	O	augmentation	dep	1	SENT_124	[p8l1239t1053r1694b1123],
6	of	IN	O	of	_	0	SENT_124	[p8l1732t1051r1799b1108],
7	inhibitory	JJ	O	inhibitory	amod	8	SENT_124	[p8l1831t1051r2152b1123],
8	effects	NNS	O	effect	prep_of	5	SENT_124	[p8l173t1145r403b1202],
9	of	IN	O	of	_	0	SENT_124	[p8l448t1145r514b1202],
10	abciximab	NN	O	abciximab	prep_of	8	SENT_124	[p8l558t1145r894b1203],
11	by	IN	O	by	_	0	SENT_124	[p8l942t1145r1016b1217],
12	asprin	NN	O	asprin	prep_by	10	SENT_124	[p8l1061t1147r1278b1217],
13	.	.	O	.	_	0	SENT_124	[p8l1061t1147r1278b1217],

1	Thromb	NNP	O	Thromb	nn	2	SENT_125	[p8l1334t1145r1587b1203],
2	Haemost	NNP	O	Haemost	_	0	SENT_125	[p8l1632t1147r1920b1202],
3	2001	CD	DATE	2001	num	2	SENT_125	[p8l1969t1146r2143b1215],
4	;	:	O	;	_	0	SENT_125	[p8l1969t1146r2143b1215],
5	85:309	CD	NUMBER	85:309	number	6	SENT_125	[p8l175t1241r436b1298],
6	—	CD	NUMBER	—	dep	2	SENT_125	[p8l175t1241r436b1298],
7	13	CD	NUMBER	13	dep	6	SENT_125	[p8l457t1241r547b1297],
8	.	.	O	.	_	0	SENT_125	[p8l457t1241r547b1297],

1	[	RB	O	[	dep	5	SENT_126	[p8l7t1333r127b1405],
2	14	CD	NUMBER	14	num	5	SENT_126	[p8l7t1333r127b1405],
3	]	CD	NUMBER	]	num	5	SENT_126	[p8l7t1333r127b1405],
4	Szczeklik	NNP	O	Szczeklik	nn	5	SENT_126	[p8l173t1333r474b1390],
5	A	NNP	O	A	_	0	SENT_126	[p8l496t1334r559b1403],
6	,	,	O	,	_	0	SENT_126	[p8l496t1334r559b1403],
7	Musial	NNP	PERSON	Musial	nn	8	SENT_126	[p8l590t1333r794b1390],
8	J	NNP	PERSON	J	appos	5	SENT_126	[p8l819t1335r872b1403],
9	,	,	O	,	_	0	SENT_126	[p8l819t1335r872b1403],
10	Undas	NNP	O	Undas	nn	11	SENT_126	[p8l908t1333r1102b1390],
11	A	NNP	O	A	appos	5	SENT_126	[p8l1125t1334r1188b1403],
12	,	,	O	,	_	0	SENT_126	[p8l1125t1334r1188b1403],
13	Sanak	NNP	O	Sanak	nn	16	SENT_126	[p8l1221t1333r1412b1390],
14	M.	NNP	O	M.	nn	16	SENT_126	[p8l1434t1335r1506b1390],
15	Aspirin	NNP	O	Aspirin	nn	16	SENT_126	[p8l1537t1334r1760b1405],
16	resistance	NN	O	resistance	appos	11	SENT_126	[p8l1791t1334r2143b1390],
17	.	.	O	.	_	0	SENT_126	[p8l1791t1334r2143b1390],

1	J	NNP	O	J	nn	3	SENT_127	[p8l170t1428r206b1483],
2	Thromb	NNP	O	Thromb	nn	3	SENT_127	[p8l237t1426r489b1483],
3	Haemost	NNP	O	Haemost	_	0	SENT_127	[p8l517t1428r806b1483],
4	2005	CD	DATE	2005	num	3	SENT_127	[p8l838t1427r1392b1494],
5	;	:	O	;	_	0	SENT_127	[p8l838t1427r1392b1494],
6	3:1655	CD	NUMBER	3:1655	number	7	SENT_127	[p8l838t1427r1392b1494],
7	—	CD	NUMBER	—	dep	3	SENT_127	[p8l838t1427r1392b1494],
8	62	CD	NUMBER	62	dep	7	SENT_127	[p8l838t1427r1392b1494],
9	.	.	O	.	_	0	SENT_127	[p8l838t1427r1392b1494],

